MULTIDIMENSIONAL SEPARATIONS WITH ULTRAHIGH PRESSURE LIQUID CHROMATOGRAPHY - MASS SPECTROMETRY FOR THE PROTEOMICS ANALYSIS OF SACCHAROMYCES CEREVISIAE by Fague, Kaitlin
MULTIDIMENSIONAL SEPARATIONS WITH ULTRAHIGH PRESSURE LIQUID 
CHROMATOGRAPHY – MASS SPECTROMETRY FOR THE PROTEOMICS 
ANALYSIS OF SACCHAROMYCES CEREVISIAE 
Kaitlin Michelle Fague 
A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in 
partial fulfillment of the requirements for the degree of Doctor of Philosophy in the  
Department of Chemistry.  
Chapel Hill 
2014 
 Approved by: 
 James W. Jorgenson 
 Gary L. Glish 
 R. Mark Wightman 





Kaitlin Michelle Fague 
ALL RIGHTS RESERVED 
 iii 
ABSTRACT 
Kaitlin Michelle Fague: Multidimensional Separations with Ultrahigh Pressure Liquid 
Chromatography – Mass Spectrometry for the Proteomics Analysis of Saccharomyces cerevisiae 
(Under the direction of James W. Jorgenson) 
Many biological pathways are controlled by proteins. For proteomics analysis, the peak 
capacity of one-dimensional separations is routinely inadequate for the number of components in 
a sample. Advances in mass spectrometry (MS) and liquid chromatography (LC) have improved 
the limits of detection and sensitivity problems associated with co-elution. However, the pressure 
capabilities of the pump on a standard ultrahigh performance LC (UPLC) limit the dimensions of 
commercial columns resulting in a maximum peak capacity of 200 in 90 minutes. Various 
multidimensional strategies have been developed to further increase the peak capacity. 
This dissertation will show the effects of 2DLC prefractionation method and frequency 
on proteome coverage. New ultrahigh pressure LC instrumentation with a constant pressure, high 
temperature approach for peptide separations is introduced. The system modified a standard 
UPLC with a pneumatic amplifier through a configuration of tubing and valves for separations 
up to 45000 psi. The modified UHPLC, coupled to a qTOF Premier, produced a peak capacity of 
500 in 90 minutes on a meter-long microcapillary column packed with sub-2 micron particles. 
Peak capacity plateaued above 800 in 12 hours. The improved prefractionation methodology and 
modified UHPLC were coupled for the separation of a model proteome, S. cerevisiae. The 
number of protein identifications and coverage improved two-fold as compared to an analogous 
separation on the standard UPLC with a commercial column. 
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for highly covered proteins. As protein coverage decreased, more proteins 
were identified with higher coverage with the separation on the 98.2 cm 
column. ....................................................................................................................... 127 
Figure 3.20. Chromatograms of MassPREP
TM
 Digestion Standard Protein 
Expression Mixture 2 were collected for separations with increasing 
gradient volume on the 39.2 cm x 75 µm ID column packed with 1.4 µm 
BEH C18 particles. Separations were completed at 30 kpsi. The insert of a 
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CHAPTER 1. An Introduction to Differential Proteomics by Multidimensional Liquid 
Chromatography-Mass Spectrometry 
1.1 Introduction 
 Protein regulation has long been studied to better understand biological processes.
1
 
Analyses of proteins are complicated because there are thousands of proteins in a cell spanning a 




 A common approach to study protein regulation is 
by differential proteomics using multidimensional chromatography to separate the complex 
mixture followed by detection with mass spectrometry (MS).
3,4
 In this introductory chapter, the 
need for studying differential protein regulation by multidimensional chromatography-MS will 
be explained.
5
 Several accomplishments made in this field will be reviewed. Building on the 
ideas discussed in this introduction, the aim of this dissertation will be to improve the coverage 
of a model proteome, Saccharomyces cerevisiae, through the development of separation methods 
and instrumentation.  
1.2 Why study proteomics? 
For many years, scientists have been trying to understand why certain phenotypes are 
observed in nature.
6,7,8
 For example, why do certain populations of people develop diabetes or 
heart disease while others do not? Some causes are environmental, such as diet and exercise, but 
other causes are inherently biological.
9,10
 The central dogma (Figure 1.1) is described as the flow 
of genetic information through the biological system.
11
 As the central dogma progresses from 
DNA, to RNA, to proteins, and finally metabolites, the complexity increases in both number of 
molecules and variety.
12
 DNA and RNA are made of four nucleotides,
13
 proteins are made from 
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20 endogenous amino acids,
11
 and metabolites can be a variety of small molecules including 
carbohydrates, lipids, etc.
14
 As complexity of the biological sample increases, the burden on the 
analytical method to study these molecules also increases.
15,16,17
  
Scientists believed that unlocking the genomic code would demystify the existence of 
certain phenotypes.
18
 In the 1990s, the United States government funded the completion of the 
human genome.
19,20
 However, scientists soon learned that not all of the genome is transcribed 
into RNA,
21
 and not all RNA is translated into proteins. Proteins control cellular pathways, and 
the metabolites, involved in these pathways actually, account for the phenotype. After 
translation, the protein can be further modified with functional groups such as acetate, phosphate, 
lipids and carbohydrates. These post-translational modifications (PTMs) extend the function of 
the protein.
11




1.2.1 Differential proteomics 
 Consider two cell types, with different genetic variants or observed phenotypes. 
Determining which proteins are up and down regulated between the two samples can shed light 
onto what biological pathways are active. This study of relative protein abundance became 
known as differential proteomics.
5,25
 For example, Figure 1.2. shows a portion of the regulatory 
pathways involved in S. cerevisiae (yeast) metabolism.
26
 Proteins in red were up-regulated in 
yeast grown on glycerol, and proteins in blue were up-regulated in yeast grown on dextrose. 
From this differential study, it is evident that the citric acid (TCA) and glyoxylate cycles are 
more active when metabolizing glycerol, and fermentation is preferred for dextrose metabolism. 
Figure 1.2. also shows how many molecules are involved in just a simple biological pathway. In 
a simple proteome, such a yeast, there are thousands of proteins to identify spanning a large 
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range of expression levels.
27
 To tackle these experimental challenges, a need arises to have better 
resolution, a large dynamic range and global yet specific detection.
28
 
1.2.2 Differential proteomic tools 
Many tools and methods have been developed to study differential proteomics.
28
 This 
chapter aims to highlight some common practices and fundamentally ground breaking 
techniques. A generic workflow is outlined in Figure 1.3. The experiment starts with a cell 
lysate. The analyte either contains intact proteins or peptides from the digested proteins. The 
sample is separated, commonly by liquid chromatography (LC), because it has a large loading 
capacity and high resolution.
4
 Loading capacity is necessary because analysis of a large amount 
of total protein may be required to detect a single analyte of low abundance. LC is also easily 
coupled to a mass spectrometer. Through electrospray, the ionization of peptides and proteins is 
possible making MS the near global detector for proteomics. Specificity of the MS, based on 
mass-to-charge, adds another level of separation.
4
 The fragmentation data, from MS/MS 
experiments, are useful in identifying the protein.
29,30
 The spectral data is compared to a genomic 
database, using complex computer algorithms, to identify peptides and proteins.
31,32
 The relative 
abundance, usually in terms of a ratio of spectral counts, is calculated to give the fold change in 
expression of a protein in two differential proteomic samples.
33
  
To help with the quantitative analysis of mass spectral data, several common strategies 
can be executed such as isobaric-tag-for-relative-and-absolute-quantification (iTRAQ), stable-
isotope-labeling-by-amino-acids-in-cell-culture (SILAC), and label-free.
25,34
 iTRAQ allows for 
absolute quantification by adding an isobaric label to the N-terminus and amine side chains of 
peptides. It is used for protein digests of samples collected from biological specimens.
35,36
 
SILAC requires growth of the cells on normal medium for one sample and on an isotopically 
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C atoms are 
used for the normal and enriched media, respectively.
37,38
 Both iTRAQ and SILAC label the 
sample, which greatly reduces analysis time, because differential samples can be pooled prior to 
the separation. The spectral data for each sample is deconvoluted by the mass shift due to the 
label. Analyzing both samples simultaneously reduces the day-to-day variability that can occur 
from temperature changes in the laboratory. The major advantages of label-free relative 
quantification are lower cost and a reduced risk of modifying the sample in the labeling process. 
Also, the spectra are not busy with isobaric and isotopic data. The validity of quantification 
based on spectral counts with the label-free method has been demonstrated in the literature.
39,40,41
  
1.3 Choice of strategy: top-down versus bottom-up 
1.3.1 Sample preparation and separation 
The first step in analyzing proteomics samples is to decide between a top-down (protein) 
or bottom-up (peptide) strategy.
30
 Typical work flows with considerations for each step are 
shown in Figure 1.4. The top-down experiment begins with the separation of intact proteins. A 
single protein may exist in many different isoforms and have different post-translational 
modifications which would contribute to band broadening.
42
 Maintaining the solubility of 
proteins outside of the cell is difficult.
43
 Low solubility has limited the development of new 
technology for the separation of intact proteins.
44
 For this reason, many scientists prefer to do a 
bottom-up experiment in which the proteins are enzymatically digested, into peptides prior to 
analysis.
39
 Trypsin, the most commonly used digest enzyme, cleaves proteins on the C-terminal 
side of arginine and lysine residues creating peptides about 20 amino acids in length.
45
 Proteins 
come in a variety of masses but an average protein sequence would have around 400 amino 
acids, and roughly 20 predicted peptides.
46
 The sample is now soluble but more complex. 
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1.3.2 Mass spectral detection 
After the separation, the analytes are introduced into the mass spectrometer. Mass 
spectrometry of large biological molecules remained elusive until the invention of matrix 
assisted laser desorption ionization (MALDI) and electrospray ionization (ESI). For MALDI, the 
matrix is ablated with a laser initiating desorption and ionization of the analyte. The resulting 
spectrum, obtained with a time-of-flight (TOF) mass analyzer, contains predominantly singly 
charged ions with large peak widths contributing to low resolution (R=
m
 m
, typically 300-400 for 
proteins).
47,48
 ESI has become the preferred source due to its easy coupling with LC where a high 
voltage electric field is applied to a narrow capillary. The liquid becomes a fine aerosol, and ions 
are completely desolvated before entering the MS.
49
 The spectrum, from an ESI-TOF-MS, 
contains multiply charged ions and has a higher resolution than MALDI (R=50000).
50
 With the 
ability to analyze peptides and proteins by MS, the sample components don’t have to be 
completely separated by LC because the MS can detect many species in a single scan. 
Furthermore, the development of gas phase ion mobility adds the option of a post-ionization 
separation without adding to the total analysis time.
51
 However, ionization suppression and 
matrix effects still plague mass spectrometric techniques, necessitating separation prior to 
analysis.
52,53  
The ESI spectral data from top-down experiments are complex due to the many charge 
states of intact proteins.
54
 Example spectra, drawn on the same intensity scale, are shown in 
Figure 1.5. Myoglobin and bovine serum albumin (BSA) were infused in similar amounts. 
Bovine serum albumin (a) is 66 kDa and much larger than 17 kDa myoglobin (b). The BSA 
molecules are distributed over more charge states than myoglobin making it less intense and 
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more difficult to detect. In contrast, the spectra are less convoluted for a bottom-up experiment 
because peptides are generally only detected in the +2 charge state.
51
  
In the MS, it is useful to fragment the parent ion into a series of y- and b- product ions to 
identify the protein, as was pioneered by the McLafferty group.
29
 Due to the size of the analyte, 
the fragmentation efficiency is not as great for proteins as it is for peptides.
55
 For top-down 
experiments, higher energy fragmentation, such as collision-induced dissociation (CID) is 
popular. For bottom-up experiments, electron-capture dissociation (ECD) or electron-transfer 
dissociation (ETD) can provide a more complete fragmentation of the peptide backbone and tend 
to retain labile post-translational modifications (PTMs).
56
 High resolution instruments, such as 
orbitraps and FTICR, are required for many top-down experiments.
57,58
 Until recently, the 
acquisition of these mass spectrometers was cost prohibited in many laboratories making the 
time of flights instruments, used in bottom-up experiments, more common.
59
  
1.3.3 Processing proteomics data 
Finally, the spectral data is processed on a high-performance computer to identify the 
proteins. For top-down experiments, the native mass, as it existed in the cell, is deconvoluted 
from the parent ion scan.
60
 For bottom-up experiments, the protein mass is calculated from the 
amino acid sequence listed in a genomic database. 
31,32,61
 An inference problem occurs with the 
rebuilding of a protein from the fragmentation data.
62
 The same peptide sequence may exist in 
two different proteins, and it is difficult to determine to which protein the peptide should be 
assigned. This is particularly troublesome when the peptide has a PTM. The assignment of a 
PTM to a particular protein can be unclear. The inference problem is greater for bottom-up 
experiments because peptides from a single protein are spread throughout the entire 
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chromatogram. For a top-down experiment, the protein is fragmented in the MS so all data 
pertaining to that protein is contained in a single spectrum.
58
  
Even with these challenges in data processing, the bottom-up approach is a more 
common practice largely due to the greater solubility of protein digests.
63
 It is reported that more 
proteins are identified in bottom-up experiments than top-down experiments. For example, the 
Coon Lab recently reported the identification of 3,977 yeast proteins in a one hour bottom-up 
analysis.
41
 Larger mass proteins are also identified by bottom-up methods. Based on the amount 
of data garnered, a bottom-up approach may be a better option with today’s technology. 
However, some scientists argue that a top-down experiment gives a clearer picture of proteins as 
they exist in the cell. Improvements to separation science and mass spectrometry are necessary to 
make the top-down approach a more common laboratory practice.
58
  
1.4 Peak capacity 
1.4.1 Theory 
Due to the complexity of proteomics samples, separation of the components is necessary 
before identification and quantification of individual proteins. A common way to describe the 
quality of a separation is through peak capacity (nc), which is the number of peaks that can be 
resolved in a defined separation window.
64,65
 Throughout this dissertation, the peak width refers 
to the width at 4σ. The separation time refers to gradient time (tg) or the time between the first 
and last eluting peak. The formula for peak capacity is as follows: 
nc 
 radient Time (tg)
Peak Width (4σ)
 1 (1-1) 
The 4σ peak width refers to the width of the peak at about 11% of the maximum peak 
height. If two adjacent peaks, with retention times tr1 and tr2, overlap at 11% of the maximum 
height, they have a resolution of 1.
66
 A formula for resolution (Rs) is shown below: 
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Now, let t be the point of overlap. If the full peak width is 4σ at the point of overlap, the 
mean-retention-time (tr) for each peak is shifted from t by 2σ i.e. half the peak width. A diagram 
of this relationship can be found in Figure 1.6. The derivation proving unity resolution is as 
follows: 
tr,1   t-2σ (1-3) 
tr,2   t 2σ (1-4) 
 s   
(t 2σ)-(t-2σ)
2(σ1 σ2)




Assuming σ1  σ2, (1-6) 
 s  
 4σ
4σ
   1 (1-7) 
An example separation of a standard enolase protein digest is shown in Figure 1.7. This 
separation had a peak capacity of 100 which is typical for a 30 minute gradient on a standard 
UPLC with a commercial column. A peak capacity of 100 is sufficient for the separation of 
peptides from the digest of a single protein. 
1.4.2 The coelution problem 
Now, consider the same separation method for a bottom-up proteomics sample, such as 
the Escherichia coli digest, in Figure 1.8. As evident from the many overlapping peaks, a larger 
peak capacity than 100 is necessary. Davis and Giddings
67
 derived a formula relating the peak 
capacity to the percentage of resolved peaks (α): 








where m̅ is the number of detectable components in a sample, s is the number of 
component peaks separated with a resolution of one or greater, and α is the saturation factor 
which is  ̅ divided by nc. 
To apply this relationship to the E. coli digest, the number of detectable components is 
related to the 4,000 proteins encoded in its genomic sequence.
68
 While it is true that not every 
protein encoded in the genome is expressed, E. coli is a simple organism so 4,000 proteins is a 
conservative value. For example, Homo sapiens (human) has more than 20,000 genes that 
encode proteins, and Mus musculus (laboratory mouse) has 30,000 protein encoding genes.
69
 For 
a bottom-up experiment, the proteins would be digested by trypsin into peptides. As mentioned 
earlier, the number of digestion sites and peptides varies from protein to protein.
46
 To make a 
very conservative generalization, the number will be estimated at 10 digest peptides per protein. 
Therefore, the number of detectable components in a bottom-up sample of E. coli would be 




    .  (1-9) 
To calculate the peak capacity necessary for a bottom-up separation of E. coli, these 
values are plugged into Equation 1-8. 
α   
m
nc
̅    
4    
nc
 (1-10) 
α   -
1
2
ln( . ) (1-11) 
4    
nc
   -
1
2
ln( . ) (1-12) 
nc     6 ,    (1-13) 
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There is no single separation that exists with the peak capacity necessary to separate 90% 
of the components in an E. coli proteome digest with the resolution of one.  
1.4.3 Advent of Ultrahigh Pressure Liquid Chromatography 
A major improvement to the separation of proteomic samples has been the invention of 
the UHPLC by the Jorgenson group.
70
 At the time of publishing, the Jorgenson lab reported a 
peak capacity of 300 in 30 minutes which more than doubled the peak capacity achieved with a 
HPLC.
71
 This technology was commercialized (as UPLC) 10 years ago and has become a 
common instrument in proteomics laboratories. UHPLC enabled the use of microcapillary 
columns with sub-2 micron particles which have greater peak capacity than standard bore 
columns. Other labs have since reported higher peak capacities through the use of longer 
columns.
72,73
 Chapter 3 of this dissertation has a more in-depth discussion on the benefits of long 
microcapillary columns and details a modified UHPLC that produces peak capacities greater 
than those previously reported in the literature.  
1.5 Multidimensional separations 
Even with the highest performing UHPLC, the peak capacity is still not sufficient for 
proteomics samples.
74
 A solution for providing more peak capacity has been multidimensional 
separations. Giddings wrote that the peak capacity of a two-dimensional separation is the product 
of the two individual peak capacities: 
nc,total = nc,1 x nc,2 (1-14) 






Traditionally, 2D separations of intact proteins were completed in space via 
polyacrylamide gel electrophoresis (2D-PAGE).
75,76
 In this technique, the sample is first 
separated by isoelectric point (pI) and then by molecular weight. The spots are then excised, 
digested, and analyzed by MALDI-MS. Both of  iddings’ rules are preserved and thousands of 
proteins can be separated by this technique, but several limitations exist. (1) Hydrophobic 
proteins may not enter the gel. (2) It is labor intensive to excise and digest spots. (3) Resolution 
is not as great for proteins with acidic or basic pI as it is for proteins with intermediate pI. (4) 
Proteins of low abundance are not easily detected with most staining techniques.
77,78
  
The limitations with 2D-PAGE have led to the development of 2D separations in time via 
liquid chromatography (2DLC).  oing back to  iddings’ second rule for 2D separations, the 
multiplicative peak capacity is only achieved if the resolution is preserved from the first to 
second dimension.
79
 For resolution to be preserved, the second dimension would have to be 
faster than practically possible in LC, or the first dimension would have to be extremely slowed 
down. Therefore, fractionation of the first dimension is often necessary when coupling two 
columns. The peak capacity of the first dimension then becomes the number of fractions. In 
order to reduce the loss of peak capacity caused by fractionation, the second dimension should 




A common 2DLC method developed by Yates and colleagues is called multidimensional 
protein identification in time (MudPIT). This method utilizes a biphasic column in which the 
stationary phase for each dimension is packed sequentially into a single column. A step gradient 
associated with the first dimension separation mode is run through the column. Between each 
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step, a linear gradient associated with the second dimension separation mode is run. The column 
effluent is sent to the MS/MS for detection. Usually, the first mode of separation is strong cation 
exchange followed by a second dimension reversed-phase separation.
82,83
 This method was 
developed for protein digests from cell lysates.  
1.5.3 Top-down proteomics 
The multidimensional separation of intact proteins has occurred online and offline. Figure 
1.9.a. shows the instrument schematic for an online approach. There are two identical columns 
(A and B) in the second dimension. The effluent from the first separation is loaded onto the head 
of column A. Using two 4-port valves, the effluent is then switched to column B, and a gradient 
is pumped through column A to complete the second-dimension separation. This cycle continues 
until the desired number of fractions from the first dimension is obtained.
84
 Alternatively, this 
can be completed with one second-dimension column using two storage loops between the 
dimensions as shown in Figure 1.9.b.
80,85
 
More recent work, associated with the Human Genome Project, focused on an offline 
separation of intact proteins by three modes before analysis by ESI-FTICR-MS. The first two 
separations were similar to 2D-PAGE because they involved electrophoretic separations by size 
and isoelectric focusing. This modern technique used Gel-Eluted Liquid Fraction Entrapment 
Electrophoresis (GELFrEE). The proteins are separated on a gel cartridge, migrated off the gel, 
and fractionated into a gel-free sample-well. The fraction is isolated in-solution which is easier 
than the manual excision required by its slab-gel ancestor. The third mode of separation was 
reversed-phase LC. The multidimensional separation took more than 45 hours and identified 




1.5.4 Practical peak capacity of 2DLC 
In reality,  iddings’ rules, for two dimensional peak capacities, are never fully met. The 
practical peak capacity is calculated by modifying  iddings’ rule with factors that describe the 
lack of orthogonality and loss of resolution in the coupling of two separations.
86,87
 To 
demonstrate the practical peak capacity of a real separation, consider the top-down 2D 
chromatogram in Figure 1.10. of S. cerevisiae.
88
 The sample was separated on a strong anion-
exchange column in the first dimension and reversed-phase column in the second dimension. 
Resolution is lost in the coupling of the two dimensions. Due to online fractionation, the peak 
capacity of the first dimension is reduced to 30. Also, the 2D space is not completely utilized. 
The top left of the chromatographic space contains few peaks. This chromatogram also 
demonstrates the difficulty of separating intact proteins. The peaks are several minutes wide and 
“ghost” as evident from the feature that appears at 1  minutes in fractions 12-25. “ hosting” 
describes an analyte that partially remains on the column after the separation method is 
complete. The analyte slowly bleeds off the column creating “ghost” peaks in subsequent 
chromatograms. In practice, only a portion of the multiplicative peak capacity, described by 
Giddings, is realized.  
Now, consider the practical peak capacity of the bottom-up 2D chromatogram in Figure 
1.11. of S. cerevisiae.
88
 A step gradient is implemented for the first dimension separation. There 
are five steps dictating the peak capacity of the first dimension. A reversed-phase column is used 
in both dimensions. The separation attempts to be orthogonal by modifying the sample with 
high-pH mobile phase in the first dimension and low-pH mobile phase in the second dimension. 
Stapels and Fadgen have demonstrated that this technique has some orthogonal attributes.
89
 
However, the orthogonality leaves a lot to be desired, as evident by the chromatograms in Figure 
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1.11. There are few late eluting peaks in the first fraction (red) and few early eluting peaks in the 
last fraction (pink).  
1.5.5 Prefractionation 
Another offline multidimensional separation has been growing in popularity. This 
prefractionation method takes advantage of both top-down and bottom-up experiments.
90,91
 The 
first dimension is an intact protein separation. Fractions of the effluent are collected, 
enzymatically digested, and analyzed by reversed-phase UPLC-MS/MS. By changing the sample 
from protein to peptide via digestion between the two dimensions, the separations are orthogonal 
even if the same separation mode is used in both dimensions. The prefractionation separations 
are more orthogonal than the example top-down and bottom-up 2D chromatograms in Figure 
1.10 and Figure 1.11. To see example prefractionation chromatograms, refer to Figure 2.7. in 
Chapter 2.  
1.6 Scope of dissertation 
The scope of this dissertation is to improve the separation of proteomic samples through 
the development of new liquid chromatography methods and instrumentation. Chapter 2 has a 
deeper discussion on the benefits of the protein prefractionation method. It studies how different 
prefractionation techniques and frequencies affect the number of protein identifications. 
Chapter 3 and 4 demonstrate the peak capacity gained by modifying a UHPLC for separations at 
elevated temperatures and pressures. The modified UHPLC is used to improve the productivity 
(protein identifications / time) of a prefractionation experiment in Chapter 5. The final chapter 
applies the methods developed in the previous chapters to conduct a differential analysis of 
S. cerevisiae grown on two different carbon sources. The benefits of these studies are 
demonstrated by the improved proteome coverage as compared to previous analyses.  
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The ideas presented in this dissertation can be used, in the future, to analyze other 
complex biological samples. As more is discovered about the transmission of biological 
information through the central dogma, an interest is metabolomics has grown.
92
 The 
instrumentation described in this dissertation has the potential for metabolomic applications. In 
reality, a panomics approach, covering genomics, transcriptomics, proteomics, and 








Figure 1.1. The explanation for the flow of genetic information through the biological system is 
referred to as the central dogma. DNA is transcribed into RNA which is translated into proteins. 
The proteins regulate metabolites which result in the observed phenotype.   
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Figure 1.2. A small portion of the regulatory pathways involved in S. cerevisiae metabolism is 
shown. Proteins in red were up-regulated in yeast grown on glycerol, and proteins in blue were 
up-regulated in yeast grown on dextrose. Small molecules involved in the pathway are in italics. 
For this differential study, it is evident that glycerol catabolism, TCA, glyoxylate cycles are more 








Figure 1.3. A workflow is outlined for a generic proteomics experiment. The experiment starts 
with a cell lysate. The analyte is either proteins or peptides. The sample is separated, commonly 
by liquid chromatography (LC), because it has a large loading capacity and peak capacity. LC is 
easily coupled to a mass spectrometer. Through electrospray, the ionization of peptides and 
proteins is possible making MS a near global detector. Specificity of MS, based on mass-to-
charge, adds another level of separation. The fragmentation data associated from MS/MS 
experiments is useful in identifying the protein. Complex algorithms process the spectral data to 
identify peptides and proteins. The relative abundance, usually in terms of spectral counts, is 






Figure 1.4. Typical work flows for top-down and bottom-up experiments with considerations for 
each step are shown.  
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a) Bovine Serum Albumin 66 kDa 
m/z 
b) Myglobin 17 kDa 
m/z 
 
Figure 1.5. Example spectra of protein envelops acquired by ESI-TOF-MS are shown drawn to 
the same intensity scale. Myoglobin and bovine serum albumin (BSA) were infused in similar 
amounts. Bovine serum albumin (a) is 66 kDa and much larger than 17 kDa myoglobin (b). The 
BSA molecules are split over more charge states than myoglobin making it less intense and more 




Figure 1.6. This diagram shows two adjacent peaks, with retention times tr,1 and tr,1 and peak 





Figure 1.7. This example separation is of a standard enolase protein digest. This separation has a 
peak capacity of 100 which is typical for a 30 minute gradient on a standard UPLC with a 














Figure 1.9. Two instrument schematics are shown for an online multidimensional separation. In 
part (a), there are two identical columns (A and B) in the second dimension. The effluent from 
the first separation is loaded onto the head of column A. Using two 4-port valves, the effluent is 
then switched to column B, and a gradient is pumped through column A to complete the second-
dimension separation. This cycle continues until the desired number of fractions from the first 
dimension is obtained.
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 Alternatively, this can be completed with one second-dimension column 







Figure 1.10. The top-down 2D chromatogram shows S. cerevisiae separated on a strong anion-





Bottom-Up Separation Nano2D Hi-Low pH 
 
Figure 1.11. The 2D chromatogram shows the bottom-up separation of S. cerevisiae. A step 
gradient is implemented for the first dimension separation. There were five steps dictating the 
peak capacity of the first dimension. A reversed-phase column is used in both dimensions. The 
separation attempts to be orthogonal by modifying the sample with high-pH mobile phase in the 
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CHAPTER 2. An Equal-Mass versus Equal-Time Prefractionation Frequency Study of 
a Multidimensional Separation for Saccharomyces cerevisiae Proteomics Analysis 
2.1 Introduction 
2.1.1 Peak capacity considerations for multidimensional separations 
Early in the field of proteomics, multidimensional separations have been employed to 
handle the complexity of the sample mixture.
1,2,3
 As described in the previous chapter, peak 
capacity is used to determine the quality of the separation. Giddings wrote that the peak capacity 
of a multidimensional separation is the product of two peak capacities of each individual 
separation (nc): 
nc,total = nc,1 x nc,2 (2-1) 
if (1) the separations are orthogonal and (2) resolution is not lost in coupling the separations.
4
 
These two qualifiers to Giddings rule are difficult to realize. Several scientists have proposed 
additional terms to Giddings equation to account for the loss of resolution and lack of 
orthogonality between two separations.
5,6
 A very practical way to assess the use of the separation 
space is to divide the 2D chromatogram into equally sized bins as seen in Figure 2.1. To 
calculate the practical peak capacity (np), a factor is added to Equation 2-1 that counts the 








When considering the methods described in this manuscript, the increase in maximum theoretical 
peak capacity is compared to how much of the 2D separation space actually contains a peak.  
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When sampling the first dimension, several factors must be considered. First, it is 
impractical to completely preserve the peak capacity of the first dimension. The peak capacity of 
the first dimension is reduced to the number of samples or fractions taken.
9
 For example, more 
frequent sampling will increase the quality of the separation.
10
 Secondly, fractionation dilutes the 
sample and raises the limit of detection by increasing the probability that an analyte will be split 
between multiple fractions.
11
 Finally, analysis time should be considered during 
multidimensional method development. The second dimension must be fast in order to be run in-
line with the first dimension, or an off-line approach must be implemented in which fractions are 
collected from the eluent of the first column for subsequent analysis. Frequent fractionation will 
add to the analysis time which is a limited resource.
12
 In summary, the variables of peak 
capacity, sample dilution, and analysis time should be taken into account when developing a 
practical multidimensional separation.  
Even with extensive method development, a complex mixture will not elute evenly over 
a linear gradient. For a bottom-up high-low pH 2D RPLC experiment, as previously reported by 
Martha Stapels, et al, she described a method to more evenly distribute the peptides across the 
first dimension separation. Briefly, the first dimension is a RPLC step gradient at high pH. Steps 
were taken at 2% increases in organic phase. The eluent was concentrated on a trap column and 
diluted with low pH mobile phase. The sample was then separated on the analytical column and 
coupled to MS. The total ion current (TIC) from these chromatograms was used to determine the 
appropriate mobile phase composition for each step of the first dimension gradient to separate 
the sample into even parts. The result was more appropriate loading of the second dimension 
column and a higher number of protein identifications.
13
 In this chapter, a similar method is 
described for an intact protein separation.  
 37 
The orthogonality requirement to Giddings rule carries with it several challenges. 
Different modes of liquid chromatography (LC) have different resolutions. Reverse phase LC 
(RPLC) is one of the higher resolution separation modes of LC as compared to ion exchange 
(IEX) or size exclusion chromatography (SEC).
14
 Since some resolution realistically is lost when 
coupling two separations, it is best to have the highest resolution separation in the second 
dimension.
15
 Commonly, RPLC followed by mass spectrometry (MS) is the final step of the 
multidimensional separation. Therefore, the first dimension has to be compatible with these 
techniques. For example, buffers used for IEX mobile phases must contain volatile salts that do 
not interfere with MS ionization. Also, SEC mobile phases must contain low amounts of organic 
to match the initial conditions of a RPLC gradient, or an auxillary pump and trap column must be 
used to dilute the organic composition before sample is loaded onto the RP analytical column. 
These restrictions are particularly challenging for intact protein samples which have poor 




2.1.2 Top-down versus bottom-up proteomics 
When developing multidimensional separations for proteomics analysis, the ongoing 
question is whether to do a top-down (protein) or bottom-up (peptide) separation. (The merits of 
both techniques are more fully explained in the first chapter.) To take advantage of the benefits 
from both top-down and bottom-up experiments, prefractionation methods have been growing in 
popularity.
18,19
 The first step in sample preparation is to isolate the intact proteins from a cell 
lysate by centrifugation. The soluble portion of the proteome is separated by LC or 
electrophoresis in the first dimension. Fractions are collected, digested with trypsin, and 
analyzed by UPLC-MS/MS. By changing the sample from protein to peptide via digestion 
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between the two dimensions, the separations are orthogonal even if the same separation mode is 
used in both dimensions. The more difficult protein separation is required in only one dimension, 
and high resolution chromatography modes such as RPLC can be used in both dimensions. The 
prefractionation method is analogous to a mass spectrometry MRM experiment in which the 
precursor ion is isolated in a mass analyzer and fragmented before analysis by a tandem mass 
analyzer.
20
 Digesting the proteins prior to introduction into the mass spectrometer simplifies the 
spectral data because peptides have many less charge states than proteins when ionized by 
electrospray.
21,22
 As opposed to bottom-up 2DLC experiments where peptides from a single 
protein may be spread over the entire chromatogram, peptides from a single protein are confined 
to a single first dimension fraction easing computational requirements. This may reduce the 




2.1.3 Prefractionation by Equal-Mass 
Sampling the first dimension chromatogram usually occurs in evenly timed intervals even 
though the analytes do not elute as evenly spaced peaks. In RPLC, for example, most proteins 
are of average hydrophobicity
24
 meaning most molecules will elute in the middle of the gradient 
with fewer at the beginning or end. For targeted analyses, a heart-cutting approach, which 
samples only the portions of the first dimension separation containing analytes of interest, may 
be employed.
25
 For an -omics approach, the goal is to have the entire sample mass evenly split 
amongst the first dimension fractions which we will prove is poorly achieved by equal-time 
prefractionation. A possible method to determine equal-mass fractionation would be to collect 
minute-wide fractions from the first dimension separation, determine the protein concentration of 
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each fraction by Bradford Assay,
26
 and then recombine the fractions to make the desired number 
of equal-mass fractions. However, this procedure would be very tedious.  
Herein, we describe a method using Saccharomyces cerevisiae as a model proteomics 
sample to form equal-mass fractions based on the UV absorbance values of the first dimension 
chromatogram. We validate this method with a comparison of the absorbance values to the TIC 
chromatograms from the second dimension and to the number of proteins identified in each 
fraction. The equal-mass fractionation method is compared to an equal-time fractionation method 
to demonstrate the increase in number of protein identifications and protein coverage. We 
propose a newly defined metric, namely Normalized Difference Protein Converge (NDPC), 
which compares protein coverage between multiple methods, will be discussed. The frequency of 
prefractionation will also be investigated as it has not been extensively studied for a 
prefractionation type 2D separation. The results of the prefractionation frequency experiments 
compare number of protein identifications to analysis time and expose the detriment of over 
fractionation. 
2.2 Materials and method 
2.2.1 Materials 
Water, acetonitrile, isopropyl alcohol and ammonium hydroxide were purchased from 
Fisher Scientific (Fair Lawn, NJ). Ammonium acetate, ammonium bicarbonate, formic acid, 
trifluoroacetic acid and iodoacetamide were purchased from Sigma-Aldrich Co. (St. Louis, MO). 
Rapigest
TM
 SF acid-labile surfactant and bovine serum album (BSA) was obtained from Waters 
Corporation (Milford, MA). Dithiothreitol was purchased from Research Products International 
(Mt. Prospect, IL) and TPCK-modified trypsin was purchased from Pierce (Rockford, IL). Water 
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and acetonitrile were Optima LC-MS grade, and all other chemicals were ACS reagent grade or 
higher. 
2.2.2 Sample preparation 
Growth media YAPG was prepared by combining 6.0 g of yeast extract, 12.0 g of 
peptone, 5 mL of glycerol, 60 mg adenine hemisulfate, 600 mL of water, and an additional 10 g 
bacto-agar for plate medium. S. cerevisiae (BY4741) was the cell line used for analysis. Plates of 
growth media were streaked with yeast and incubated for four days when sizeable colonies were 
obtained. A single colony was then used to inoculate a 150 mL small-scale culture. These 
cultures were grown to an O.D. greater than two before being used to inoculate a 2 L (in a 4 L 
flask) prep scale batch. The yeast cells were harvested when the O.D. was 2.0. Cells were 
centrifuged at 7000 Xg in a Sorvall GS-3 rotor for 30 minutes until pelleted. Cells were then 
stored at -80°C until processed.  
Cells were resuspended by pipet in 2 volumes of 50 mM ammonium bicarbonate with 
protease inhibitors present (Pierce protease inhibitor tablets, 88661) prepared to manufacturer’s 
recommendations. A homogenate was prepared by 8 passes through a chilled french press cell 
dropwise at 20,000 psi. The homogenate was centrifuged (Beckman JA20 rotor, 30,000 Xg, 20 
min, 4°C) and a cytosolic fraction was prepared from the cleared lysate by ultracentrifugation at 
120,000 Xg for 90 min, 4 °C. Cytosolic fractions determined to be between 10-13 mg/mL of 
total protein using the Bio-Rad (Hercules, CA) protein assay with BSA standard. Immediately 
prior to analysis, each fraction was diluted with formic acid (Fisher) to a final protein 
concentration of 7.3 mg/mL. 
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2.2.3 Intact protein prefractionation  
The prefractionation of intact proteins, outlined in Figure 2.2, begins with a separation on 
a 4.6 x 250 mm PLRP-S column with 5 µm particles (Agilent, Santa Clara, CA) heated to 80 °C. 
Four milligrams of total protein were injected onto the column. The flow rate, mobile phase 
compositions and gradient profile is shown in Table 2.1. One-minute-wide fractions were 
collected from 2 to 42 minutes, yielding 40 fractions. Fractions were stored at -80º C until 
needed. 
2.2.4 Protein digestion 
Fractions were transferred to microcentrifuge tubes, then lyophilized and reconstituted in 
25 µL of 5  mM ammonium bicarbonate, pH 8. Three microliters of 6.6 % (w/v)  api est™ SF 
in buffer were added (15 min, 80 ºC) to denature the proteins. The proteins were reduced by 
adding 1 µL of 100 mM dithiothreitol (30 min, 60ºC), and then alkylated with 1 µL of 200 mM 
iodoacetamide (30 min, room temperature, protected from light). The proteins were then digested 
by adding 10 µL of 320 ng/µL TPCK-modified trypsin in 50 mM ammonium bicarbonate, pH 8 
(overnight, 37ºC). The trypsin amount was approximated to be a 25:1 (w/w) protein to enzyme 
ratio if the initial protein amount was equally distributed across the 40 fractions. The digestion 
was quenched and the  api est™ SF was degraded using 44 µL of 1% (v/v) trifluoroacetic acid 
(2 h, 60ºC). The fractions were centrifuged for 20 minutes at 14,000 Xg to pellet the hydrolyzed 
surfactant, after which they were ready for analysis. The samples were transferred to LC vials 
and spiked with 4.21 µL of a 1 pmol/L internal standard BSA digest (Waters). This set of 40 
fractions was recombined in the following configurations to investigate prefractionation 
frequency and the method for selecting fractions.  
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2.2.5 Equal-time fractionation 
To vary the prefractionation frequency, 10 µL of each fraction were pooled in the 
following three configurations: (1) every other fraction was combined to yield 20 two-minute 
wide fractions, (2) every four fractions were combined to yield 10 four-minute wide fractions, 
and (3) every 8 fractions were combined to yield 5 eight-minute wide fractions. These samples 
will be referred to as equal-time fractions.  
2.2.6 Peptide analysis by LC-MS/MS  
Each fraction was analyzed in duplicate by capillary RPLC-MS/MS using a Waters 
nanoAcquity/QTOF Premier system. To normalize the concentration of each fraction, the sample 
injection volume was adjusted based on the width of the first dimension fractionation. For 
example, a 1 µL injection was used for a one-minute wide fraction, and a 4 µL injection was 
used for a four-minute wide fraction. While total column load varied for each injection, the 
amount of each peptide loaded remained constant. Mobile phase A was Optima Grade water with 
0.1% formic acid (Fisher), and mobile phase B was Optima-grade acetonitrile with 0.1% formic 
acid (Fisher). The samples were pre-concentrated on a 180 µm x 20 mm Symmetry C18 trap 
column with 5 µm particles at  .5% mobile phase B, and then separated on a 25  mm x  5 μm 
ID capillary column packed with 1.  μm silica bridged-ethyl particles with a C18 stationary 
phase (Waters). At a flow rate of 300 nL/min, a 90 minute gradient from 5-40% B was used to 
separate the peptides, followed by a 5 minute column wash at 85% B, after which the mobile 
phase was returned to 5% B. The outlet of the RPLC column was directly connected to an 
uncoated fused silica nanospray emitter with a 20 µm ID and pulled to a 10 µm tip (New 
Objective, Woburn, MA) operated at 2.7 kV. Data-independent acquisition, or MS
E
 scans, was 
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performed and the instrument was set to acquire parent ion scans from m/z 50-1990 over 0.6 sec 
at 5.0 V. The collision energy was then ramped from 15-40 V over 0.6 sec.  
2.2.7 Equal-mass fractionation 
The TIC chromatograms were integrated for the sample set with 40 equal-timed fractions 
as demonstrated in Figure 2.3. For each fraction, the peak area (A) of that fraction and all 
previous fractions were summed as follows:  
Summed Integrated TIC (Σ∫TIC)   ∑ Arean
n
1 , (2-3) 
where n=fraction number and Area is the TIC chromatogram peak area. 
The normalized      was plotted versus the first dimension separation time in Figure 
2.4. These values were documented in Table 2.2. The y-axis was annotated with hash marks in 
increments of 0.2, 0.1, or 0.05 which, respectively, split the axis into 5, 10 or 20 equal parts. 
Lines were drawn from the hash marks on the y-axis to the corresponding x-coordinate on the 
normalized      curve. These x-coordinates were used to determine size of the equal-mass first 
dimension fractions. These fractions were then analyzed by LC-MS/MS as described in the 
previous section.  
2.2.8 Peptide data processing 
The peptide LC-MS/MS data were processed using ProteinLynx Global Server 2.5 
(Waters). The MS
E
 spectra were searched against a database of known yeast proteins from the 
Uni-Prot protein knowledgebase ( www.uniprot.org) with a 1X randomized sequence appended 
to the end. The false discovery rate was set to 100% to yield data compatible for further 
processing. 
After the database search was complete, the results were imported into Scaffold 3.1.4.1 
(Proteome Software, Portland, OR). The minimum protein probability and peptide probability 
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filters were set to a 5% false discovery rate, and the number of peptides required for protein 
identification was set 3. Peptides matching multiple proteins were exclusively assigned to the 
protein with the most evidence. The spectral counts for each peptide assigned to a protein were 
summed to give the quantitative value of that protein. The value was normalized by multiplying 
the average total number of spectra, for all yeast samples, divided by the individual sample’s 




2.3.1 Equal-time versus equal-mass fractionation 
Herein, the merits of increasing fractionation frequency will be discussed. A comparison 
will be made between two fractionation techniques, equal-time and equal-mass. The equal-time 
fractionation method split the first dimension in to evenly timed fractions. The first dimension 
LC separation attempted to evenly distribute the proteins throughout the separation window. 
However, few proteins eluted at the beginning and end of the chromatogram with most proteins 
eluting between 30 to 40% mobile phase B. The equal-mass method attempted to split the first 
dimension into fractions with equal amounts of protein. As described in the methods section, the 
first dimension separation was sampled frequently i.e. every minute. The fractions were digested 
and analyzed by LC-MS. Data from these fractions were used to create the Σ∫TIC plot in Figure 
2.4. For many assays and in many laboratories, time may not be available for extensive method 
development. As an alternative, the normalized summed absorbance (ΣA) from the first 
dimension chromatogram was a good approximation to the number of proteins in each fraction 
(Figure 2.4a). The first dimension separation was followed by UV detection to give a qualitative 
chromatogram of the separation. The wavelength was set to 280 nm, which is the lambda max of 
tryptophan. This method is in no way specific for the yeast proteome but is used to monitor the 
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separation. Summing of the absorbance values began after the void time because the spike in 
absorbance due to formic acid in the injection plug did not correlate to the number of proteins 
identified in these fractions. This fractionation scheme was analogous to dividing the UV 
chromatogram into parts with equal area under the curve as seen in Figure 2.4b-d.  
The first dimension separation produced 40 fractions. Analyzing all the fractions by LC-
MS
E
 took 80 hours which was longer than most proteomics laboratories would be willing to 
spend on a single sample. The time requirement would be even worse when considering that a 
study may include 3 biological replicates and at least two sample types. Therefore, it was 
important to investigate the benefits, which may include protein identifications and protein 
coverage, of increasing prefractionation frequency.  
As fractionation frequency was increased, peak capacity also increased. By coupling the 
separation with mass spectrometry, it was not necessary to fully resolve the peptides 
chromatographically because the analytes were also resolved by their mass-to-charge ratio. 
Increasing the fractionation frequency also diluted the analytes and at a certain frequency a 
protein may have been split between multiple fractions. At this point, the intensity of its peptide 
peaks may have dropped below the limit of detection. This trend is demonstrated in Figure 2.5. 
As the number of first dimension fractions increased from 5 to 10 to 20, more proteins were 
identified but the graph leveled off between 20 and 40 fractions. Also, the equal-mass 
fractionation method identified more proteins than the equal-time fractionation method at every 
level of fractionation frequency.  
To understand the differences between the fractionation methods qualitatively, the 2D 
chromatograms in Figure 2.6, Figure 2.7, Figure 2.8, and Figure 2.9 should be considered. The 
vertical axis represented the first dimension protein separation, and the x-axis showed the second 
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dimension peptide separation. The peak height was represented by false color in the z-direction. 
For the chromatograms of the equal-time fractions, the number of peaks decreased towards the 
end of the chromatogram. This corresponds to fractions 30-40 in Figure 2.6, 16-20 in Figure 
2.7a, 8-10 in Figure 2.8a, and fraction 5 in Figure 2.9a. In fact, the same trypsin autolysis peaks 
dominated the chromatograms of these fractions. In comparison, the equal-mass chromatograms 
appeared to have unique bands for each fraction.  
2.3.2 Proteins per fraction 
To confirm that more proteins were identified in the late eluting fractions of the equal-
mass method, the number of protein identifications was plotted for each fraction in the bar 
graphs in Figure 2.10, Figure 2.11, Figure 2.12, and Figure 2.13. The light gray bars showed the 
total number of proteins identifications in each fraction, and the dark gray bars signified the 
number of unique proteins found in each fraction. Proteins found in multiple fractions were 
assigned to the fraction in which it was most intense. The first eluting fractions, corresponding to 
the injection plug, contained few protein identifications. A couple of factors may have 
contributed to the low number of identifications. (1) There were no proteins eluting in the 
injection plug. (2) The injection plug contains large proteins or agglomerated proteins that were 
excluded from the stationary phase. Large proteins were often difficult to digest because they did 
not fully denature blocking trypsin from the digestion sites. The total number of proteins 
identified in the late eluting fractions remained relatively constant for both the equal-time and 
equal-mass fractionation methods. However, the number of unique protein identifications in the 
late eluting fractions was greater for the equal-mass than the equal-time fractionation method. 
For the equal-mass fractions, the number of unique protein identifications was more even 
fraction to fraction. With the instrumentation used for this experiment, it seemed that a limited 
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maximum number of proteins could be identified per fraction. By more evenly distributing the 
proteins between the fractions, as achieved with the equal-mass fractionation method, the 
number of unique protein identifications increased. Figure 2.5 showed a 19% increase in 
identifications for 5 fractions, 22% for 10 fractions, and 10% for 20 fractions.  
2.3.3 Venn comparison 
The Venn diagram of proteins identifications in Figure 2.14a showed that most of the 
proteins identified in the 5 equal-time fractions were also identified in the 10 equal-time 
fractions. Additionally, 103 new proteins were identified with only 9 identifications lost which 
yielded an improvement of 40%. Similarly, when equal-time fractionation was increased to 20, 
175 more identifications were made with only a loss of 8 identifications which was also a gain of 
40%. A similar trend was observed for the equal-mass fractions in Figure 2.15. However, the 
Venn diagram in Figure 2.14b showed that while 78 new proteins were identified in the 40 
equal-time fractions, 41 were lost. In doubling the analysis time, protein identifications were 
only improved by 9%. It was hypothesized that the loss of 41 protein identifications was due to 
proteins being split between multiple fractions.  
2.3.4 Fractions per protein 
Ideally, a protein peak should not be split between multiple fractions. The probability of 
peak splitting increases as fractionation frequency increases. Also, a protein may have appeared 
in multiple fractions due to different post translational modifications and variations in its tertiary 
structure. To determine the amount of peak splitting between multiple first dimension fractions, 
the percentage of protein identifications that were identified in only one fraction, two fractions, 
and three-or-more fractions were plotted in Figure 2.16. For every fractionation scheme, the 
majority of the proteins were identified in only one fraction. The highest percentage of proteins 
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being identified in only one fraction occurred when only 5 first dimension fractions were taken. 
This percentage decreased as fractionation frequency increased. The percentage of proteins 
identified in multiple fractions was similar for the 5 and 10 first dimension fraction sets. A nearly 
50% increase of proteins found in multiple fractions was observed when prefractionation was 
increased to 20 and 40 fractions. When considering the equal-mass fractionation method, a larger 
portion of proteins was identified in only one fraction as compared to the equal-time 
fractionation method. For example, 80% of the proteins were identified in only one fraction in 
the 5 equal-mass fractionation set, and 70% of proteins were identified in only one fraction in the 
5 equal-time fractionation set. A larger percentage of proteins were identified in 3 or more 
fractions by the equal-time than the equal-mass fractionation method.  
2.3.5 Normalized Difference Protein Coverage 
When discussing the merit of multidimensional proteomic separations, it was not merely 
enough to report the total number of proteins identifications without further commenting on 
protein coverage. To compare the methods, coverage is reported in Table 2.3. for several proteins 
involved in the metabolic processes of yeast. On average, coverage increased with higher 
fractionation frequency. For a large data set containing hundreds of proteins, comparing the 
coverage for each protein is not straight forward. For example, reducing protein coverage to an 
average can be misleading. The additional proteins identified in a separation with higher peak 
capacity were usually of lower abundance and had lower coverage, bringing down the average. 
Alternatively, comparing only proteins identified by both methods would limit the analysis to 
only easily detectible proteins which usually had higher coverage and, thus, mute the difference 
between the methods. Herein, an original method to compare protein coverage based on the 
mathematical concept of a normalized difference is described. We named this metric the 
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normalized difference protein coverage (NDPC) and define it as the difference in coverage of a 
protein between two methods divided by the sum of the coverage. The NDPC was calculated as 
follows: 
NDPC   
Coveragea,i- Coveragea, 
Coveragea,i  Coveragea, 
, (2-4) 
where             was the percent coverage of protein a in method i, and             
was the percent coverage of protein a in method j. For example, the NDPC for fumarate 
hydratase (FUMH), a protein involved in the citric acid cycle of S. cerevisiae, was calculated to 
compare 10 equal-time and 10 equal-mass fractions:  













   .1  (2-6) 
With this example, a protein found with higher coverage in the 10 equal-mass fractions 
would have a positive NDPC. A negative NDPC would signify that the protein was found with 
higher coverage in the 10 equal-time fractions. A value of +1 meant the protein was only 
identified in the 10 equal-mass fractions, and a value of -1 meant the protein was only identified 
in the 10 equal-time fractions. The equal-time and equal-mass prefractionation methods were 
compared for 5 fractions in Figure 2.17, for 10 fractions in Appendix A.1. and for 20 fractions in 
Appendix A.2. The NDPC values were plotted with the proteins ordered from largest to smallest 
denominator, putting the proteins with highest coverage on the left, and the lowest coverage on 
the right. The absolute values of NDPC increased as the denominator (summed protein coverage) 
decreased. These figures were large and split amongst several pages. To better comprehend the 
trend, the protein identifier information was removed so the graph could fit onto a single page. 
The abundance of red lines in Figure 2.18.a. and Figure 2.18.b. signified higher coverage in the 5 
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and 10 equal-mass fractions. When fractionation increased to 20 (Figure 2.18.c.), there was little 
difference in coverage between the two methods.  
In an attempt to further simplify the comparison of coverage between multiple methods, 
while maintaining the meaning of the values, we propose the Grand NDPC which is calculated 
by the difference between the grand total protein coverage in method one and method two 
normalized by the grand sum of protein coverage in both methods. An example calculation is 
shown in Equation 2-5: 











Perhaps a more relevant interpretative of the Grand NDPC would be to relate it to a fold-
change improvement in coverage as follows:  






1  rand NDPC
1- rand NDPC
  (2-8) 
If the fold-change was less than one, the negative reciprocal of the value was used as is 
conventional with fold-change calculations. The Grand NDPC and Fold-Change in Coverage is 
listed in Table 2.4 for each fractionation frequency. Positive values represented higher coverage 
with the equal-mass fractionation method, and negative values represented higher coverage with 
the equal-time fractionation method. The Grand NDPC and Fold-Change Coverage increased in 
favor of the equal-mass method for 5 and 10 fractions. The largest fold-change improvement was 
1.4 with the 10 fraction comparison. No significant difference in coverage was observed between 
the two methods with 20 first dimension fractions.  
2.4 Conclusion 
While this was a limited study of only one organism, it can serve as a guide for 
multidimensional method development with prefractionation. Protein identifications increased as 
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fractionation frequency was increased. These benefits had diminishing returns with respect to 
time as prefractionation increased to more than 20 fractions. The equal-mass prefractionation 
method proved to be a good technique to get more information out of a sample in the same 
amount of time as compared to the equal-time fractionation method. Future improvements could 
be made to the second dimension separation. The use of a LC with higher pressure limitations 
could make possible the use of smaller particles and longer columns to improve peak capacity 















+ 0.2% TFA 
(%B) 
0 1.0 100 0 
2 1.0 100 0 
5 1.0 75 25 
40 1.0 50 50 
45 1.0 35 65 
45.1 1.0 0 100 
50 1.0 0 100 
50.1 1.0 100 0 
 
Table 2.1. Chromatographic conditions for the reversed-phase prefractionation of intact proteins. 
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  Integrated TIC of 40 Fractions 
Fraction Rep 1 (x107) Rep 2 (x107) Rep 3 (x107) Average Summed Normalized 
1 0.38 0.31 0.20 0.30 0.30 0.00 
2 0.64 0.32 0.21 0.39 0.68 0.01 
3 1.93 0.96 1.15 1.35 2.03 0.02 
4 2.22 1.26 1.29 1.59 3.62 0.03 
5 1.92 2.03 1.40 1.78 5.40 0.05 
6 4.59 4.56 3.07 4.07 9.48 0.09 
7 6.31 3.94 4.11 4.78 14.26 0.13 
8 6.20 5.32 4.32 5.28 19.54 0.18 
9 3.42 3.42 2.48 3.11 22.65 0.20 
10 2.98 2.18 2.02 2.40 25.04 0.23 
11 2.96 2.37 1.98 2.43 27.48 0.25 
12 2.97 2.26 1.85 2.36 29.84 0.27 
13 4.14 3.19 2.22 3.18 33.02 0.30 
14 3.43 2.65 2.21 2.76 35.78 0.32 
15 4.73 4.25 3.12 4.03 39.81 0.36 
16 6.01 5.86 3.66 5.18 44.99 0.41 
17 9.41 8.76 5.37 7.85 52.84 0.48 
18 6.23 6.27 3.89 5.46 58.30 0.53 
19 8.47 6.16 5.01 6.55 64.84 0.59 
20 8.64 6.01 4.82 6.49 71.34 0.64 
21 8.14 4.85 3.92 5.64 76.97 0.69 
22 9.03 5.65 4.64 6.44 83.41 0.75 
23 5.82 3.00 2.59 3.80 87.22 0.79 
24 5.94 2.67 3.01 3.87 91.09 0.82 
25 6.32 5.01 3.92 5.09 96.18 0.87 
26 3.27 2.26 2.26 2.60 98.77 0.89 
27 2.95 1.84 2.02 2.27 101.04 0.91 
28 1.99 1.22 1.44 1.55 102.59 0.93 
29 2.22 0.95 1.39 1.52 104.11 0.94 
30 0.21 0.82 1.10 0.71 104.82 0.95 
31 1.16 0.53 0.78 0.83 105.65 0.95 
32 1.05 0.48 0.76 0.76 106.41 0.96 
33 0.54 0.25 0.44 0.41 106.82 0.96 
34 1.02 0.41 0.55 0.66 107.48 0.97 
35 0.89 0.37 0.54 0.60 108.08 0.98 
36 0.80 0.28 0.50 0.53 108.61 0.98 
37 0.91 0.37 0.64 0.64 109.25 0.99 
38 0.81 0.26 0.61 0.56 109.81 0.99 
39 0.60 0.22 0.52 0.44 110.26 1.00 
40 0.65 0.26 0.63 0.52 110.77 1.00 
 
Table 2.2. Integrated TIC values, summed integrated TIC, and normalized summed integrated 





   
Protein Coverage (%) 
   
Number of equal-time fractions 
 
Number of equal-mass fractions 
Name Accession 
 
5 10 20 40 
 
5 10 20 
6-phosphogluconate dehydrogenase 6PGD1 
 
61% 39% 76% 70% 
 
29% 54% 63% 
Isocitrate lyase ACEA 
 
- - 29% 38% 
 
3% 31% 41% 
Aconitate hydratase, mito ACON 
 
38% 46% 47% 49% 
 
44% 48% 40% 
Acetyl-coenzyme A synthetase 1 ACS1 
 
25% 30% 51% 49% 
 
24% 42% 55% 
Alcohol dehydrogenase 1 ADH1 
 
60% 58% 65% 69% 
 
62% 69% 59% 
Alcohol dehydrogenase 2 ADH2 
 
66% 72% 71% 73% 
 
69% 73% 67% 
Alcohol dehydrogenase 3, mito ADH3 
 
8% - 19% 17% 
 
- 22% 18% 
Alcohol dehydrogenase 6 ADH6 
 
- - 3% - 
 
- - - 
K-activated aldehyde dehydrogenase ALDH4 
 
75% 72% 81% 88% 
 
75% 87% 83% 
Aldehyde dehydrogenase 5, mito ALDH5 
 
- - - - 
 
- - - 
Fructose-bisphosphate aldolase ALF 
 
69% 76% 69% 81% 
 
73% 71% 75% 
Citrate synthase, mito CISY1 
 
31% 35% 52% 57% 
 
45% 53% 61% 
Dihydrolipoyl dehydrogenase, mito DLDH 
 
39% 38% 77% 70% 
 
32% 39% 72% 
Enolase 1 ENO1 
 
73% 80% 79% 83% 
 
76% 84% 81% 
Enolase 2 ENO2 
 
76% 78% 86% 87% 
 
83% 81% 87% 
Fumarate reductase FRDS 
 
- 8% 21% 24% 
 
6% 22% 25% 
Fumarate hydratase, mitoc FUMH 
 
26% 36% 43% 53% 
 
27% 52% 49% 
Glyceraldehyde-3-P dehydrogenase 1 G3P1 
 
71% 70% 85% 77% 
 
74% 79% 76% 
Glyceraldehyde-3-P dehydrogenase 2 G3P2 
 
83% 71% 89% 87% 
 
83% 84% 88% 
Glyceraldehyde-3-P dehydrogenase 3 G3P3 
 
90% 78% 92% 90% 
 
91% 92% 91% 
Glucose-6-phosphate isomerase G6PI 
 
61% 60% 69% 60% 
 
52% 64% 65% 
Hexokinase-1 HXKA 
 
52% 56% 80% 75% 
 
50% 68% 76% 
Hexokinase-2 HXKB 
 
60% 53% 84% 74% 
 
61% 67% 69% 
Glucokinase-1 HXKG 
 
54% 40% 69% 68% 
 
57% 72% 67% 
6-phosphofructokinase subunit α K6PF1 
 
8% 8% 32% 28% 
 
24% 31% 24% 
Pyruvate kinase 1 KPYK1 
 
59% 68% 85% 81% 
 
76% 83% 81% 
Malate dehydrogenase, cyto MDHC 
 
26% 35% 64% 44% 
 





   
Protein Coverage (%) 
   
Number of equal-time fractions 
 
Number of equal-mass fractions 
Name Accession 
 
5 10 20 40 
 
5 10 20 
Malate dehydrogenase, mito MDHM 
 
75% 78% 74% 76% 
 
68% 82% 76% 
Pyruvate dehydrogenase E1 comp β ODPB 
 
- - 17% 29% 
 
- 9% 33% 
Phosphoenolpyruvate carboxykinase PCKA 
 
41% 53% 59% 61% 
 
46% 57% 59% 
Pyruvate decarboxylase isozyme 1 PDC1 
 
63% 65% 74% 74% 
 
55% 68% 67% 
Phosphoglycerate kinase PGK 
 
79% 70% 84% 86% 
 
83% 88% 84% 
Phosphoglycerate mutase 1 PMG1 
 
76% 79% 76% 69% 
 
78% 76% 54% 
Pyruvate carboxylase 1 PYC1 
 
- - 18% 38% 
 
- 4% 38% 
Succinyl-CoA ligase subunit α SUCA 
 
60% 67% 84% 71% 
 
60% 72% 69% 
Succinyl-CoA ligase subunit β SUCB 
 
- 16% 38% 37% 
 
13% 38% 30% 
Transketolase 1 TKT1 
 
15% 22% 43% 51% 
 
27% 54% 49% 
Transketolase 2 TKT2 
 
- - 6% 20% 
 
- 14% 21% 
Triosephosphate isomerase TPIS 
 
76% 75% 82% 89% 
 
80% 88% 86% 
           Average 
  
55% 54% 60% 62% 
 
53% 58% 60% 
 
Table 2.3. The protein coverage (%) was reported for some of the proteins involved in S. cerevisiae metabolism. Generally, protein 
coverage increased with fractionation frequency.  
 
 56 
Number of Fractions Grand NDPC Fold-Change in Coverage 
5 0.050 1.1 
10 0.17 1.4 
20 -0.0093 -1.0 
 
Table 2.4. The Grand NDPC and Fold-Change in Coverage was listed in for each fractionation 
frequency. Positive values represented higher coverage with the equal-mass fractionation 
method, and negative values represented higher coverage with the equal-time fractionation 
method. The Grand NDPC and Fold-Change in Coverage favored of the equal-mass method for 
5 and 10. The largest fold-change improvement was 1.4 with the 10 fraction comparison. No 






Figure 2.1. This 2D chromatogram was divided in to bins by Davis and coworkers.
7
 A perimeter 
was drawn around the bins containing a circle, which represented a sample peak, to illustrate the 
orthogonality of the separation.  
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Figure 2.2. The workflow for the prefractionation method started with HPLC-UV of the intact 
proteins. Forty fractions were collected, lyophilized, and digested with trypsin. The forty one-
minute-wide fractions were pooled into 20, 10, and 5 equal-time and equal-mass fractions before 
the second dimension analysis by UPLC-MS. The spectral data was searched against a genomic 
database to identify the proteins.   
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Figure 2.3. The representative TIC chromatogram from a peptide (second dimension) separation 
of the 40 equal-time fraction set showed an example of peak integration. The peak area was the 
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Figure 2.4. (a) The normalized Σ∫TIC, Σ absorbance, and summed unique protein count were 
plotted versus the first dimension separation time and fraction number. The similarity of the 
three traces should be noted. The y-axis was annotated with hash marks in increments of 0.2, 0.1, 
or 0.05, as shown in parts (b), (c), and (d), respectively. Lines were drawn from the hash marks 
on the y-axis to the corresponding x-coordinate on the normalized equal-mass curve. These x-
coordinates were used to determine size of the first dimension fractions.   
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Figure 2.5. The number of protein identifications was plotted versus number of first dimension 
fractions. The blue and red traces were for the equal-time and equal-mass fractionation methods, 
respectively. The number of protein identifications increased with increased prefractionation up 
to 40 fractions. At all prefractionation frequencies, the equal-mass prefractionation method 




Figure 2.6. The 2D chromatogram for 40 first dimension fractions was plotted with the first 
dimension (protein) separation time and fraction number plotted on the vertical axes and the 
second dimension (peptide) separation on the bottom axis. Starting with fraction 30, the peak 







a) Equal-Time Fractions 
 
b) Equal-Mass Fractions 
 
Figure 2.7. The 2D chromatograms for 20 first dimension fractions were plotted with the first dimension (protein) separation time or 
fraction number plotted on the vertical axes and the second dimension (peptide) separation on the bottom axis. Peak intensity was 
plotted in the z-direction. In the later eluting fractions, more peaks were observed in (b) the equal-mass fractionation chromatogram 










































































































a) Equal-Time Fractions 
 
b) Equal-Mass Fractions 
 
Figure 2.8. The 2D chromatograms for 10 first dimension fractions were plotted with the first dimension (protein) separation time or 
fraction number plotted on the vertical axes and the second dimension (peptide) separation on the bottom axis. Peak intensity was 
plotted in the z-direction. In the later eluting fractions, more peaks were observed in (b) the equal-mass fractionation chromatogram 
















































































































a) Equal-Time Fractions 
 
b) Equal-Mass Fractions 
 
Figure 2.9. The 2D chromatograms for 5 first dimension fractions were plotted with the first dimension (protein) separation time or 
fraction number plotted on the vertical axes and the second dimension (peptide) separation on the bottom axis. Peak intensity was 
plotted in the z-direction. In the later eluting fractions, more peaks were observed in (b) the equal-mass fractionation chromatogram 






























































































Figure 2.10. The light gray bars show the total protein identifications in each fraction, and the 
dark gray bars signify the unique protein identifications in each fraction for 40 first dimensional 
fractions. The number of unique protein identifications decreased in the last 15 fractions faster 








Figure 2.11. The light gray bars show the total protein identifications in each fraction, and the 
dark gray bars signify the unique protein identifications in each fraction for 20 first dimensional 
fractions. By more evenly distributing the sample mass between the fractions, as with the equal-
mass fractionation method (b), the number of unique protein identifications was more even 








Figure 2.12. The light gray bars show the total protein identifications in each fraction, and the 
dark gray bars signify the unique protein identifications in each fraction for 10 first dimensional 
fractions. By more evenly distributing the sample mass between the fractions, as with the equal-
mass fractionation method (b), the number of unique protein identifications was more even 
fraction to fraction and increased in the late eluting fractions as compared to the equal-time 







Figure 2.13. The light gray bars show the total protein identifications in each fraction, and the 
dark gray bars signify the unique protein identifications in each fraction for 5 first dimensional 
fractions. By more evenly distributing the sample mass between the fractions, as with the equal-
mass fractionation method (b), the number of unique protein identifications was more even 
fraction to fraction and increased in the late eluting fractions as compared to the equal-time 











Figure 2.14. Venn diagram (a) showed the overlap in protein identifications for 5, 10, and 20 equal-time fractions. Increasing 
fractionation to 20 led to new protein identifications while still identifying most of the proteins identified in the five and ten fraction 
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Figure 2.15. The Venn diagram showed the overlap in protein identifications for 5, 10, and 20 
equal-mass fractions. Increasing fractionation to 20 led to new protein identifications while still 
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Figure 2.16. Fractions per protein described the percentage of protein identifications that were detected in one, two, or more fractions 
(3+). As prefractionation frequency increased, more proteins were identified in multiple fractions. This effect was heightened for the 
equal-time fractions (blue) as compared to the equal-mass fractions (red). 
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Figure 2.17. To compare the 5 equal-mass and 5 equal-time fractions, the Normalized 
Difference Protein Coverage (NDPC) was plotted with proteins with higher coverage on the left, 
and proteins with lower coverage on the right. If a protein was identified with higher sequence 
coverage in the 5 equal-mass fractions, its NDPC value was positive (red bars). The blue bars 
signified higher coverage in the 5 equal-time fractions. Differences in coverage were minimal for 
highly covered proteins. As protein coverage decreased, more proteins were identified with 
higher coverage in the equal-mass fractions. The dashed lines indicate a level of two-fold greater 
protein coverage.  
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Figure 2.17. (continued) 
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Figure 2.18. The NDPC compared the equal-mass and equal-time methods for 5 (part a), 10 
(part b), and 20 (part c) first dimension fractions. If a protein was identified with higher sequence 
coverage in the equal-mass fractions, the NDPC value was positive (red lines). The blue lines 
signified higher coverage in the equal-time fractions. Proteins with higher coverage were plotted 
on the left, and proteins with lower coverage were on the right. Differences in coverage were 
minimal for highly covered proteins. As protein coverage decreased, more proteins were 
identified with higher coverage by the equal-mass method for 5 and 10 fractions. There was little 
difference in NDPC for 20 equal-mass and 20 equal-time fractions.  
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CHAPTER 3. Increasing Peak Capacities for Peptide Separations Using Long 
Microcapillary Columns and Sub-2 μm Particles at 30,000+ psi 
3.1 Introduction 
The field of proteomics is growing in popularity as understanding protein expression in 
biological systems is essential to elucidating the mechanism of diseases.
1
 Analysis of proteins is 
complicated because there are thousands of proteins in a cell spanning a large range of 




 To reduce the complexity, many proteomic experiments include 
a separation by reversed phase liquid chromatography (RPLC) before introduction into the mass 
spectrometer.
3
 Because protein separations are plagued by sample carryover, and the ionization 
and fragmentation efficiency of proteins are low, many experiments start with a digestion before 
the separation which increases the number of components in the mixture.
4,5,6,7
  
3.1.1 Coupling LC with MS 
To date, no single-dimension separation technique exists with the peak capacity to 
completely resolve an entire proteome.
8
 This issue has been mitigated by the coupling of LC to 
MS which can detect many species in a single scan. Efforts have been made in the field of mass 
spectrometry to increase acquisition rates while simultaneously improving limits of detection. 
The invention of nanoESI resulted in higher ionization efficiency, reduced matrix effects, and 
facilitated the coupling of LC to MS.
9,10,11,12
 Incorporating ion mobility into the mass 
spectrometer adds another level of analyte separation based on drift time without increasing total 
analysis time.
13
 To handle the massive amounts of information acquired during proteomic 
experiments, bioinformaticians have developed several programs to mine the data for 
 81 
information such as retention time, drift time, and parent and product ion mass/charge to identify 
proteins with higher probability and increased peptide coverage.
14
 Even with these 
improvements, the most advanced proteomic workflows still can’t cover the complete proteome 
in a single analysis of a simple organism such yeast.
15
  
3.1.2 Peak capacity improvements 
Developing more efficient liquid chromatography techniques for introducing the sample 
as fully resolved analytes to the mass spectrometer has potential to increase the total number of 
peptide and protein identifications. For example, more efficient separations reduce the problem 




The effectiveness of a separation is often described by the peak capacity, defined as the 
maximum number of components that can be resolved within a given separation time. The 




)  1 (3-1) 
where tg is gradient time and 4σ describes the width of the peak.
17,18 
Peak capacity can be increased by extending the gradient time but will level off as 
gradients become more shallow.
19
 Peak capacity can also be increased by improving column 
performance. For instance, efficiency can be gained from the use of narrow bore columns 
because flow dispersion decreases.
20
 An additional benefit from capillary columns is the 
improvement to signal intensity which is inversely proportional to the column diameter squared. 
Improvements to intensity are important for proteomic experiments because sample is often 
limited, and the analytes include proteins of low abundance.
11,12
 Other column dimensions that 
affect efficiency are length and particle diameter.
20-21
 Sub-2 µm particles reduce multipath 
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dispersion and the resistance to mass transfer.
22
 Peak capacity is proportional to the square root 
of column length for a given particle diameter, and it is inversely proportional to the square root 
of the particle diameter at a given column length. The pressure requirement, however, increases 
proportionally to column length and inversely proportional to the particle diameter cubed.
23
 
3.1.3 Previous UHPLC systems 
Several manufacturers produce LC systems capable of delivering nanoflow gradients at 
pressures up to 15 kpsi. Smith and coworkers developed an automated 20 kpsi RPLC-MS to run 
40-200 cm x 50 µm ID columns packed with 1.4-3 µm particles. These separations obtained 
peak capacities of 1000-1500 in 400-2000 minutes (calculated using peak widths at half 
maximum).
24
 A gradient LC system capable of delivering preloaded gradients at constant 
pressures up to 50000 psi was previously reported from the Jorgenson group.
25,26
 This system, 
however, was built around a now obsolete LC pump and required a splitter to deliver nanoflow 
to the column which resulted in the loss of sample.
27
 More recently, Gritti and Guichon
28
 
compared gradients delivered by constant pressure and constant flow modes and found that peak 
capacities were similar for both modes. When comparing peak capacity to analysis time, the 
constant pressure mode showed a slight advantaged as the system is always running at the 
maximum pressure and flow rate. In flow mode, the flow rate is limited by the pressure produced 
when the viscosity of the mobile phase in the column is at the maximum.
29
  
Herein, we describe a new constant pressure LC system capable of delivering split-less 
nanoflow gradients up to 45 kpsi. This automated system is built around a modified nanoAcquity 
and controlled by MassLynx. The peak capacities achieved with this system for a standard 
peptide mixture ranged from 174 in 22 minutes for fast, steep gradients and 773 in 360 minutes 
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for slower shallower gradients. These improved peak capacities led to an increase in protein 
identifications and protein coverage for an Escherichia coli digestion standard. 
3.2 Materials and methods 
3.2.1 Materials 
Optima grade water + 0.1% formic acid, acetonitrile + 0.1% formic acid, L-ascorbic acid, 
and acetone were purchased from Fisher Scientific (Fair Lawn, NJ). MassPREP
TM
 Digestion 
Standard Protein Expression Mixture 2, enolase digestion standard and E. coli digestion standard 
were obtained from Waters Corporation (Milford, MA). Water and acetonitrile were Optima LC-
MS grade, and all other chemicals were ACS reagent grade or higher. All hardware including 
valves, ferrules, nuts, connector-tees, unions and stainless steel tubing were purchased from 
Valco Instrument Co. (Houston, TX) unless otherwise noted. All fused silica capillary tubes were 
purchased from Polymicro Technologies, Inc. (Phoenix, AZ). 
3.2.2 Column preparation 
Analytical columns were packed in 75 µm I.D. capillaries and characterized with 
hydroquinone as previously described by the Jorgenson lab.
23,25
 The packing material selected 
was a silica bridged ethyl hybrid (BEH) particle with a C18 functional group (Waters). The 
particle diameters evaluated were 1.1 µm, 1.4 µm and 1.9 µm. Column lengths were shortened as 
particle size decreased to produce nominal flow rates of 300 nL/min at the operating pressure. 
The final columns evaluated were as follows: 28.5 cm x 75 µm, 1.1 µm BEH C18; 39.2 cm x 75 




The chromatographic system was built around a nanoAcquity as depicted in Figure 3.1. 
Several 3  cm long pieces of 5  μm ID fused silica capillary tubing connected the sample 
manager injection valve to a nano-tee (Waters) which split flow to the vent valve (10 kpsi pin 
valve, Valco) and the high pressure isolation valve (40 kpsi pin valve, Valco). The vent valve 
was a safety measure should valves isolating the nanoAcquity from the ultrahigh pressure fail. 
To this point, all connections were made with a peek ferrule and a 1/32” nut. From the high 
pressure isolation valve, a 6  cm length of the 5  μm ID silica capillary was directed through a 
freeze/thaw valve and to a second nano-tee. The freeze/thaw valve, developed by Dourdeville,
30
 
was added to the system because the high pressure isolation valve failed to reliably block all flow 
at pressures above 30 kpsi. Freezing was driven by a Peltier heat pump with fans to dissipate the 
heat on the hot side. A dual-output linear power supply by way of a double-pole, double-throw 
relay drove the direction of the heating and cooling configuration. The output voltage from the 
power supply was adjusted for the valve to reach -55°C in the freeze state and 7°C in the thaw 
state. At the second nano-tee, the analytical column and gradient storage loop were joined to the 
high pressure isolation valve. The gradient storage loop consisted of 10 m of 50 μm ID silica 
capillary joined by a zero dead volume union (Valco) to 40 m of 250 µm ID stainless steel tubing 
(Valco). A third nano-tee connected the end of the storage loop to the gradient storage loop valve 
(40 kpsi pin valve, Valco) and a 903:1 pneumatic amplifier pump, with a 75 kpsi pressure 
maximum (Haskel International Inc., Burbank,CA). The pump was connected to the third nano-
tee by 1  μm ID silica capillary connected with a polyamide cylinder capillary compression 
fitting previously described.
25
 All other high pressure connections were made with a PEEK 
ferrule and PEEK tubing compressed with a 1/32” nut, collet and collar. The very narrow, 1  μm 
 85 
ID, silica capillary was selected to provide a flow limiter. If a large leak were to form farther 
down the fluidic network, most pressure, applied by the pneumatic amplifier, would drop across 
this narrow ID capillary. All valves were actuated through FET gates controlled by the on/off 
switches on the rear panel of the nanoAcquity.  
3.2.4 Operating procedure 
The system operating procedure began with the vent valve closed, and the high pressure 
isolation valve, freeze/thaw valve, and the gradient storage loop valve opened. Mobile phase A 
was Optima Grade water with 0.1% formic acid, and mobile phase B was Optima-grade 
acetonitrile with 0.1% formic acid. The desired gradient program had a 4-40% B linear gradient 
followed by a 4 µL wash at 85% B and re-equilibration step at 4% B. To produce this gradient, it 
had to be programmed in reverse order, with the high organic content first and low organic 
content last, into the MassLynx (Waters) method. The gradient method was loaded onto the 
gradient storage loop at 5 μL/min. Next, one μL of the MassPrep digest sample was loaded with 
a push of  .5% B at 5 μL/min. A total of 10 µL of mobile phase was required to push the sample 
out of the 1µL injection loop, through the transfer tubing and onto the storage loop. After the 
gradient and sample were parked on the storage loop, the vent valve was closed; and the high 
pressure isolation valve, the freeze/thaw valve, and gradient storage loop valve were closed. 
After waiting 2.5 min for the mobile phase to freeze in the Peltier device, the pneumatic 
amplifier pump was initiated, to begin the high pressure separation. The method as programmed 
into MassLynx is listed in Table 3.1 
3.2.5 Gradient volume determination 
Traditionally, gradient lengths are reported in time. For a constant pressure system, 
reporting gradient length in terms of volume is more appropriate. The gradient volume was 
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calculated as the time to load the gradient multiplied by the flow rate (5 µL/min). The length of 
the linear gradient was programmed to produce a 1, 2, or 4% change in %B per column mobile 
phase volume. The column mobile phase volume was determined empirically by multiplying the 
retention time of an unretained compound (L-ascorbic acid) by the flow rate in 
50:50 acetonitrile:water with the column run at room temperature. The volumetric flow rate was 
determined by the time necessary to fill a 10 µL glass micropipette (Fisher) with column 
effluent. Flow rates and gradient volumes for every method were reported in Table 3.2.  
3.2.6 Gradient linearity determination 
To measure the gradient profile, mobile phase B was spiked with 10% acetone. The 
analytical column was replaced with a 55 cm x 5 μm ID open tubular silica capillary run at 30 
kpsi with a measure flow rate of 290 nL/min. The flow from the capillary was directed to a 
Waters CapLC248  UV/Vis Detector with a  5 μm bubble cell and set to acquire data at 265nm.  
3.2.7 Retention time repeatability 
To test the repeatability of retention time, a 1µL injection of enolase digest, prepared as 
per manufacturer’s instructions, was run once a day for 12 days. The separation occurred on a 
110 cm x 75 µm ID column packed with 1.9 µm BEH C18 particles run at 65°C and 30 kpsi. The 
gradient volume was 12.5 µL from 4-40% B. The retention times were tracked for 17 peptide 
peaks.  
3.2.8 Peptide analysis 
The Standard Protein Expression Digestion Mixture 2 was run in duplicate, and the E. 
coli digestion standard was run in triplicate for each chromatographic method. The outlet of the 
RPLC column was coupled to a qTOF Premier (Waters) via a 30 cm x 20 µm I.D. piece of silica 
capillary and a stainless steel nanospray emitter with a 2  μm ID and a 1  μm tip (Waters). Spray 
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voltage (+2.5kV) was applied via electrical contact with the zero-dead-volume union in the 
nanoflow sprayer. MS
E
 scans were performed in data-independent analysis mode. The 
instrument was set to acquire parent ion scans from m/z 50-1990 at 5.0 V. The collision energy 
was then ramped from 15-40 V. Scan times were set to 0.3 sec for analysis of sub-20 second 
wide chromatographic peaks and 0.6 sec for wider peaks with a 0.1 sec interscan delay in both 
cases.  
3.2.9 Peptide data processing 
The LC-MS/MS data were processed using ProteinLynx Global Server 2.5 (Waters). The 
Standard Protein Expression Digestion Mixture 2 data were searched against a database of 
alcohol dehydrogenase, bovine serum albumin, glycogen phosphorylase b, and enolase. The E. 
coli spectral data was search against a database of known E. coli proteins. The amino acid 
sequences were found from the Uni-Prot protein knowledgebase (www.uniprot.org) and 
appended with a 1X reversed sequence. The false discovery rate was set to 4%.  
3.2.10 Calculating peak capacity 
The Standard Protein Expression Digestion Mixture 2 data were used to determine peak 
capacity. The full width at half maximum intensity (FWHM) of each peptide peak was 
determined by ProteinLynx Global Server ion accounting output. The average (arithmetic mean) 
FWHM was multiplied by 1.  to calculate the 4σ peak width. The peak capacity was ultimately 
determined by the separation widow divided by the average (arithmetic mean) 4σ peak width. 
The separation window was the time between the elution of the first and last peak. The sample 
was sufficiently complex to have peaks eluting throughout the entire gradient length.  
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3.3 Discussion 
3.3.1 Instrumental design 
Previous attempts proved the difficulty of producing linear gradients at ultrahigh 
pressures.
25
 Two challenges included keeping dead times and mixing volumes low. To reduce 
mixing, narrow bore capillaries are used. The combination of narrow bore capillaries and nano-
flow prior to the column can greatly increase the solvent delay and dead time. Commercially 
available systems, like the nanoAcquity UPLC used in these experiments, accurately and 
reproducibly generate linear gradients up to 10 kpsi.
31
 The nanoAcquity also provides software 
for easy method programing and provides on/off switches used to control additional valves. For 
these reasons, the nanoAcquity was selected as the base for the UHPLC. The gradients were 
generated by the nanoAcquity at lower pressures (2-4 kpsi) and loaded onto a storage loop. 
Therefore, the gradient merely needs to be pushed but not formed at ultrahigh pressures. 
Gradient loading only adds a few minutes onto the run time because loading occurred at 5 
µL/min as opposed the 0.2-0.6 µL/min playback flow rate. The gradient was loaded on to the 
front of the storage loop in reverse order, and played back in a last-in-first-out (LIFO) workflow. 
LIFO allowed the loading time to be directly proportional to the gradient volume. If the gradient 
was loaded in order, it would have to be loaded into the back of the storage loop causing the dead 
volume of the instrument to be the volume of the storage loop minus the volume of the gradient. 
By loading the gradient onto the end of the storage loop closest to the head of the column, the 
system basically had zero dead volume. The only dead volume was from the 150 µm i.d. bore 
through the tee that connects the storage loop to the column.  
When the valves were configured for ultrahigh pressure mode, the pressure was delivered 
by the Haskel pneumatic amplifier pump which was capable of working at 75 kpsi. The system 
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was prohibited from working at this pressure by the fittings and pin-valves. The silica capillary 
fittings start leaking at 50 kpsi. Previously published fittings
23
 compatible with pressures greater 
than 50 kpsi were much larger and would require the use of a larger tee to connect the gradient 
storage loop to the column. Larger tees have larger dead volumes allowing mixing of mobile 
phase in the tee and mostly likely interfere with the focusing of the injection plug onto the head 
of the column.  
3.3.2 Gradient storage loop dimensions 
When designing the system, the versatility was desired to run both long gradients for long 
columns and fast gradients on short columns with smaller particles. The storage loop must 
provide ample volume to accommodate larger gradients while having a narrow internal diameter 
to reduce Taylor-Aris mixing of the mobile phase.
32
 Mixing of the mobile phase in the storage 
loop is best described by the height equivalent of a theoretical plate (HCM) in an open tube. HCM 
is proportional to the inner diameter of an open tube (dc), where Dm is the diffusion of a molecule 
in the mobile phase
33
 as shown in Equation 3-2. 











2  (3-3) 
Larger gradients are less affected by the inner diameter of the storage loop because the number 






  (3-4) 
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The derivation comparing band broadening for different storage loops and gradient 
volumes can be found in table Table 3.3. For the larger, 125 μL, gradient, 23   theoretical plates 
were calculated with a  . 25 cm ID storage loop. For a shorter, 5 μL, gradient, there were only 
91 theoretical plates. To achieve 2300 theoretical plates for the shorter gradient, a 0.0050 cm 
storage loop had to be used. A balance must be made, however, between the internal diameter 
and the practicality of the length of the storage loop. To provide storage of larger gradients 
without compromising the integrity of shorter gradients two storage loops were used in tandem. 
The first section was 10 m of 50 μm I.D. silica capillary, which stored 2  μL. The second section 
was 10 m of 250 µm ID stainless steel tubing capable of storing 0.5 mL. As shown in Figure 3.2, 
a linear gradient was not delivered with only the 250 µm ID storage loop installed. The 17 μL 
gradient should produce a 56-min-long linear section from 4-40%B followed by a ramp to a 
85%B wash. The red trace shows mixing of the gradient when it was loaded at 10 μL/min into 
the 250 µm ID storage loop. The loading flow rate was reduced to 5 μL/min which slightly 
improved the linearity of the delivered gradient (blue trace). The addition of the 50 μm ID silica 
capillary produced a very linear, 56-minute-long gradient that was not mixed with the 85%B 
wash (green trace). With the narrow ID storage loop inline, the desired gradient profiles were 
delivered after storage in the loop.  
3.3.3 Selecting the flow rate for gradient loading 
The Hcm-term is also proportional to the linear velocity (u) making the flow rate (F)
34
 at 




2  (3-5) 
The effect of gradient loading flow rate is shown in Figure 3.2. When the gradient is loaded at 10 
µL/min, the playback of the gradient is not as desired. Reducing the gradient loading flow rate to 
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5 µL/min improved the gradient profile as depicted in Figure 3.3.a. with the playback of 
gradients of varying volumes. The time of the linear portion of the gradient profile was plotted 
versus the gradient volume in Figure 3.3.b. The linear fit of the data produced an R
2
 value of 
0.999. The equation of the line was y = 3.33x +4.19. The inverse slope was 0.300 µL/min and 
corresponded to the playback flow rate.  
3.3.4 Repeatability 
The repeatability was accessed for a 12.5 µL gradient run at 30 kpsi and 65°C on a 110 
cm x 75 µm ID column packed with 1.9 µm BEH C18 particles. Enolase was separated by this 
method on twelve different days. The retention times are listed in Table 3.4 for peptides 
identified in all the analyses. The mean ( ̅), standard deviation (s), and relative standard 
deviations (%RSD) were calculated from these results. All peptides had retention times with a 
4.5%RSD or less. The retention time residual for each peptide was calculated as the retention 
time on a given day minus the average retention time. The residuals were plotted versus day of 
analysis in Figure 3.4. On most days (replicates 1-6, 10 and 12), retention times vary by less than 
two minutes from the mean. As evident from the tight clusters of data (except for replicates 1, 7 
and 11), the retention time shifts were similar for all peaks on any given day. Since this is a 
constant pressure system, longer retention times, for replicated 9 and 10, may be attributed to 
partial clogging of the pigtail or spray tip after the column. 
3.3.5 Elevated temperature separations 
Though not a requirement for operating the system, there were several motivations to 
heat the column to 65°C. Higher temperatures reduce the viscosity of the mobile phase. 
Therefore, longer columns can be used without reducing flow rate and increasing analysis time at 
a given pressure. The higher temperatures also reduced the change in mobile phase viscosity. 
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The gradient varied from 4-40% acetonitrile in water. Through the gradient, the viscosity and 
flow rate would fluctuate by nearly 10% at 25°C but only 5% at 65°C.
35,36,37
 The resistance to 
mass transfer is reduced at high temperatures which flattens the C-term portion of a Van 
Deemter plot and consequently shifts optimal velocity to a higher value. Analysis time can then 
be reduced because a separation with a higher flow rate will not suffer as great a loss of 
theoretical plates when run at 65°C versus 25°C.
34
  
3.3.6 Column selection 
To test the performance capabilities of the UHPLC, columns of varying length with 
several different particle diameters were selected. The internal column diameter was kept 
constant at 75 µm to be compatible with the volume necessary for nanoESI. Before use the 
column performance was evaluated by isocratic elution to confirm that all columns had similar 
reduced Van Deemter terms which is evident in Figure 3.5. The h-min of the 28.5 cm x 75 µm 
ID column with 1.1 µm BEH C18 stationary phase was slightly higher than the other columns 
evaluated. However, 1.1 µm particles were difficult to pack, especially to a length of 28.5 cm, 
and an h-min around 2.5 was very acceptable.  
3.3.7 Separations at ultrahigh pressures 
Once it was determined that the system delivered gradients as desired, separations were 
conducted at a variety of gradient volumes as shown in Figure 3.6. Resolving power increased as 
gradient volume increased for separations at 15 kpsi of the standard protein digest on a 44.1 cm x 
75 µm, 1.4 µm BEH C18 column. From each of the chromatograms, a representative peak, 
selected for its average intensity and retention time, was extracted and plotted in the insert of 
Figure 3.6. As gradient volume increased, peak width increased and peak height decreased. This 
same experiment was carried out at 15, 30 and 45 kpsi. Example chromatograms in Figure 3.7 of 
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a 56 µL gradient run at the three different pressures illustrated how run time decreased and flow 
rate increased as the operating pressure increased. The insert in Figure 3.7 of a representative 
peak from all three chromatograms showed how peak width decreased at higher pressure while 
peak intensity remained constant.  
A summary of the peak capacity data can be found in Table 3.5. The goal was to increase 
gradient volumes until a leveling off of peak capacity versus separations window was observed. 
As presented in Figure 3.8, the peak capacity from the separations at 45 kpsi plateaued at a lower 
value than for the separations at 30 kpsi. The separations at 15 kpsi reached a higher maximum 
peak capacity as compared to the higher pressure separations. At 15 kpsi, the linear velocity was 
8 cm/min which is closer to the optimum velocity. At the higher pressures and flow rates, a 
higher C-term contributed more to the band broadening. 
To determine how a proteomics sample would behave on this column, the same methods 
at various gradient volumes and pressures were used to separate the E. coli digestion standard. 
Though example separations at 15 kpsi in Figure 3.9 were very busy, an increase in resolution 
was observed as gradient volume increase which was indicated by the signal being closer to 
baseline between adjacent peaks. The benefit of reduced run time at higher pressures is shown in 
Figure 3.10 for a 56 µL gradient. In Figure 3.11, the number of E. coli peptide and protein 
identifications are plotted versus the separation window in parts a and b, respectively. The 
separations at 15 kpsi contained the most identifications followed by the separations at 30 kpsi 
and then by 45 kpsi. The peptide identifications begin to level off with respect to time faster than 
the protein identifications. For the shallowest gradients, peptide identifications actually start to 
decrease which was mostly likely due to the decrease in peak intensity for long separations. 
When the peptide identifications were plotted against peak capacity in part c, there was no strong 
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correlation. However, protein identifications were very linear when plotted against peak capacity 
as can be seen in part d. Because the peak capacity always increased as the separation window 
increased, the data points in parts c and d were still in order from smallest to largest gradient 
volume when reading the graph from left to right. 
Beyond measuring the number of protein identifications, it was also important to consider 
productivity which can be described as protein identifications per minute. The highest 
productivity measured was for the most aggressive gradient (4% change in mobile phase B per 
column volume) at 45 kpsi, and the lowest productivity was observed for the shallowest gradient 
(0.5% change in mobile phase B per column volume) at 15 kpsi. The productivity for all 
separations was plotted in Figure 3.12. For high-throughput laboratories, the higher pressure 
separations would be most useful.  
3.3.8 Separations with long columns 
The greatest benefit from having the ability to run ultrahigh pressure separations was 
observed when running with a long column. In the red chromatogram in Figure 3.13, the 
standard protein digest was separated on a 44.1 cm x 75 µm ID column with 1.9 µm BEH C18 
particles at 15 kpsi. The blue trace was from a 30 kpsi separation of the same sample on a 98.2 
cm x 75 µm ID column with 1.9 µm BEH C18 particles. By increasing the pressure, the flow 
rates and run times were similar between the two separations. As evident from inset graph, the 
width of a representative peak decreased at higher pressure yet peak intensity remained the same. 
Several gradient volumes were run on the 98.2 cm column. The results are summarized in Table 
3.5 and Figure 3.14 which also includes data from a shorter commercial column run on the 
standard nanoAcquity. By increasing the operating pressure, the peak capacity increased for 
separations on a longer column in the same amount of time as separations on a shorter column at 
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lower pressures. Also, the peak capacity plateaued at a higher value for the longer columns than 
the shorter columns.  
The E. coli digestion standard was also run on the 98.2 cm column at varying gradient 
volumes as seen in Figure 3.15. An enlarged view of a portion of the longest chromatogram is 
shown in Figure 3.16. The return of the signal to baseline between several adjacent peaks 
demonstrated the gain in resolution from using long columns at elevated pressures and 
temperature for proteomics analysis. The number of peptide and protein identifications plotted in 
Figure 3.17 was higher for separations on the modified UHPLC than the commercial system with 
an increase of nearly 50%. However, there was little difference in the number of protein 
identifications between the 98.2 cm column run at 30 kpsi and the 44.1 cm column run at 15 kpsi 
even though the 98.2 cm column had a larger peak capacity.  
The number of protein identifications is not the only metric by which to compare the 
results of two proteomics analyses. Improvement of protein coverage, or the percent amino acid 
sequence coverage, can also describe the merit of the experiment. For a large data set containing 
hundreds of proteins, comparing the coverage for each protein is not straight forward. For 
example, reducing protein coverage to an average can be misleading. The additional proteins 
identified in a separation with higher peak capacity were usually of lower abundance and had 
lower coverage, bringing down the average. Alternatively, comparing only proteins identified by 
both methods would limit the analysis to only easily detectible proteins which usually had higher 
coverage and, thus, mute the difference between the methods.  Herein, an original method to 
compare protein coverage based on the mathematical concept of a normalized difference is 
described. We named this metric the normalized difference protein coverage (NDPC) and define 
it as the difference in coverage of a protein found in two methods divided by the sum of the 
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coverage. For example, consider the protein pyruvate kinase, which is involved in E. coli 
glycolysis.
38
 For a 360 minute separation, pyruvate kinase had 47% coverage on the 98 cm 
column and 27% coverage on the 44.1 cm column. The NDPC is 0.27 as calculated in 
Equation 3-6.  
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The Normalized Difference Protein Coverage (NDPC) is plotted in Figure 3.18 for each 
protein identified with the 360 minute gradient separation. If a protein was identified with higher 
sequence coverage from the separation on the 98.2 cm column run at 30 kpsi, its NDPC value 
was positive (blue bars). The red bars signified higher coverage with the separation on the 44.1 
cm column at 15 kpsi. Proteins were plotted in order of decreasing coverage i.e. proteins wither 
higher coverage were plotted on the left and proteins with lower coverage on the right. 
Differences in coverage were minimal for highly covered proteins. As protein coverage 
decreased, more proteins had higher coverage with the 98.2 cm column. Similar comparisons 
were made for the 90 minute and 180 minute gradient separations and can be found in 
Appendix B.1. and Appendix B.2., respectively. To provide a better visual of the trend in 
coverage, the protein identifiers were removed from the graphs, and the NDPC were plotted in 
Figure 3.19. parts a, b, and c for the 90, 180, and 360 minute gradient separations, respectively. 
As evident by the larger portion of blue bars in part c, the greatest improvement in coverage 
between the long and shorter column was with shallowest gradient.  
In an attempt to further simplify the comparison of coverage between multiple methods,  
while maintaining the meaning of the values, we propose the Grand NDPC which is calculated 
by the difference between the grand total protein coverage in method one and method two 
 97 
normalized by the grand sum of protein coverage in both methods. A formula for the Grand 
NDPC is shown in Equation 3-7: 











Perhaps a more relevant interpretation of the Grand NDPC would be to relate it to a fold-
change improvement in coverage as follows:   






1  rand NDPC
1- rand NDPC
  (3-8) 
If the Fold-Change was less than one, the negative reciprocal of the value was used as is 
conventional with fold-change calculations. The Grand NDPC and Fold-Change in Coverage is 
listed in Table 3.6 for the E. coli digest standard 90, 180, and 360 min gradient separations on the 
98.2 cm column run at 30 kpsi and the 44.1 cm column at 15 kpsi. Positive values represented 
higher coverage on the long column, and negative values represented higher coverage on the 
shorter column. Grand NDPC and Fold-Change Coverage increased in favor of the long column 
as gradient length increased.  
3.3.9 Separations with smaller particles 
The last variable that was evaluated on the UHPLC was the use of columns with smaller 
particles. Flow rate, running pressure, and column diameter were kept constant for these 
experiments. Column length was shortened to compensate for the additional back pressure 
necessary for running with smaller particles. The standard protein digest was separated on a 39.2 
cm x 75 µm ID column packed with 1.4 µm BEH C18 particles at increasing gradient volumes as 
shown in Figure 3.20. The inlaid graph depicted a representative peak. Similar to separations 
shown for columns previously discussed in the chapter, the peak width increased and peak height 
decreased as gradient volume increased. The smallest particles tested were 1.1 µm BEH C18 
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packed into a 28.5 cm x 75 µm ID column. These separations are shown in Figure 3.21. The 
inset graph of the representative peak had a width of 0.1 minute for the fastest gradient which 
was the narrowest width of any peak shown in this chapter. The peak width increased to 0.26 
minutes for the slowest gradient on this column. A summary of the peak capacities are listed in 
Table 3.5 and plotted in Figure 3.22. The red line represents separations at 30 kpsi on a 39.2 cm 
x 75 µm ID column with 1.4 µm BEH C18 particles. The blue line represents separations on a 
98.2 cm x 75 µm ID column with 1.9 µm BEH C18 particles. The green line represents 
separations on a 28.5 cm x 75 µm ID column with 1.1 µm BEH C18 particles. The black line 
represents separations on a commercial UPLC with a commercial column. The highest peak 
capacities were achieved with the longest column and the largest particles. Even for very short 
analysis times, peak capacities were higher with an aggressive gradient on a long column than a 
shallower gradient on a shorter column packed with smaller particles. Pressure requirements 
were proportional to length and inversely proportional to the particle diameter cubed. Therefore, 
length had to be sacrificed when running a column with smaller particles which resulted in the 
lower peak capacities.  
The 39.2 cm x 75 µm ID column packed with 1.4 µm BEH C18 particles was also run at 
15 and 45 kpsi as represented in Appendix B.3. The E. coli digestion standard was also analyzed 
at all these conditions with example chromatograms shown in the Appendix B.4. and 
Appendix B.5. The results are summarized in Table 3.5. Conclusions from this data were similar 
to that discussed in the “Separations at ultrahigh pressures” section. The 28.5 cm x  5 µm ID 
column with 1.1 µm BEH C18 particles broke before the E. coli digestion standard was 
analyzed. There were not enough particles to pack another column with similar performance.  
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3.3.10 Literature comparison 
Several labs have employed longer columns and ultrahigh pressures to improve peak 
capacity and number of identifications for proteomic analyses. A representation of this work 
from the literature, data from the commercial system, and data from this chapter are plotted in 
Figure 3.23. The Marto group at Harvard
39
 packed 5 µm particles into a long narrow capillary of 
100 cm x 25 µm ID and ran on a commercial system at 8 kpsi nominal back pressure. The Smith 
group at PNNL
24
 separated peptides on three different columns at 20 kpsi. The column length 
decreased to accommodate for the pressure required to use smaller particles. Data from this 
chapter collected at 30 kpsi with the 98.2 cm x 75 µm ID column packed with 1.9 µm BEH C18 
particles outperformed the results found in the literature in less times. 
3.4 Conclusions 
A gradient elution system capable of 45 kpsi has been developed to improve the separation of 
proteomic samples. By implementing longer columns and smaller particles, the peak capacity 
and productivity were increased. The peak capacities achieved with this system for a standard 
peptide mixture ranged from 174 in 22 minutes for fast, steep gradients and 773 in 360 minutes 
for slower shallower gradients. The highest peak capacities were achieved with the longest 
column. Even for very short analyses, peak capacities were higher for an aggressive gradient on 
a long column than a shallower gradient on a shorter column with smaller particles. The peak 
capacities associated with this system led to increased protein identifications and sequence 
coverage.  
This instrument would be well suited to perform the second dimension separations in a 
prefractionation-type multidimensional proteomics separation
7
 or as the first dimension followed 
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by a fast separation on a microchip.
40
 The improved separation efficiency available through this 


























Gradient Loading Method 
Initial 5 96.0 4.0 - Off On Off 
1.0 5 15.0 85 11 Off On Off 
1.8 5 60.0 40 11 Off On Off 
x + 1.8 5 96.0 4 6 Off On Off 
x + 2.4 5 99.5 0.5 11 Off On Off 
x + 4.0 4 99.5 0.5 11 Off On Off 
x + 4.1 3 99.5 0.5 11 Off On Off 
x + 4.2 2 99.5 0.5 11 Off On Off 
x + 4.3 1 99.5 0.5 11 Off On Off 
x + 4.4 0.01 99.5 0.5 11 Off On Off 
x + 5.0 (end) 0.01 99.5 0.5 11 Off On Off 
Sample Loading Method 
Initial 0.01 99.5 0.5 - Off On Off 
0.1 1 99.5 0.5 11 Off On Off 
0.2 2 99.5 0.5 11 Off On Off 
0.3 3 99.5 0.5 11 Off On Off 
0.4 4 99.5 0.5 11 Off On Off 
0.5 5 99.5 0.5 11 Off On Off 
2.0 5 99.5 0.5 11 Off On Off 
2.5 0.01 50 50 11 On Off Off 
5.0 0.01 50 50 11 On Off On 
Ultra High Pressure Separation Method 
Initial 0.01 50 50 11 On Off On 
y 0.01 96 4 11 On On Off 
y + 5.0 (end) 0.01 96 4 11 On On Off 
Table 3.1. The methods as programmed into MassLynx were listed along with the valve timings. The gradient loading time was listed 
as x, where x equals the gradient volume divided by the flow rate when loading the gradient. The time to play back the gradient was 
listed as y.  
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  Column A Column B Column C Column D 
Column Length 
(cm) 
 44.1 98.2 39.2 28.5 
Internal Diameter 
(µm) 
 75 75 75 75 
Particle Diamter 
(µm) 
 1.9 1.9 1.4 1.1 
 Flow Rate (nL/min) 
Pressure 
15kpsi  350 - 190 - 
30kpsi  730 330 410 370 
45kpsi  1160 - 610 - 





4.0%  14 31 12.5 8 
2.0%  28 62 25 16 
1.0%  56 124 50 31 
0.5%  113 249 100 62 
Table 3.2. The dimensions for each of the analytical columns tested in this manuscript were 
listed along with their measured flow rates and programmed gradient volumes.  
  
 103 
Gradient Volume, V, (μL) 125 5.0 5.0 
Inner Diameter, dc, (cm) 0.025 0.025 0.0050 
Gradient Loading  
Flow Rate, F, (μL/min) 
5.0 5.0 5.0 
Linear Velocity, (cm/s) 
  
  
   
  
0.17 0.17 4.2 
HETP (cm) 
    
  
  
    
 
0.11 0.11 0.11 
Gradient Length (cm) 
  
  
   
  
250 10 250 
Number of Plates 
  
 
   
 
2300 91 2300 
Table 3.3. The number of theoretical plates was calculated for several gradient storage loop 








   
Analysis Day 
   
 
Peptide Sequence m/z 
 
1 2 4 8 9 9 10 11 13 14 15 16 
  ̅  s %RSD 
HLADLSK 392.2 
 
41.8 38.6 38.9 40.1 40.4 40.0 37.8 38.2 43.2 41.0 43.5 40.5 
 
40.3 1.8 4.5 
IATAIEK 745.5 
 
44.3 41.8 42.4 42.8 43.6 43.2 40.5 40.9 46.1 43.6 46.6 43.5 
 
43.3 1.8 4.2 
IGSEVYHNLK 580.3 
 
45.4 43.3 44.0 44.2 45.1 44.8 42.0 42.4 47.6 44.9 48.2 45.0 
 
44.8 1.8 4.1 
LNQLLR 756.5 
 
50.3 48.3 49.1 49.1 50.2 49.9 46.9 47.4 52.8 50.3 53.7 50.0 
 
49.8 2.0 4.0 
TFAEALR 807.4 
 
50.8 48.9 49.7 49.7 50.8 50.4 47.5 48.0 53.4 50.9 54.3 50.6 
 
50.4 2.0 3.9 
SIVPSGASTGVHEALEMR 619.6 
 
51.2 49.4 50.2 50.2 51.3 51.0 48.0 48.6 54.1 51.6 55.1 51.3 
 
51.0 2.0 4.0 
IEEELGDNAVFAGENFHHGDK 776.7 
 
52.7 51.0 51.9 51.8 53.0 52.7 49.6 50.2 55.8 53.3 56.9 52.9 
 
52.7 2.1 4.0 
GNPTVEVELTTEK 708.9 
 
52.9 51.2 52.1 52.0 53.1 52.8 49.8 50.3 56.0 53.4 57.1 53.1 
 
52.8 2.1 4.0 
VNQIGTLSESIK 644.9 
 
53.4 51.7 52.5 52.4 53.7 53.3 50.2 50.8 56.5 53.9 57.6 53.6 
 
53.3 2.1 3.9 
YDLDFK 800.4 
 
54.1 52.4 53.2 53.2 54.4 54.0 50.9 51.6 57.3 54.7 58.3 54.3 
 
54.0 2.1 3.9 
AADALLLK 814.5 
 
55.5 53.9 54.6 54.5 55.8 55.4 52.3 52.9 58.6 56.1 59.9 55.6 
 
55.4 2.1 3.9 
NVNDVIAPAFVK 643.9 
 
59.9 58.6 59.4 59.1 60.5 60.1 56.9 57.6 63.6 60.9 65.1 60.4 
 
60.2 2.3 3.8 
TAGIQIVADDLTVTNPK 878.5 
 
60.9 59.6 60.7 60.3 61.8 61.4 58.2 58.9 65.0 62.2 66.6 61.8 
 
61.5 2.4 3.9 
LGANAILGVSLAASR 706.9 
 
62.7 61.4 62.3 61.8 63.6 63.0 59.7 60.5 66.8 63.9 68.6 63.3 
 
63.1 2.5 3.9 
AVDDFLISLDGTANK 789.9 
 
64.9 64.7 65.6 65.0 66.9 66.4 62.1 62.9 69.2 67.2 71.2 65.8 
 
66.0 2.5 3.8 
SGETEDTFIADLVVGLR 911.5 
 
69.8 69.0 70.0 69.3 71.1 70.6 67.1 67.9 74.3 71.6 77.0 71.2 
 
70.8 2.7 3.8 
YGASAGNVGDEGGVAPNIQTAEEALDLIVDAIK 1086.6 
 
72.3 72.0 72.9 72.1 74.1 73.5 69.9 70.7 77.3 74.6 80.3 74.3 
 
73.7 2.9 3.9 
Table 3.4. The retention times, in minutes, were listed for several peptides identified in an enolase digest standatd separated on a 110 
cm x 75 µm column packed with 1.9 µm BEH C18 particles. The gradient volume was 12.5 µL and was repeated 12 times on 12 





















25 cm x  
75 µm ID 
1.9 µm dp 
8 
4 15 0.17 88 111 1060 
2 30 0.29 103 169 1540 
1 60 0.37 161 201 1876 
0.5 120 0.92 191 196 1493 
44.1 cm x  
75 µm ID  
1.9 µm dp 
15 
4 35 0.13 264 207 2534 
2 69 0.18 385 255 2982 
1 132 0.29 455 302 3127 
0.5 275 0.46 596 362 2742 
30 
4 18 0.10 174 156 1652 
2 34 0.14 254 199 2048 
1 67 0.18 379 232 2029 
0.5 137 0.32 433 260 2020 
45 
4 11 0.09 125 127 1371 
2 24 0.14 174 166 1664 
1 47 0.18 269 212 1984 
0.5 93 0.27 344 238 1990 
98.2 cm x  
75 µm ID  
1.9 µm dp 
30 
4 90 0.20 457 265 2682 
2 180 0.29 622 290 2868 
1 360 0.47 773 395 2883 
0.5 720 0.82 877 343 2003 
39.2 cm x  
75 µm ID 
1.4 µm dp 
15 
4 67 0.21 316 222 3038 
2 113 0.29 385 263 3363 
1 198 0.41 482 291 3160 
0.5 400 0.55 724 232 1775 
30 
4 34 0.14 246 184 2347 
2 60 0.17 352 273 3346 
1 123 0.34 366 321 3758 
0.5 240 0.42 566 359 2711 
45 
4 21 0.10 215 147 1502 
2 42 0.15 293 178 1786 
1 83 0.23 376 223 2030 
0.5 162 0.34 481 193 1460 
28.5 cm x  
75 µm ID  
1.1 µm dp 
30 
4 22 0.13 174 
n/a n/a 
2 38 0.17 220 
1 70 0.23 309 
0.5 125 0.36 352 
 
Table 3.5. The average separation window, peak width (4σ), peak capacity, and number of 
protein and peptide identifications were listed for each column at each running condition. 
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Gradient Length (min) Grand NDPC Fold-Change Coverage 
90 -0.0050 -1.01 
180 0.057 1.12 
360 0.10 1.22 
 
Table 3.6. The Grand NDPC and Fold-Change Coverage were compared for E. coli digest 
separated on the 98.2 cm column run at 30 kpsi to the 44.1 cm column run at 15 kpsi for three 
gradient lengths. Positive values represented higher coverage on the long column, and negative 
values represented higher coverage on the shorter column. Grand NDPC and Fold-Change 





Figure 3.1. The nanoAcquity is shown with the additional tubing and valves necessary for 
separations at 45 kpsi driven by the Haskel pneumatic amplifier pump. 
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Figure 3.2. The gradient playback time of the UHPLC was monitored by the UV absorbance of 
acetone in mobile phase B. The gradient linearity was improved by using a lower flow rate for 
gradient loading and employing the 50 µL ID tubing at the head of the gradient storage loop. 






Figure 3.3. The gradient playback time of the UHPLC was monitored by the UV absorbance of 
acetone in mobile phase B and plotted in part (a) for several different gradient volumes which 
were noted on the graph. The playback time of the linear region was plotted versus gradient 
volume in part (b). A best fit line had the equation y = 3.33x – 4.19 and R2 value of 0.999. The 




































y = 3.33x - 4.19
R² = 0.999
Inverse Slope = 0.300 µL/min
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Figure 3.4. The retention time residuals were plotted versus run order for several peptides 
identified in an enolase digest standard separated on a 110 cm x 75 µm column packed with 1.9 
µm BEH C18 particles. The gradient volume was 12.5 µL and was repeated 12 times on 12 
different days. The variability of retention times was random with the R
2
 values for a 5
th
 order 
polynomial fit of the residuals ranging between 0.57 and 0.69.   
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Figure 3.5. The Van Deemter plots with reduced terms of hydroquinone demonstrate the 
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Figure 3.6. Chromatograms of MassPREP
TM
 Digestion Standard Protein Expression Mixture 2 
were collected for separations with increasing gradient volume on the 44.1 cm x 75 µm ID 
column packed with 1.9 µm BEH C18 particles. Separations were completed at 15 kpsi. The 
insert of a representative peptide peak with 724 m/z extracted from all four chromatograms 










Figure 3.7. Chromatograms of MassPREP
TM
 Digestion Standard Protein Expression Mixture 2 
were collected for separations with increasing pressure and flow rate on the 44.1 cm x 75 µm ID 
column packed with 1.9 µm BEH C18 particles. Separations were completed with a 56 µL 
gradient volume. The insert of a representative peptide peak with 724 m/z extracted from all 
three chromatograms showed the decrease in peak width and constant signal intensity as pressure 












45 kpsi, 1160 nL/min
30 kpsi, 730 nL/min
56 µL Gradient Volume
1% Change MPB per Column Volume
15 kpsi, 350 kpsi
 114 
 
Figure 3.8. Peak capacity versus separation window was displayed for separations on a 44.1 cm 
x 75 µm ID column with 1.9 µm BEH C18 particles. Each line represented a different running 
pressure, and each point on a line (from left to right) represented the gradient profiles of 4, 2, 1, 

























Figure 3.9. Chromatograms of MassPREP
TM
 E. coli Digestion Standard were collected for 
separations with increasing gradient volume on the 44.1 cm x 75 µm ID column packed with 1.9 
µm BEH C18 particles. Separations were completed at 15 kpsi. Though the chromatograms were 
very busy, an increase in resolution was observed as gradient volume increased which was 
indicated by the signal being closer to baseline between two adjacent peaks.   
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Figure 3.10. Chromatograms of MassPREP
TM
 E. coli Digestion Standard were collected for 
separations with increasing pressure and flow rate on the 44.1 cm x 75 µm ID column packed 
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Figure 3.11. The peptide and protein identifications for E. coli were plotted versus the separation 
window and peak capacity for several separations on a 44.1 cm x 75 µm ID column with 1.9 µm 
BEH C18 particles. Each line represents a different running pressure, and each point on a line 
(from left to right) represented the gradient profiles of 4, 2, 1, or 0.5 percent change in mobile 
























































































Figure 3.12. Protein identifications per minute or productivity was plotted for the E. coli protein 
identifications from analyses at varying gradient volumes and pressures on the 44.1 cm x 75 µm 
ID column with 1.9 µm BEH C18 particles. Productivity was highest for the steepest gradient 
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Figure 3.13. Chromatograms of MassPREP
TM
 Digestion Standard Protein Expression Mixture 2 
were collected for separations with increasing pressure on a short and long column. The 
separation time was similar for the 98.2 cm x 75 µm ID column and 44.1 cm x 75 µm ID column 
packed with 1.9 µm BEH C18 particles. The insert of a representative peptide peak with 724 m/z 
extracted from both chromatograms showed the decrease in peak width and constant signal 














98.2 cm Length, 3.5 µL Column Volume 
2% Change per Column Volume
15 kpsi
44.1 cm Length, 1.6 µL Column Volume 
1% Change per Column Volume
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Figure 3.14. The increasing peak capacity versus separation window plot demonstrated the 
benefit of using higher pressures to run longer columns in the same amount of time as shorter 
columns. The red line represented separations at 15 kpsi on a 44.1 cm x 75 µm ID column with 
1.9 µm BEH C18 particles. The blue line represented separations at 30 kpsi on a 98.2 cm x 75 
µm ID column with 1.9 µm BEH C18 particles. The gray line represented separations on a 
commercial UPLC with a commercial column (25 cm x 75 µm ID column with 1.9 µm BEH C18 
particles). Each point on a line (from left to right) represented the gradient profiles of 4, 2, 1, or 
















98 cm x 75 µm, 1.9 µm BEH C18
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Figure 3.15. Chromatograms of MassPREP
TM
 E. coli Digestion Standard were collected for 
separations with increasing gradient volume on the 98.2 cm x 75 µm ID column packed with 1.9 
µm BEH C18 particles. Separations were completed at 30 kpsi. Though the chromatograms were 
very busy, an increase in resolution was observed as gradient volume increased which was 
indicated by the signal being closer to baseline between two adjacent peaks. These were the 





Figure 3.16. This chromatogram of MassPREP
TM
 E. coli Digestion Standard from the 98.2 cm x 
75 µm ID column packed with 1.9 µm BEH C18 particles is a zoomed in version of the purple 
chromatogram in Figure 3.15. The return of signal to baseline between several adjacent peaks 
demonstrated the gain in resolution from using long columns at elevated pressures and 




   
 
Figure 3.17. The peptide and protein identifications for E. coli were plotted versus the separation 
window in parts a and b, respectively. The red line represented separations at 15 kpsi on a 44.1 
cm x 75 µm ID column with 1.9 µm BEH C18 particles. The blue line represented separations at 
30 kpsi on a 98.2 cm x 75 µm ID column with 1.9 µm BEH C18 particles. The gray line 
represented separations on a commercial UPLC with a commercial column (25 cm x 75 µm ID 
column with 1.9 µm BEH 18 particles). Each point on a line (from left to right) represented the 







































98 cm x 75 µm, 1.9 µm BEH C18
 30 kpsi,   330 nL/min
44 cm x 75 µm, 1.9 µm BEH C18
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25 cm x 75 µm, 1.9 µm BEH C18




Figure 3.18. The NDPC comparing the analysis on the 98.2 cm column run at 30 kpsi to the 44.1 
cm column run at 15 kpsi for a 360 min gradient was plotted for each protein identified in an E. 
coli digest standard. If a protein was identified with higher sequence coverage with the 
separation on the 98.2 cm column, its NDPC value was positive (blue bars). The red bars 
signified higher coverage with the separation on the 44.1 cm column. Proteins with higher 
coverage were plotted on the left, and proteins with lower coverage were on the right. 
Differences in coverage were minimal for highly covered proteins. As protein coverage 
decreased, more proteins were identified with higher coverage with the separation on the 98.2 cm 




Figure 3.18. (continued) 
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Figure 3.19. The NDPC comparing the analysis on the 98.2 cm column run at 30 kpsi to the 44.1 
cm column run at 15 kpsi was plotted for each protein identified in an E. coli digest standard 
separated with a for a 90 min (part a), 180 min (part b), and 360 min (part c) gradient . If a 
protein was identified with higher sequence coverage with the separation on the 98.2 cm column, 
its NDPC value was positive (blue bars). The red bars signified higher coverage with the 
separation on the 44.1 cm column. Proteins with higher coverage were plotted on the left, and 
proteins with lower coverage were on the right. Differences in coverage were minimal for highly 
covered proteins. As protein coverage decreased, more proteins were identified with higher 








Figure 3.20. Chromatograms of MassPREP
TM
 Digestion Standard Protein Expression Mixture 2 
were collected for separations with increasing gradient volume on the 39.2 cm x 75 µm ID 
column packed with 1.4 µm BEH C18 particles. Separations were completed at 30 kpsi. The 
insert of a representative peptide peak with 724 m/z extracted from all four chromatograms 







Figure 3.21. Chromatograms of MassPREP
TM
 Digestion Standard Protein Expression Mixture 2 
were collected for separations with increasing gradient volume on the 28.5 cm x 75 µm ID 
column packed with 1.1 µm BEH C18 particles. Separations were completed at 30 kpsi. The 
insert of a representative peptide peak with 724 m/z extracted from all four chromatograms 
showed the increase in peak width and decrease in peak height as the as gradient volume 
increased. These were the fasted separations demonstrated in this manuscript. The gain in speed 






Figure 3.22. The increasing peak capacity versus separation window plot demonstrated the 
difference in performance for columns with different particle sizes. The red line represented 
separations at 30 kpsi on a 39.2 cm x 75 µm ID column with 1.4 µm BEH C18 particles. The 
blue line represented separations on a 98.2 cm x 75 µm ID column with 1.9 µm BEH C18 
particles. The green line represented separations on a 28.5 cm x 75 µm ID column with 1.1 µm 
BEH C18 particles. The gray line represented separations on a commercial UPLC with a 

















 98.2 cm x 75 um, 1.9 µm BEH 30kpsi
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Figure 3.23. The peak capacity versus separation window plot compared the highest peak 
capacities demonstrated in this manuscript, as obtained with the 98.2 cm x 75 µm ID column 
with 1.9 µm BEH C18 particles, separations on the commercial nanoAcquity and several data 





). The data presented in this manuscript achieved higher peak capacities in 
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CHAPTER 4. Study of Peptide Stability in RPLC Mobile Phase at Elevated 
Temperatures and Pressures 
4.1 Introduction 
Proteomics samples are very diverse coming from a variety of organisms with different 
genomes and expressed phenotypes.
1
 Biological samples contain many different proteins with 
different post-translational modifications.
2,3
 Due to sample complexity, a separation with high 
peak capacity is required prior to analysis by mass spectrometry.
4,5
  
As shown in Chapter 3, much higher peak capacities could be achieved through the use of 
long microcapillary columns packed with sub-2 micron particles. These separations took up to 10 
hours and required elevated temperatures and pressures to achieve reasonable flow rates and 
dead times. The higher peak capacity, afforded by the modified UHPLC described in Chapter 3, 
yielded protein identifications and coverage much greater than that from a standard UPLC with a 
commercial column.  
During development of a liquid chromatographic method, stability of the sample on the 
column is an important parameter to investigate. Several variables that can affect analyte stability 
are time on the column, temperature, pressure and mobile phase composition.
6,7
 Peptide stability 
has not been previously investigated for the extreme liquid chromatography conditions described 
in Chapter 3.  
Based on the reports of other biological assays, the following degradation pathways may 








 Peptide bond 
hydrolysis is the only degradation pathway, from the previous list, that disrupts the peptide back 
 137 
bone. The c-terminal side of serine, threonine, and asparagine are more susceptible to hydrolysis. 
Under acidic conditions, the rate of hydrolysis greatly increases. 
8
  
Many RPLC-MS methods have formic acid in the mobile phase which reduces the pH to 
less than 3. Formic acid is added because it neutralizes acidic analytes increasing their retention 
factor.
14
 The presence of formic acid in the mobile phase may also formylate of the N-terminus 
of the peptide resulting in a mass shift of +28 Da.
15
  
Deamidation is a common post-translational modification that may occur endogenously to 
asparagine and glutamine residues. The reaction begins with protonation of the amine group 
before it is hydrolyzed to form a free carboxylic acid.
16
 The side group changes from –NH2 
(16 Da) to –OH (17 Da) which results in a mass shift of +1 Da.17 Evidence of deamidation, as a 
result of sample processing, was observed after several days according to the literature. Exposure 
to elevated temperatures increases the reaction rate. However, the referenced study aged the 
peptide in a buffer similar to physiological conditions (0.1 M phosphate buffer, pH 7, 37°C),
10
 
and it is unknown how fast deamidation will occur in RPLC conditions.  
Methionine and histidine are very susceptible to oxidation. Methionine can be converted to 
methionine sulfoxide or methionine sulfone through the addition of one or two oxygen atoms, 
respectively. Histidine residues can be oxidized to 2-oxo-histidine.
18
 A mass shift of +16 Da is 
observed for the addition of each oxygen atom. To minimize the presence of oxygen and 
oxidation catalysts in the analytical method, mobile phases are degassed,
19
 and ultra-pure 
(Optima LC-MS grade) solvents are used.
20
 Due to the increased reaction rate at high 
temperatures and the likelihood of oxidation occurring endogenously, this modification is often 




On-column stability will differ from peptide to peptide making it impossible to predict and 
observe all possible degradation products.
6
 To get a general idea of analyte stability, we exposed 
several standard protein digests to elevated temperatures and pressures mimicking the on-column 
conditions for the modified UHPLC described in Chapter  3. The stressed samples were analyzed 
by a fast LC-MS method and compared to a control. Exposure of the sample to high pressure (45 
kpsi) resulted in no significant variability in the intensity of the identified peptides. Storage for 
more than two hours in an acidic, highly aqueous mobile phase at high temperature (>45°C) 
generated impurity peaks in the chromatogram. No significant difference was observed between 
the samples stored up to 45°C for 10 hours in mobile phase and the control. It should be noted 
that this is a limited study, and on-column sample stability should always be reassessed for 
samples and methods not investigated in this chapter.  
4.2 Materials and method 
4.2.1 Materials 
Optima grade water  + 0.1% formic acid and acetonitrile + 0.1% formic acid were 
purchased from Fisher Scientific (Fair Lawn, NJ). MassPREP
TM
 Digestion Standard: Protein 
Expression Mixture 2 (Standard, Part #186002866) and enolase digest (Part #186002325) were 
obtained from Waters Corporation (Milford, MA). Argon gas was purchased from Airgas 
(Radnor, PA).   
4.2.2 Sample stability at elevated pressures and temperatures 
Standard 2 was reconstituted according to the product manual with 1 mL water + 0.1% 
formic acid. The modified UHPLC previously described in Chapter 3 was used to store and 
analyze the sample. The gradient was loaded in reverse onto the storage loop followed by 1 µL 
of the sample. The end of the storage loop, closest to the analytical column, was blocked by 
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placing it in the Freeze/Thaw peltier device and closing the high pressure isolation valve as 
portrayed in Figure 4.1.a. The sample was stored for 10 hours in the loop at ambient temperature 
and 45 kpsi. At 10 hours, the peltier valve was thawed, and the fluidic tubing was reconfigured 
for normal running conditions diagramed in Figure 4.1.b. The aged sample was then run at 15 
kpsi and 30°C on a 30 cm x 75 µm column packed with 1.9 µm BEH C18 particles. The nominal 
flow rate was 300 nL/min. The gradient was 4-4 %B in 2  μL followed by a high organic wash 
and equilibration to initial conditions. The column was coupled to a Waters qTOF Premier via 
nanoESI set for data-independent, MS
E
, acquisition with 0.6 scans. The experiment was repeated 
at several different storage conditions as outlined in Table 4.1. 
4.2.3 Sample stability at elevated temperatures 
To test a larger number of storage conditions, enolase digest standard was reconstituted 
as per the manufacturer’s guidelines with 1 mL of 80:20 water:acetonitrile + 0.1% formic acid. 
From the stock solution, 2 aliquots of 200 µL were transferred to separate microcentrifuge vials 
and diluted to a final volume of 1 mL. One aliquot was diluted to a final concentration of 96:4 
water:acetonitrile + 0.1% formic acid to represent the initial conditions of the gradient 
separation. The other aliquot was diluted to a final concentration of 60:40 water:acetonitrile + 
0.1% formic acid to represent the final gradient composition. From each solution, 80 µL portions 
were transferred to individual 1.7 mL polypropylene centrifuge tubes and bedded with argon. 
Samples were stored from ambient temperature to 65° for 2 to 10 hours. See Table 4.2. for a full 
list of sample storage conditions. Samples of diluent (4% and 40% acetonitrile in water + 0.1% 
formic acid) were also stored at 65° for 10 hours. The samples stored in 60:40 water:acetonitrile 
+ 0.1% formic acid were lyophilized and reconstituted with 94:4 water:acetonitrile + 0.1% 
formic acid prior to analysis. All stability samples were transferred to glass Total Recovery 
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autosampler vials (Waters), bedded with Argon and closed with a pre-slit screw cap. Vials were 
stored on the autosampler at 10°C until analysis. The samples were analyzed in triplicate on a 
standard Waters nanoAcquity UPLC operated in trapping mode. Mobile phase A and B were 
water and acetonitrile, respectively, modified with 0.1% formic acid. One microliter of sample 
was injected and trapped on a 2 cm x 180 µm Symmetry C18 column at 0.5% mobile phase B. 
The samples were separated on a 25 cm x 75 µm analytical column packed with 1.9 µm BEH 
C18 particles run at 30°C. The gradient was 4-40% B over 30 minutes at 300 nL/min (7.5 kpsi 
nominal pressure). The column was coupled to a Waters qTOF Premier via nanoESI set for data-
independent acquisition, MS
E
 mode, with 0.6 second scans.  
4.2.4 Peptide data processing 
The LC-MS/MS data were processed using ProteinLynx Global Server 2.5 (Waters). The 
MS
E
 spectra were searched against a database of alcohol dehydrogenase, bovine serum albumin, 
glycogen phosphorylase b, and/or enolase, as appropriate to the sample, and appended with a 1X 
reversed sequence. The amino acid sequences were found from the Uni-Prot protein 
knowledgebase (www.uniprot.org). The false discovery rate was set to 4%. Peptide intensities 
were extracted from the ProteinLynx ion accounting spreadsheet for the standard digest mixture. 
For the enolase standard, manual peak intensities were measured of each identified precursor ion. 
The peak intensities for each stability sample were compared to a freshly prepared sample by the 
2-tailed student’s T test. A significant difference was reported with  5% confidece if the p-value 
was less than 0.05.  
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4.3 Discussion 
4.3.1 Stability testing considerations 
The storage conditions discussed in this chapter aimed to age the samples in an 
environment similar to on-column conditions. To achieve this, the samples had to be stored in 
two different ways: (1) in the storage loop of the UHPLC and (2) in centrifuge tubes. The 
UHPLC storage loop enabled storage of a small sample volume at elevated temperatures and 
pressures. The sample was in a narrow (50 µm) internal diameter silica capillary similar to the 
on-column environment. However, the sample could only be stored in initial mobile phase 
conditions because it was to be subsequently loaded onto the column. Storage in highly organic 
mobile phase would inhibit trapping of the analytes into a narrow band at the head of the column 
and cause peak broadening. Another disadvantage to this storage method was the time 
investment. Only one sample could be stored at a time and other samples could not be run while 
a sample was being stored. Throughput was low allowing analysis of only two samples per day. 
After storage, there was only one chance for analysis. If there was bad electrospray or a clog, for 
example, the sample could not be recovered, and the storage procedure had to restart from time 
zero. For these reasons, it was difficult to test a large variety of stress conditions with replicate 
analyses. Therefore, the UHPLC storage loop method was only used to test sample stability at 45 
kpsi. The offline method was used to evaluate sample stability at high temperatures and in 
solvents with a high organic composition.  
The second method focused on storage at elevated temperatures in high and low percent 
organic solvents. This was an offline method allowing storage at many different conditions at 
once. There were 80 µL of sample stored at each condition which allowed for replicate analysis. 
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To provide conditions closest to on-column, the samples were bedded with argon to remove 
oxygen containing air that may have caused degradation.  
An alternative storage method that was not explored would be to age the samples at high 
pressure in a column packing apparatus followed by off-line analysis. This method would 
consume a lot of sample (about 0.5 mL per condition), and it would be time consuming because 
only one condition can be tested at a time. Also, setting up the apparatus in an oven would be 
difficult. Another concern was that pushing fluid from the pump could contaminate or dilute the 
sample. Therefore, only the UHPLC storage loop and centrifuge tubes were used as vessels to 
age the sample.  
4.3.2 Stability at high pressure 
The chromatograms in Figure 4.2. compare the standard protein digest at initial 
conditions (black) to storage at elevated pressure (red), elevated temperature (blue), and elevated 
temperature and pressure (green) for 10 hours. The initial observation was that there were no 
catastrophic differences between the chromatograms. For both the samples stored at 45 kpsi (red 
and green traces), there were a few extra peaks eluting early in the chromatogram as compared to 
the chromatogram of the unstressed sample (black). For the samples stored at 65ºC (blue and 
green traces), less peaks appeared towards the end of the chromatogram as compared to the 
unstressed sample (black). However, this sort of qualitative and visual comparison of the 
chromatograms was very limited. There were many peaks in the middle of the chromatogram 
that were difficult to compare visually because the chromatogram was crowded in this region. 
4.3.3 Database searching considerations 
To more objectively compare the results, PLGS was used to identify the peaks as specific 
peptides from the Standard Protein Digest. The identifications were useful to track peptide 
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intensities at the different storage conditions. The typical PLGS workflow searches a database of 
tryptic peptides with the following variable post-translational modifications: acetylation of the 
N-terminus; deamidation of asparagine and glutamine; and oxidation of methionine. This peptide 
search would not include many degradation products formed during exposure to stress 
conditions. Therefore, additional digestion sights and peptide modifications were added to the 
workflow. These modifications were based on the predicted degradation pathways discussed in 
the introduction: formylation of the N-terminus due to formic acid in the mobile phase, 
asparagine and glutamine deamidation, and methionine and histidine oxidation. In addition to 
tryptic cleavage at arginine and lysine, cleavage at serine, threonine, and asparagine was also 
added to the search options because these residues are susceptible to hydrolysis under acidic 
conditions and high temperatures.  
4.3.4 Venn diagram comparison 
The similarities in peptide identifications were compared between the stressed and 
control samples in Figure 4.3. As a benchmark, the control sample was analyzed in duplicate. 
Run 1 and 2 identified 171 and 176 peptides, respectively, with 151 of those peptides identified 
in both replicates. The percent overlap of identifications was calculated as follows: 
% overlap   
2 number ofoverlapping peptides identifications
total number of peptide identifications 
 1    (4-1) 
% overlap  
2(151)
(1 1 1 6)
 1     8 % (4-2) 
The overlap of 151 peptide identifications correlated to 87% of the results (Figure 4.3.a.). 
A similar number of identifications and percent overlap is seen in Figure 4.3.b. for the 
comparison of the control to the sample stored at 45 kpsi and ambient temperature for 10 hours. 
The overlap was 150 identifications (86%) with 176 peptides identified in the sample stored at 
high pressure. When comparing the control to the samples stored at elevated temperatures, 
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similarities in peptide identifications decreased. For the sample stored at 65ºC and ambient 
pressure for 10 hours, peptide identifications reduce to 125 with only 96 identifications (65%) 
overlapping with the control (Figure 4.3.c). When the sample was stored at 65ºC and 45 kpsi for 
10 hours, only 118 peptides were identified with 101 peptides (70%) also identified in the control 
(Figure 4.3.d). From these comparisons, it was evident that exposure to high pressure did not 
change the number or identify of peptides in the sample but exposure to elevated temperature for 
10 hours did change the sample.  
4.3.5 Peptide intensity comparison 
Changes in peptide intensities were also used as a metric for measuring sample stability. 
Results from the database search provided the precursor peak intensity for each identified 
peptide. To determine if a change in peptide precursor intensity was significant, the change had 
to be larger than that due to analytical variability. The analytical variability was assessed by 
plotting the log precursor intensities from the control sample to a replicate analysis in Figure 4.4. 
Dots close to the dashed y=x line represent peptide peaks with little variability between the two 
analyses. To describe variability from the y=x line, colored lines are drawn with the formula 
y=mx+b, where b was a constant level of uncertainty, and the m factor accounted for uncertainty 
relative to signal intensity (x). The mirror lines are also plotted across the y=x line. Several 
arbitrary values for m and b were selected for this equation as listed in the figure legend. Beside 
each equation in the legend is a percentage which corresponds to the number of points that are 
contained within these confidence curves. The greens lines, which plot y=1.3x+10
4.6
, contained 
94.4% of the points. When comparing two analyses, we expect a minimum of 94.4% of the data 
points to fall within these green lines. A smaller value would indicate changes in intensity due to 
factors other than analytical variability. Figure 4.5. compares the sample stored at high pressure 
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(45 kpsi) and ambient temperature to the control. Peptide intensities are relatively symmetrical 
around the y=x line with 95.2% of the data points falling between the confidence lines. This 
percentage is better than that measured for analytical variability which indicates no change in 
peptide intensity from storage at 45 kpsi for 10 hours. Figure 4.6. compares the high temperature 
(65ºC)/ambient pressure sample to the control. Slightly less of the data, 91.5%, was within the 
confidence curves. When a sample stored at elevated temperature (65ºC) and pressure (45 kpsi) 
was compared to the control, 88.8% of the points were contained within the confidence curves 
(Figure 4.7.). For Figure 4.6 and Figure 4.7., most of the variability occurs from data points 
falling below the y=x line which indicates a decrease of intensity for peptides in the elevated 
temperature sample.  
Though this study had a small sample size, it indicated that temperature is a larger factor 
than pressure in sample stability. Therefore, a more thorough study was completed looking at 
stability of peptides stored in mobile phase at elevated temperatures.  
4.3.6 Temperature degradation study 
As stated earlier, storage in the sample loop was time consuming. To test more 
temperatures, exposure times, and mobile phase compositions, an offline approach was 
implemented. Also a simpler sample, enolase digest, was used to make it easier to track peaks. 
The samples were stored in 96:4 and 60:40 water:acetonitrile + 0.1% formic acid to match 
mobile phase compositions at the beginning and ending of the gradient. Blank solutions were 
also stored to determine if degradation products were being formed from the polypropylene 
microcentrifuge tubes used as storage containers. Every sample was run in triplicate and 
compared to the control. Stability was determined if the peak intensities were not calculated to be 
significantly different with a 95% confidence by a 2-tailed student’s T test.  
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In the enolase control sample A, 19 peptide peaks were identified. The values in Table 
4.3. list the number of significantly different peak intensities for the sample stored in 4% mobile 
phase B at 25, 35, 45, 55, and 65°C for 2, 4, 6, 8, and 10 hours. Most peptide peaks do not have 
significantly different intensities when stored at any temperature for 6 hours. After 8 and 10 
hours, many more peptides have significantly different intensities. About 6-7 peaks, or 35% of 
all identifications, have differential intensities.  
The samples stored in high organic mobile phase were compared to a different control 
sample, namely control sample B. This was necessary to account for any changes happening to 
the sample through sample preparation. There was interest in degradation occurring from 
exposure to high organic mobile phase at elevated temperatures. However, the high organic had 
to be removed by lyophilization before analysis which may modify the sample. Therefore, 
control sample B was prepared in 40% mobile phase B, lyophilized and reconstituted in 4% 
mobile phase B. In this control sample, 13 peptide peaks were identified. The number of 
significantly different peak intensities is listed in Table 4.4. for the enolase digest sampled stored 
in 40% mobile phase B at elevated temperatures for a period up to 10 hours. Most of the 13 
identified peptide peaks do not have significantly different intensities when stored at any 
temperature for 6 hours. After 8 hours at 65°C, a couple more peptides have significantly 
different intensities. At this extreme condition, two to three peaks, or 19% of all identifications, 
had significantly different intensities. 
The data was further mined for peptides with significantly different intensities. These 
were all identified to be tryptic peptides with no posttranslational modifications corresponding to 
possible degradation products. 
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A visual inspection was completed of all chromatograms to check for degradation peaks 
that were not identified by PLGS. In both the 4% and 40% organic samples, two additional peaks 
appeared in the chromatograms when stored at 55°C and 65°C. A third peak was observed in the 
4% organic sample stored at 55°C and 65°C. The retention times and mass-to-charge ratios for 
these peaks are listed in Table 4.5. These peaks were not found in the control samples but two 
peaks (460.4 and 780.9 m/z) were observed in the chromatogram in Figure 4.8. of the blank 
sample stored at 55°C and 65°C. It is therefore concluded that these peaks are from the 
degradation of the polypropylene microcentrifuge tubes and not from enolase peptide 
degradation. The 199.1 m/z peak appeared when the enolase digest standard was stored in 4% 
mobile phase B for extended periods of time. The intensity of this peak (199.1 m/z) is plotted 
versus time exposed to 4% mobile phase B at elevated temperature in Figure 4.9. This peak 
appeared above baseline when the sample was stored above 45°C. This peak is not observed 
when the sample was stored in 40% mobile phase B.  
4.3.7 Sources of analytical variability  
Some sources of the previously mentioned analytical variability will be discussed. 
Electrospray instability may lead to random error in peak intensities. Over time the spray will 
begin to flutter reducing the ionization efficiency. A poor spray will lead to reduced peak 
intensities. After ionization, the analyte is fragmented in the mass spectrometer during MS
E
, 
data-independent acquisition. In this type of experiment, the mass analyzer voltage is ramped 
causing more collision induced fragmentation. These are randomly timed events which lead to 
variability of ion intensity. The variability of intensity can lead to variability in the protein 
database search. A higher intensity leads to a higher probably of the peak being assigned to a 
peptide for identification. Reduced intensities may lead to the probability falling below the 
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threshold necessary to confidently assign the peak to a peptide. Efforts were taken to reduce the 
analytical variability but the results indicate that some is present.  
4.4 Conclusion 
Through the studies conducted in this Chapter, it is concluded that the exposure of peptides 
to ultrahigh pressures, up to 45 kpsi, did not cause measurable degradation. Exposure to elevated 
temperatures greater than 45°C in an acidic mobile phase environment for an excess of two hours 
may cause sample degradation. For separations greater than two hours, the column temperature 
should be no greater than 45°C. On-column degradation may occur at any temperature after 6 
hours. These conclusions were made based on variability in peptide identifications and precursor 
peak intensities in excess of that observed from analytical variability.  
The implementation of elevated pressures and temperatures increases peak capacity 
without increasing analysis time (Chapter 3). This research supports the use of elevated pressures 
and temperatures for proteomics analysis but recommends that on-column time does not exceed 
two hours for temperature greater than 45°C, or column temperature should not exceed 45°C for 






Ambient Ambient (25°C) 
Ambient 65°C 
45 kpsi Ambient (25°C) 
45 kpsi 65°C 
 
Table 4.1. To assess the stability of peptides at elevated pressures and temperatures, the 
MassPrep standard protein digest was storage for 10 hours at the conditions listed in this table. 
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Temperature  Time (h) 
(°C)  2 4 6 8 10 
25  X X X X X 
35  X X X X X 
45  X X X X X 
55  X X X X X 
65  X X X X X 
 
Table 4.2. To assess the stability of peptides at elevated temperatures for 2-10 hours, the enolase 
digest standard was storage at the conditions marked by an “X” on this table.   
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Temperature  Time (h) 
(°C)  2 4 6 8 10 
25  0 3 1 4 7 
35  1 1 0 4 6 
45  2 1 0 3 6 
55  2 0 0 0 7 
65  1 1 2 0 2 
 
Table 4.3. The number of significantly different peak intensities are listed for the enolase digest 
sample stored in 4% mobile phase B at 25, 35, 45, 55, and 65°C for 2, 4, 6, 8, and 10 hours. 
Intensities were compared to the unstressed, control sample A in which 19 peptide peaks were 
identified. Most of the identified peptide peaks do not have significantly different intensities 
when stored at any temperature for 6 hours. After 8 and 10 hours, many more peptides have 
significantly different intensities. At these extreme conditions, about 6-7 peaks, or 35% of all 
identifications, have significantly different intensities.  
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Temperature  Time (h) 
(°C)  2 4 6 8 10 
25    1 1 1 2 
35    4 1 1   
45  1   1     
55  1 1 1 1   
65  1 1 1 3 2 
 
Table 4.4. The number of significantly different peak intensities are listed for the enolase digest 
sample stored in 40% mobile phase B at 25, 35, 45, 55, and 65°C for 2, 4, 6, 8, and 10 hours. 
Intensities were compared to the unstressed, control sample B in which 13 peptide peaks were 
identified. Most of the identified peptide peaks do not have significantly different intensities 
when stored at any temperature for 6 hours. After 8 hours at 65°C, a couple more peptides have 
significantly different intensities. At this extreme condition, two to three peaks, or 19% of all 
identifications, had significantly different intensities.  
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Sample Retention Time (min) m/z 
4% Mobile Phase B 28-31 199.1 
4% and 40% Mobile Phase B 35.0 460.4 
4% and 40% Mobile Phase B 36.2 780.9 
 
Table 4.5. The retention times and mass-to-charge ratios (m/z) are listed for peaks that appeared 
after the enolase digest was stored in the indicated sample solution. The 199.1 m/z peak appeared 
when the enolase digest standard was stored in 4% mobile phase B for extended periods of time 
above 45°C. This peak is not observed when the sample was stored in 40% mobile phase B. The 
other two peaks were degradation products extracted from the polypropylene microcentrifuge 








Figure 4.1. The instrument diagram (a) shows the fluidic configuration for sample storage at 
elevated pressures and temperatures. Part (b) shows the fluidic configuration for gradient/sample 
loading and sample analysis. For gradient/sample loading, all valves were opened except the 
nanoAcquity vent valve. For sample storage and analysis, all valves were closed except the 
nanoAcquity vent valve. The haskel pump and column heater were regulated to the desired 
pressure and temperature to stress the sample. During analysis, the haskel pump and column 
heater were regulated to 15 kpsi and 30°C.  






Figure 4.2. These chromatograms were from the analysis of the standard protein digest stored in the gradient storage loop. Storage 
conditions are listed above each chromatogram. 
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a 
Control Run 1  Control Run 2 
Ambient Temperature Ambient Temperature 
Ambient Pressure Ambient Pressure 
0 hours 0 hours 




 20 151 25 
 b 
Control Run 1  High Pressure 
Ambient Temperature Ambient Temperature 
Ambient Pressure 45 kpsi 
0 hours 10 hours 




 21 150 26 
c 
Control Run 1  High Temperature 
Ambient Temperature  65ºC 
Ambient Pressure Ambient Pressure 
0 hours 10 hours 




 75 96 29 
 d 
Control Run 1  High Temperature and Pressure 
Ambient Temperature  65ºC 
Ambient Pressure 45 kpsi 
0 hours 10 hours 




 70 101 17 
 
Figure 4.3. These Venn diagrams show the similarities in peptide identification for the standard 
protein digest control sample compared to a replicate analysis and to analysis of the sample 





Figure 4.4. The log peptide intensities are plotted comparing two replicate analyses of the 
control standard protein digest. The confidence lines drawn on the graph are used to describe the 
scatter from the dashed y=x line due to analytical variability. The formulas for each line and the 





Figure 4.5. The log peptide intensities are plotted for the standard protein digest stored at 45 kpsi 
and ambient temperature for 10 hours compared to the control. As listed in the legend, 95.2% of 
the data points are contained within the green lines. This percentage is greater than that expected 
due to analytical variability which indicates no change in peptide intensity from storage at 
45 kpsi for 10 hours.   
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Figure 4.6. The log peptide intensities are plotted for the standard protein digest stored at 65°C 
and ambient pressure for 10 hours compared to the control. As listed in the legend, 91.5% of the 
data points are contained within the green lines. This percentage is less than that expected due to 
analytical variability. Most of the variability occurs from data points falling below the y=x 
dashed line which indicates a decrease of intensity for peptides in the elevated temperature 
sample.   
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Figure 4.7. The log peptide intensities are plotted for the standard protein digest stored at 65°C 
and 45 kpsi for 10 hours compared to the control. As listed in the legend, 88.8% of the data 
points are contained within the green lines. This percentage is less than that expected due to 
analytical variability. Most of the variability occurs from data points falling below the y=x 




Figure 4.8. These red and blue chromatograms are from the analysis of the enolase digest 
control and stress sample stored at 65°C for 10 hours. Feature A (199.1 m/z) is a degradation 
peak that appeared when enolase was stored in 4% mobile phase B at elevated temperatures. The 
green chromatogram of mobile phase stored in the polypropylene microcentrifuge tubes at 65°C 
for 10 hours shows that peak B (460.4 m/z) and peak C (780.9 m/z) were extracted from the tube 





Figure 4.9. The intensity is plotted versus storage time for a degradation peak (199.1 m/z) that 
appeared when the enolase digest standard was stored in 4% mobile phase B for extended 
periods of time. This peak appeared when the sample was stored above 45°C. This peak is not 
observed when the sample was stored in 40% mobile phase B.
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CHAPTER 5. Prefractionation Frequency Study with a 32 kpsi UHPLC for the 
Multidimensional Separation of the Saccharomyces cerevisiae Proteome 
5.1 Introduction 
Studying the proteome gives understanding to the biological pathways that are occurring in 
the cell.
1,2,3
 Due to the large number of protein encoding genes (6000 for S. cerevisiae),
4
 
separation of the components in a biological mixture is required before analysis.
5
 There is no 
single dimension separation with the peak capacity necessary to completely resolve all the 
components of a cell lysate.
6
 Multidimensional separations have commonly been used to provide 
more peak capacity.
7,8
 According to Giddings, the peak capacity of a multidimensional 
separation is the multiplicative product of the peak capacities of the individual separations if the 
separations are orthogonal and resolution is not lost in coupling the separations.
9
 For resolution 
to be preserved, the second dimension would have to be faster than practically possible in liquid 
chromatography (LC), or the first dimension would have to be extremely slowed down. 
Therefore, fractionation of the first dimension is often necessary when coupling two columns. 
The peak capacity of the first dimension then becomes the number of fractions. In order to 
reduce the loss of peak capacity caused by fractionation, the second dimension should have the 
greater peak capacity of the two separations.
10,11
 
5.1.1 Prefractionation frequency 
The peak capacity of the first dimension separation could be increased by taking more 
fractions. However, higher prefractionation frequencies increase the analysis time and increase 
the probability of splitting a peak across multiple fractions.
12
 Peak splitting dilutes the analyte 
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and lowers the limit of detection.
13
 From the study of prefractionation frequency in Chapter 2, 
we learned that protein identifications plateaued when 20 or more fractions were taken.  
5.1.2 Separations at elevated pressures and temperatures 
Therefore, it is necessary to pursue solutions for increasing the peak capacity of the 
second dimension. For liquid chromatography, ultrahigh performance LC (UPLC) has enabled 
the use of microcapillary columns with sub-2 micron particles which have greater peak capacity 
than standard bore columns.
14
 However, the pressure capabilities of the pump on a standard 
UPLC limit the dimensions of commercial columns resulting in a maximum peak capacity of 200 
in 90 minutes. In Chapter 3, new LC instrumentation with a constant pressure, high temperature 
approach for peptide separations was introduced. The system modified a standard UPLC with a 
pneumatic amplifier through a configuration of tubing and valves for separations up to 
45000 psi. For a peptide analysis, the modified UHPLC, coupled to a qTOF Premier, produced a 
peak capacity of 500 in 90 minutes on a meter-long microcapillary column packed with sub-2 
micron particles. Peak capacity plateaued above 800 in 12 hours. Several columns of varying 
lengths, packed with particles ranging from 1.1-1.  μm, were characterized on the modified 
UHPLC. For faster analysis, higher peak capacities and protein identifications were realized 
when running an aggressive gradient on a long column with 1.  μm particles than a shallower 
gradient on a shorter column with smaller particles. The peak capacities produced with the 
modified UHPLC were greater than that previously reported in the literature.
15,16
 
Separations at higher temperatures reduce the viscosity of the mobile phase. Therefore, 
longer columns can be used without reducing flow rate and increasing analysis time at a given 
pressure. The higher temperatures also reduce the change in mobile phase viscosity throughout 
the gradient on a constant pressure system.
17,18,19
 The resistance to mass transfer is reduced at 
 167 
high temperatures which flattens the C-term portion of a Van Deemter plot and consequently 
shifts optimal velocity to a higher value.
20
 The stability of the analyte, exposed to elevated 
pressure and temperatures, was assessed in Chapter 4. Exposure of peptides to ultrahigh 
pressures, up to 45 kpsi, did not show evidence of degradation. Peptide stability in acidic 
reversed-phase LC solvents was confirmed for up to 2 hours at 65°C and for up to six hours at 
45°C.  
5.1.3 Orthogonality through prefractionation 
For proteomics separations, benefits of the top-down (protein) and bottom-up (peptide) 
strategies are often debated.
21
 Commonly, proteins are digested into peptides prior to analysis to 
increase the solubility of the analyte.
22
 However, the sample is now more complex because there 
are numerous peptides for each protein.
23
 Also, an inference problem occurs with the rebuilding 
of a protein from the spectral data.
24
 The same peptide sequence may exist in two different 
proteins, and it is difficult to determine to which protein the peptide should be assigned. Even 
with these challenges, the bottom-up approach is more commonly practiced due to the greater 
solubility of protein digests.
25
 
More recently, a prefractionation approach has been implemented in which the intact 
proteins are fractionated by the first dimension separation, and fractions are enzymatically 
digested prior to analysis by LC-MS.
26,27
 Experimentally, prefractionation methods are more 
orthogonal than other multidimensional separations because the sample is completely changed 
via digestion between separations.
28
 Digestion, most commonly by trypsin, between the 
separations enables the use of reversed-phase columns in both dimensions which tend to have 
higher peak capacity than other LC separation modes such as ion exchange and size exclusion 
chromatography.
29
 As opposed to bottom-up 2DLC experiments where peptides from a single 
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protein may be spread over the entire chromatogram, peptides from a single protein are confined 
to a single fraction easing computational requirements. This may reduce the protein inference 
problem in which a single peptide may be mistakenly assigned to multiple proteins.
24
  
5.1.4 Equal-mass prefractionation 
The practical 2D peak capacity increases if each fraction contains the same amount of 
protein. The summed absorbance from the first dimension chromatogram is an appropriate guide 
for determining equal-mass prefractionation (Chapter 2). The efficiency of the digestion can also 
be increased with equal-mass fractionation as shown in this chapter. For most prefractionation 
experiments, the enzyme to protein ratio is determined by assuming that the total protein loaded 
onto the first dimension column was evenly distributed amongst the fractions.
28
 If there is excess 
enzyme, autolysis of trypsin will occur.
30
 Peaks from trypsin peptides dominate the second 
dimension chromatograms for these fractions (Chapter 2). A low enzyme to protein ratio 
increases the probability that proteins are not fully digested.
31
 A poor digestion leads to poor 
amino acid sequence coverage of the protein and the inability to detect the protein.
23
  
The scope of this chapter was to couple prefractionation by equal-mass with the modified 
UHPLC for the analysis of a model proteome, S. cerevisiae (Baker’s yeast). The effect of 
prefractionation frequency on proteome coverage was assessed. The results were compared to 
separations, of equal-mass fractions, on a standard UPLC as studied in Chapter 2. By 
incorporating the modified UHPLC into the 2D experiment, the number of protein identifications 
and percent sequence coverage increased as compared to the results in Chapter 2. The 
improvement was realized with a lower prefractionation frequency and 2D separation time.  
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5.2 Materials and method 
5.2.1 Materials 
Water, acetonitrile, isopropyl alcohol and ammonium hydroxide were purchased from 
Fisher Scientific (Fair Lawn, NJ). Ammonium acetate, ammonium bicarbonate, formic acid, 
trifluoroacetic acid and iodoacetamide were purchased from Sigma-Aldrich Co. (St. Louis, MO).  
Rapigest
TM
 SF acid-labile surfactant and bovine serum album (BSA) digest standard were 
obtained from Waters Corporation (Milford, MA). Dithiothreitol was purchased from Research 
Products International. Water and acetonitrile were Optima LC-MS grade, and all other 
chemicals were ACS reagent grade or higher. The harvest and lysis of the S. cerevisiae on 
glycerol was previously described in Chapter 2.  
5.2.2 Intact protein prefractionation  
The prefractionation of intact proteins, as outlined in Figure 5.1., was performed on a 
4.6 x 250 mm PLRP-S column with 5 µm particles, 300 Å (Agilent, Santa Clara, CA) heated to 
80 °C. Four milligrams of total protein were injected onto the column. The mobile phase 
composition and gradient profile is shown in Table 5.1. The separation was followed by UV 
spectrophotometry to give a qualitative chromatogram. The wavelength was set to 214 nm, 
which is the lambda max of the peptide bond.
32
 One-minute wide fractions were collected in 
microcentrifuge tubes, lyophilized and stored at -80°C until further analysis.  
5.2.3 Equal-mass fractionation 
Each absorbance value for the UV chromatogram was summed with all previous 
absorbance values from 10 to 48 minutes which corresponded to the time after the injection plug 
and before the wash as follows 





where A = absorbance, t = time, td = dead time, and tg = gradient time.  
The ΣA was normalized and plotted versus the first dimension separation time in Figure 
5.2.a. The y-axis was annotated with hash marks in increments 0.05 which split the axis into 20 
even parts. Lines were drawn from the hash marks on the y-axis to the corresponding x-
coordinate on the normalized ΣA curve. These x-coordinates were used to determine size of the 
first dimension fractions. Each lyophilized one-minute-wide fraction (described in section 5.2.2.) 
was reconstituted in 25 µL of 50 mM ammonium bicarbonate, pH 8. Three microliters of 6.67% 
(w/v)  api est™ SF in buffer were added. Solutions were vortexed, sonicated for 15 minutes, 
and incubated at 80 ºC for 15 minutes to denature the proteins. The solutions were distributed 
into 20 equal-mass fractions, as outlined in Table 5.2.  
5.2.4 Protein digestion 
The digestion is more efficient when carried out in a minimal amount of solvent. 
Therefore, the 20 equal-mass fractions were lyophilized and reconstituted in 25 µL of 50 mM 
ammonium bicarbonate. Three microliters of 6.67% (w/v) RapiGest™ SF in buffer were added. 
Solutions were vortexed, sonicated for 15 minutes, and incubated at 80 ºC for 15 minutes to 
denature the proteins. The proteins were reduced by adding 1 µL of 100 mM dithiothreitol, 
vortexed, sonicated for 5 minutes, and incubated for 30 min at 60ºC. Proteins were then alkylated 
with 1 µL of 200 mM iodoacetamide, vortexed, sonicated for 5 minutes, and stored protected 
from light for 30 min at room temperature. The proteins were then digested by adding 10 µL of 
667 ng/µL TPCK-modified trypsin in 50 mM ammonium bicarbonate (overnight, 37ºC). The 
trypsin concentration was approximated to be a 50:1 (w/w) protein to enzyme ratio if the initial 
protein amount was equally distributed across the 20 fractions. The digestion was quenched and 
the  api est™ SF was degraded using 44 µL  8:1:1 (v:v:v) water:acetonitrile:trifluoroacetic 
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acid (45 min, 37ºC). The fractions were centrifuged for 10 minutes at 14,000 Xg to pellet the 
hydrolyzed surfactant, after which they were ready for analysis. The samples were transferred to 
LC vials and spiked with 1.3 µL of a 1 pmol/L internal standard BSA digest (Waters).   
To form the set of 10 fractions, 20 µL of neighboring pairs of fractions from the set of 20 
was combined, lyophilized, and reconstituted with 10 µL 50 mM ammonium bicarbonate and 10 
µL 98:1:1 (v:v:v) water:acetonitrile:trifluoroacetic acid. Likewise, the set of 5 fractions was 
formed by combining 20 µL of every 4 consecutive fractions from the set of 20, lyophilizing, 
and reconstituting with 10 µL 50 mM ammonium bicarbonate and 10 µL 98:1:1 (v:v:v) 
water:acetonitrile:trifluoroacetic acid. All fractionation schemes are outlined in Table 5.2 and 
depicted in Figure 5.2. 
5.2.5 Peptide analysis by UHPLC-MS/MS  
Each fraction was analyzed in duplicate by capillary RPLC-MS/MS using the UHPLC 
system described in Chapter 3 coupled to a QTOF Premier MS. Mobile phase A was Optima 
Grade water with 0.1% formic acid (Fisher), and mobile phase B was Optima-grade acetonitrile 
with 0.1% formic acid (Fisher). Two microliters of the sample were pre-concentrated at the head 
of a 110 cm x 75 µm, 1.9 µm BEH C18 column with 0.5% mobile phase B, and then separated 
with a 25 µL gradient from 4-40%B followed by a wash at 85%B and equilibration at initial 
conditions (Table 5.3). The column was run at 32 kpsi and 65°C to produce a 300 nL/min flow 
rate. The outlet of the RPLC column was connected via a 30 cm x 20 µm ID piece of fused silica 
capillary to an uncoated fused silica nanospray emitter with a 20 µm ID and pulled to a 10 µm 
tip (New Objective, Woburn, MA) operated at 2.6 kV. Data-independent acquisition, or MS
E
 
scans, was performed with the instrument set to acquire parent ion scans from m/z 50-1990 over 
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0.6 sec at 5.0 V. The collision energy was then ramped from 15-40 V over 0.6 sec with 0.1 sec 
interscan delay.  
5.2.6 Peptide data processing 
The peptide LC-MS/MS data were processed using ProteinLynx Global Server 2.5 
(Waters). The MS
E
 spectra were searched against a database of known yeast proteins from the 
Uni-Prot protein knowledgebase ( www.uniprot.org) with a reversed sequence appended to the 
end. The false discovery rate was set to 100% to yield data compatible for further processing. 
After the database search was complete, the results were imported into Scaffold 4.2.0 
(Proteome Software, Portland, OR). The minimum protein probability and peptide probability 
filters were set to a 5% false discovery rate, and the minimum number of peptides required for 
protein identification was set to 3. Peptides matching multiple proteins were exclusively assigned 
to the protein with the most evidence. The spectral counts for each peptide assigned to a protein 
were summed to give the quantitative value of that protein. The value was normalized by 
multiplying the average total number of spectra, for all yeast samples grown on the same media, 
divided by the individual sample’s total number of spectra.33,34  
5.3 Discussion 
5.3.1 Protein identifications 
By combining the prefractionation techniques studied in Chapter 2 with the new UHPLC 
developed in Chapter 3, the return on protein identifications per unit time was greatly increased. 
In Figure 5.3, the number of protein identifications versus number of fractions is plotted for each 
prefractionation experiment. The number of fractions is proportional to the separation time as 
each fraction had a 1.5 hour retention window. The red line shows the improvement for equal-
mass fractionation versus equal-time fractionation (blue line) as was discussed in Chapter 2. The 
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green line demonstrates the improvement in protein identifications when UHPLC with a 110 cm 
long column was employed for the second dimension separation. The set of 5 fractions analyzed 
on the long column identified 472 proteins which exceeded the number of proteins identified by 
the analysis on the standard system even with increased first dimension fractionation. When first 
dimension sampling was increased to 10 fractions, 701 proteins were identified. The number of 
identifications leveled off at 20 fractions with 776 protein identifications. With the ability to 
operate at higher pressures, the peak capacity gained through the use of a longer column resulted 
in the identification of more proteins with less first dimension fractions and less total separation 
time.  
5.3.2 Analysis time 
To make a fair comparison between the standard UPLC and modified UHPLC system, 
the second dimension separation times had to be similar. This was somewhat difficult as the 
standard system is programmed with a gradient time and constant flow rate whereas the modified 
system is programmed with a gradient volume and constant pressure. The gradient volume was 
25 μL, and modified UHPLC was pressured to 32 kpsi. The measured flow rate was 3   nL/min 
at 65°C and 4% mobile phase B. Because mobile phase composition was changing throughout 
the run, the flow rate was also changing slightly but theoretically by less than 5% as previously 
explained.
17,18,19
 Peaks eluted for 100 minutes as evident by the chromatograms in Figure 5.4.  
Though the separation window was similar for the separation on the modified UHPLC 
and standard UPLC, the total run time for the separations on the modified system was longer. 
The standard system had a trap column to preconcentrate the sample and ultimately reduce the 
injection time. Addition of a trap column to the modified system resulted in band broadening 
which was suspected to occur from mixing in the nano-tee between the trap and analytical 
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column. In the future, the modified system should be engineered to have a total run time more 
comparable to the standard system.  
5.3.3 Increased peptide peak intensity 
Another observation from the 2D chromatograms in Figure 5.4. is that peak intensities 
are much greater with the modified UHPLC. Chapter 3 demonstrated that through the use of long 
columns and elevated pressures, narrower peak widths could be achieved as compared to a 
separation with the standard system. The peptides were focused into narrow peaks which 
contributed to the higher intensity. With increased intensity, more peptide peaks were above the 
limit of detection which contributed to the increase in protein identifications with the modified 
UHPLC system.  
5.3.4 Protein identifications per fractions 
To further discuss the number of protein identifications achieved with the modified 
UHPLC, the number of proteins identified per fraction is plotted in Figure 5.5. for each 
prefractionation frequency. The light gray bars show the total protein identifications in each 
fraction, and the dark gray bars signify the unique protein identifications in each fraction. The 
total protein count was defined as any protein found within a given fraction; thus, if a protein 
were to be found in multiple fractions it would be counted in each fraction. The unique protein 
values count each protein entry only once. Proteins identified in multiple fractions were assigned 
to the fraction in which it was most intense. Though there were few peaks during the beginning 
and end of the first dimension chromatogram, as evident from the overlaid red trace, proteins 
were still identified in the analysis of the peptide digests of these fractions. On average, more 
unique proteins were identified per fraction as prefractionation frequency decreased but total 
proteins identifications per fraction remained constant.  
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To compare the number of proteins identified per fraction with the modified UHPLC to 
that run on the standard system, Figure 5.6, Figure 5.7 and Figure 5.8 should be considered for 
20, 10 and 5 fractions, respectively. In each figure, part (a) shows the protein identifications per 
fraction using the long column at elevated pressures while part (b) shows data collected with the 
standard system. At every fractionation frequency, more proteins were identified per fraction 
especially for the first fraction with the modified UHPLC. The increased peak capacity from 
using the long column at elevated pressure contributed to the increase in protein identifications.  
5.3.5 Protein digestion 
As observed in Figures 5.5 – 5.7, there was a large increase in protein identifications in 
fraction one when the second dimension analysis occurred at 32 kpsi. The increase in 
identifications was greater for this particular fraction due to when the digestion occurred in the 
experimental protocol and due to the incorporation of sonication after each step of the protocol. 
For the samples run on the standard system, digestion occurred before the equal-time fractions 
were combined into equal-mass fractions. For the samples run on the modified system, digestion 
occurred after recombination into equal-mass fractions, and sonication was incorporated 
throughout the digestion protocol. Combining the fractions based on first dimension separation 
data, more evenly distributed the proteins amongst the fractions. Therefore, the enzyme to 
protein ratio was more consistent for each fraction. With a better estimation of this ratio, 
autolysis of the enzyme was less likely in fractions corresponding to less intense first dimension 
peaks. Also, less protein remained undigested in the fractions containing large amounts of 
protein. Sonication aided in the denaturing of proteins which facilitated the delivery of enzyme 
to the digestion sights. Digestion of equal-mass fractions is recommended for future 
prefractionation experiments.  
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5.3.6 Protein molecular weight distribution 
The molecular weight distributions of identified proteins are displayed in in Figure 5.9a 
for the separations at 32 kpsi and Figure 5.9b for the separations at 8 kpsi. The molecular weight 
distribution corresponding to the 5, 10 and 20 fractions are portrayed by the black, gray and 
white bars, respectively. Proteins were identified with molecular weight s up to 250 kDa. For all 
methods, the median molecular weight was 39-40 kDa which was similar to the literature value 
of approximately 42.2 kDa for the S. cerevisiae proteome.
35
 For the fractions run at 32 kpsi, the 
increase in identifications occurred mostly for lower molecular weight proteins, 20-70 kDa.  
The molecular weight chromatograms in Figure 5.10 for 20 (parts a,b), 10 (parts c,d), and 
5 (parts e,f) first dimension fractions plot protein mass on the y-axis and first dimension fraction 
on the x-axis. The log quantitative value for each protein is plotted as a gray-scale intensity in the 
z-direction. The molecular weight chromatograms on the left (Figure 5.10 a,c,e) were from the 
modified UHPLC at 32 kpsi with a 110 cm column, and the chromatograms on the right (Figure 
5.10 b,d,f) were from the standard UPLC at 8 kpsi with a 25 cm commercial column. The 
correlation between protein molecular weight and first dimension fraction was stronger for the 
separations at 32 kpsi. In other words, the later fractions contained proteins with larger molecular 
weights. Larger proteins would have more sites to interact with the stationary phase causing 
them to elute later in the first dimension fractions. Though the first dimension separation method 
was the same for all experiments, the separations at 8 kpsi and 32 kpsi were completed with two 
different first dimension prefractionation sets due to limited sample volume. The differences in 
the mass chromatograms may also be due to the changes the digestion protocol as explained in 
the previous section.  
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5.3.7 Venn diagram comparisons 
Analysis on the long column at elevated pressures resulted in a greater than two fold-
change in protein identifications as compared to the standard system for the analysis of 5 and 10 
fractions as seen in Figure 5.11. (a and b). About 90% of the proteins identified with the standard 
system were also identified by analysis on the modified UHPLC. When first dimension sampling 
increased to 20 fractions, the improvement between analysis on the modified and standard 
UHPLC systems decreased to 79% more identifications. An 84% overlap in identifications was 
observed for the 20 fractions run on both systems. The increased fractionation frequency may 
cause proteins to be split amongst multiple fractions resulting in the slightly lower improvement 
for this data set. 
In Figure 5.12, the overlap in protein identifications was compared for 5, 10 and 20 first 
dimension fractions analyzed by the modified UHPLC-MS. When fractionation was doubled 
from 5 to 10, 198 additional proteins were identified, and 46 protein identifications were lost for 
a net increase of 27%. Another doubling of fractionation from 10 to 20, resulted in 212 
additional protein identifications at a cost of 51 protein identifications for a net gain of 22%. The 
total number of protein identifications in the Venn diagrams in Figure 5.11 and Figure 5.12 
included every unique protein entry in the replicate analyses. The numbers were slightly larger 
than the protein identifications in Figure 5.3 which corresponded to the average number 
(arithmetic mean) of identifications between two replicate analyses. The Venn comparisons 
further demonstrate that excessive prefractionation should be avoided to reduce peak splitting. 
With the modified UHPLC and long microcapillary column, the peak capacity in the second 
dimension is increased reducing the need for a high prefractionation frequency.  
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5.3.8 Fractions per protein 
The first dimension chromatogram was crowded with many overlapping peaks making it 
impractical to determine peak widths for individual proteins. As an alternative merit, fractions 
per protein was defined as the number of fractions in which a single protein was identified. The 
graph in Figure 5.13 shows the percentage of proteins identified in one, two and three-or-more 
fractions for each prefractionation frequency. The majority of proteins were identified in only 
one fraction. As fractionation frequency increased, more proteins were identified in multiple 
fractions. These fractions may or may not be adjacent. When a protein was split between 
multiple fractions, it was diluted which may cause it to fall below the limit of detection. When 
comparing the fractions per protein for data collected with the modified and standard UHPLC, a 
larger percentage of proteins were identified in multiple fractions with the modified system. 
Since the first dimension separations were identical, there could not be increased protein peak 
splitting or broadening. Also, blank runs after the second dimension separations did not show 
evidence of carryover. The increased identification of proteins across multiple fractions was 
most likely related to the increased peak intensities in the second dimension separation as 
explained earlier and shown in Figure 5.4. Hypothetically, a protein peak split across two 
fractions has the majority of the peak contained in fraction 1 and the tail of the peak contained in 
fraction 2. When both fractions are digested and analyzed by LC-MS, the corresponding peptide 
peaks would be more intense in fraction 1 than fraction 2 because most of the protein molecules 
are contained in fraction 1. For fraction 2, the intensity of the peptide peaks run on the standard 
system may fall below the limit of detection. With the peak intensity gained from the long 
column run at elevated pressures, the protein could be identified in fraction 2 from its assigned 
peptides.  
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5.3.9 Protein coverage 
Besides increasing the number of protein identifications, the separations at 32 kpsi also 
increased the protein coverage. To compare the methods, coverage was reported in Table 5.4. for 
several proteins involved in the metabolic processes of yeast. However, looking at coverage 
protein by protein for a complete proteome can be overwhelming. Averaging the coverage for all 
identified proteins would be misleading as the additional proteins identified in a separation with 
higher peak capacity are usually of lower abundance and have a lower coverage, bringing down 
the average. Alternatively, only proteins found by both methods could be considered. However, 
this would limit the comparison to easily detectible proteins which usually have higher coverage 
and, thus, mute the difference between the methods. Thus, we proposed the normalized 
difference protein coverage (NDPC), as described in Chapter 2, and will use NDPC to compare 
coverage between the separations on the modified and standard UHPLC.  
The NDPC is defined as the difference in coverage for a particular protein between two 
methods normalized by the sum of its coverage in the two methods as shown in the following 
equation: 
NDPC   
Coveragea,i- Coveragea, 
Coveragea,i  Coveragea, 
, (5-2) 
where             was the percent coverage of protein a in method i, and             was the 
percent coverage of protein a in method j. For example, the NDPC for fumarate hydratase 
(FUMH), a protein involved in the citric acid cycle of S. cerevisiae, is calculated to compare 5 
fractions run on at 32 kpsi on the modified UHPLC and 8 kpsi on the standard UPLC:  
NDPC   
CoverageFUMH,5 Fractions, 32 kpsi- CoverageFUMH, 5 Fractions, 8 kpsi 





   .2  (5-4) 
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With this example, a protein found with higher coverage in the fractions run on a longer 
column at 32 kpsi would have a positive NDPC. A negative NDPC signifies the protein was 
found with higher coverage in the fractions run on the standard UPLC. A value of +1 means the 
protein was only identified in the fractions run on the longer column at 32 kpsi, and a value of -1 
means the protein was only identified in the fractions run on the standard system. Equal coverage 
in both methods results in a NDPC value of zero. The data collected with the modified and 
standard UHPLC are compared for 5 fractions in Figure 5.14, for 10 fractions in Appendix C.1. 
and for 20 fractions in Appendix C.2. The NDPC values are plotted with the proteins ordered 
from largest to smallest denominator, putting the proteins with highest coverage on the left, and 
the lowest coverage on the right. The NDPC increases as the denominator (summed protein 
coverage) decreased. This highlights the fact that comparing proteins identified by both methods 
would mute the improvement to protein coverage. These figures are large and split amongst 
several pages. To better comprehend the trend, the protein identifier information was removed so 
the graphs could fit onto a single page in Figure 5.15. The abundance of positive values signifies 
higher coverage with the 110cm long column at 32 kpsi for every fractionation frequency.  
In an attempt to further simplify the comparison of coverage between multiple methods, 
while maintaining the meaning of the values, we propose the Grand NDPC which is defined by 
the difference between the grand total protein coverage in method one and method two 
normalized by the grand sum of protein coverage in both methods as shown in Equation 5-3: 











Perhaps a more relevant interpretation of the Grand NDPC would be to relate it to a fold-
change improvement in coverage as follows:   
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1  rand NDPC
1- rand NDPC
  (5-6) 
If the fold-change is less than one, the negative reciprocal of the value is used as is 
conventional with fold-change calculations. The Grand NDPC and Fold-Change in Coverage is 
listed in Table 5.5. Positive values represent higher coverage with the 110 cm long column at 32 
kpsi. For each prefractionation frequency, a greater than two-fold change in protein coverage 
was observed when the second dimension separation occurred on the 110cm long column at 32 
kpsi as opposed to the 25 cm commercial column at 8 kpsi.  
5.4 Conclusions 
A challenge in proteomics has always been to obtain more information from the sample 
without increasing the analysis time. By using S. cerevisiae lysate as a model proteome for a 
prefractionation type multidimensional separation, the effects of prefractionation frequency and 
second dimension peak capacity on protein identifications were investigated. The gained peak 
capacity from performing the second dimension separation on a long column at 32 kpsi yielded 
an increase in protein identifications and approximately doubled the amino acid sequence 
coverage compared to separations on a standard system. With five first dimension fractions, the 
modified UHPLC identified 472 proteins while only 171 proteins were identified with the 
standard UPLC. It took 20 fractions, which quadrupled the separation time, to yield a maximum 
of 456 fractions with the standard UPLC. Identifications reached 776 proteins with 20 fractions 
run on the modified UHPLC. The instrumentation and methods described in this chapter will 
enable completion of differential proteomics studies in a shorter amount of time and produce 















+ 0.2% TFA 
(%B) 
0 1.0 100 0 
2 1.0 100 0 
5 1.0 75 25 
40 1.0 50 50 
45 1.0 35 65 
45.1 1.0 0 100 
50 1.0 0 100 
50.1 1.0 100 0 
 
Table 5.1. Chromatographic conditions for the reversed-phase prefractionation of intact proteins. 
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1 10-13 0.05 
 
1 10-16 0.1 
2 14-16 0.1 
 
2 17-18 0.2 
3 17 0.15 
 
3 19-20 0.3 
4 18 0.2 
 
4 21-22 0.4 
5 19 0.25 
 
5 23-24 0.5 
6 20 0.3 
 
6 25-26 0.6 
7 21 0.35 
 
7 27-28 0.7 
8 22 0.4 
 
8 29-30 0.8 
9 23 0.45 
 
9 31-32 0.9 
10 24 0.5 
 
10 33-48 1 
11 25 0.55 
    12 26 0.6 
    13 27 0.65 
 
c) 






ΣAbsorbance 15 29 0.75 
 16 30 0.8 
 
1 10-18 0.2 
17 31 0.85 
 
2 19-22 0.4 
18 32 0.9 
 
3 23-26 0.6 
19 33-35 0.95 
 
4 27-30 0.8 
20 35-48 1 
 
5 31-48 1 
Table 5.2. The fractionation schemes for a set of 20 (a), 10 (b), and 5 (c) first dimension 
fractions are listed with the associated first dimension separation times and the normalized 



















High Pressure Isolation Valve 
Freeze/Thaw Valve 
 &Vent Valve 
Pneumatic Amplier 
Pump Initiation 
Gradient Loading Method 
Initial 5 96.0 4.0 - Off On Off 
1.0 5 15.0 85 11 Off On Off 
1.8 5 60.0 40 11 Off On Off 
6.8 5 96.0 4 6 Off On Off 
7.4 5 99.5 0.5 11 Off On Off 
8.0 4 99.5 0.5 11 Off On Off 
8.1 3 99.5 0.5 11 Off On Off 
8.2 2 99.5 0.5 11 Off On Off 
8.3 1 99.5 0.5 11 Off On Off 
8.4 0.01 99.5 0.5 11 Off On Off 
9.0 (end) 0.01 99.5 0.5 11 Off On Off 
Sample Loading Method 
Initial 0.01 99.5 0.5 - Off On Off 
0.1 1 99.5 0.5 11 Off On Off 
0.2 2 99.5 0.5 11 Off On Off 
0.3 3 99.5 0.5 11 Off On Off 
0.4 4 99.5 0.5 11 Off On Off 
0.5 5 99.5 0.5 11 Off On Off 
2.0 5 99.5 0.5 11 Off On Off 
2.5 0.01 50 50 11 On Off Off 
5.0 0.01 50 50 11 On Off On 
35.0 (end) 0.01 50 50 11 On Off On 
Ultra High Pressure Separation Method 
Initial 0.01 50 50 11 On Off On 
150.0 0.01 96 4 11 On On Off 
155.0 (end) 0.01 96 4 11 On On Off 
 
Table 5.3. The method for the second dimension separation at ultrahigh pressure as programmed into MassLynx is listed along with 
the valve timings.  
 185 
   





Shotgun 5 10 20 
 
Shotgun 5 10 20 
Isocitrate lyase ACEA 
 
- 43 71 69 
 
- 19 35 36 
Aconitate hydratase ACON 
 
20 65 53 69 
 
13 53 54 72 
Acetyl-coenzyme A synthetase 1 ACS1 
 
33 63 46 64 
 
18 53 63 69 
Acetyl-coenzyme A synthetase 2 ACS2 
 
- 10 10 20 
 
- 2 4 8 
Alcohol dehydrogenase 1 ADH1 
 
56 74 73 74 
 
11 26 29 29 
Alcohol dehydrogenase 2 ADH2 
 
68 76 79 77 
 
26 42 45 47 
Alcohol dehydrogenase 3 ADH3 
 
- 35 55 65 
 
- 10 16 20 
Alcohol dehydrogenase 6 ADH6 
 
- - 13 38 
 
- - 3 11 
Aldehyde dehydrogenase 2 ALDH2 
 
- 39 50 61 
 
- 15 19 26 
Aldehyde dehydrogenase 3 ALDH3 
 
- 9 19 20 
 
- 2 3 3 
K-activated aldehyde dehydrogenase ALDH4 
 
75 88 83 85 
 
37 53 63 66 
Fructose-bisphosphate aldolase ALF 
 
54 73 80 91 
 
17 29 34 38 
Citrate synthase CISY1 
 
35 61 59 65 
 
15 35 35 46 
Succinate dehydrogenase DHSA 
 
- 26 31 53 
 
- 10 15 25 
Dihydrolipoyl dehydrogenase DLDH 
 
23 65 70 76 
 
6 32 36 42 
Enolase 1 ENO1 
 
75 86 86 88 
 
31 21 25 26 
Enolase 2 ENO2 
 
72 88 83 92 
 
12 51 57 62 
Fumarate reductase FRDS 
 
- 42 55 60 
 
- 18 22 30 
Fumarate hydratase FUMH 
 
- 54 61 57 
 
- 24 28 31 
Glyceraldehyde-3-P dehydrogenase 1 G3P1 
 
83 92 85 92 
 
14 45 28 32 
Glyceraldehyde-3-P dehydrogenase 2 G3P2 
 
88 91 85 91 
 
6 10 10 13 
Glyceraldehyde-3-P dehydrogenase 3 G3P3 
 
92 92 96 94 
 
35 24 49 52 
Glucose-6-phosphate isomerase G6PI 
 
44 62 69 68 
 
21 37 45 50 
Glycerol-3-phosphate dehydrogenase GPD1 
 
- 65 63 59 
 
- 24 27 27 
Glycerol-3-phosphate dehydrogenase GPD2 
 
- 11 32 26 
 
- 2 8 9 
Glycerol-3-phosphatase 2 GPP2 
 
- - - 19 
 
- - - 4 
Hexokinase-1 HXKA 
 
42 68 75 83 
 
16 30 37 51 
Hexokinase-2 HXKB 
 
40 73 71 82 
 
11 31 42 42 
Glucokinase-1 HXKG 
 
57 74 71 87 
 
23 41 51 57 
Isocitrate dehydrogenase 1 IDH1 
 
11 59 59 65 
 
3 23 22 24 
Isocitrate dehydrogenase 2 IDH2 
 
12 71 64 81 
 
2 17 16 24 
6-phosphofructokinase subunit α K6PF1 
 
23 57 57 68 
 
15 62 76 86 
Pyruvate kinase 1 KPYK1 
 
77 86 82 88 
 
33 54 61 64 
Malate synthase 1 MASY 
 
- 48 48 57 
 
- 26 22 38 
Malate dehydrogenase, cyto MDHC 
 
10 52 53 56 
 
3 16 16 22 
Malate dehydrogenase, mito MDHM 
 
60 77 75 84 
 
15 24 24 31 
2-oxoglutarate dehydrogenase E1 ODO1 
 
9 34 54 51 
 
6 29 47 56 
γ-glutamyl phosphate reductase ODO2 
 
- 38 47 48 
 
- 14 19 25 
Pyruvate dehydrogenase E1 comp β ODPB 
 
- 49 37 66 
 
- 11 10 18 
Phosphoenolpyruvate carboxykinase PCKA 
 
44 72 83 74 
 
19 48 54 59 
Pyruvate decarboxylase isozyme 1 PDC1 
 
62 69 65 71 
 
30 40 45 53 
Pyruvate decarboxylase isozyme 5 PDC5 
 
- - 17 27 
 
- - 5 13 
Pyruvate decarboxylase isozyme 6 PDC6 
 
- 19 28 37 
 
- 5 11 19 
Phosphoglycerate kinase PGK 
 
87 90 83 93 
 
38 54 57 61 
Phosphoglycerate mutase 1 PMG1 
 
84 83 90 80 
 
22 26 29 31 
Pyruvate carboxylase 1 PYC1 
 
- 43 40 48 
 
- 40 42 23 
Pyruvate carboxylase 2 PYC2 
 
- 34 34 44 
 
- 10 9 52 
Succinyl-CoA ligase subunit α SUCA 
 
52 75 69 72 
 
12 22 26 27 
Succinyl-CoA ligase subunit β SUCB 
 
19 49 59 72 
 
7 31 37 40 
Transaldolase 1 TAL1 
 
24 62 62 81 
 
6 17 35 41 
Transaldolase 2 TAL2 
 
- 65 41 61 
 
- 21 15 25 
Transketolase 1 TKT1 
 
- 54 73 68 
 
- 35 48 50 
Transketolase 2 TKT2 
 
- 32 42 48 
 
- 16 24 29 
Triosephosphate isomerase TPIS 
 
71 90 93 88 
 
15 28 28 31 
Average 
  
50 59 60 66 
 
17 27 31 36 
Table 5.4. For the separations on the modified UHPLC, the protein coverage (%) and number of 
peptides used to identify each protein is reported for the some of the proteins involved in S. 
cerevisiae metabolism   
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Fractions Grand NDPC Fold Change In Coverage 
5 0.48 2.9 
10 0.39 2.3 
20 0.37 2.2 
 
Table 5.5. The Grand NDPC and Fold-Change in Coverage are listed for each fractionation 
frequency. Positive values represent higher coverage when the 110cm long column at 32 kpsi 
was used for the second dimension separation as compared to the shorter column run on the 





Figure 5.1. The workflow for the prefractionation method started with HPLC-UV of the intact 
proteins. Thirty-eight one-minute-wide fractions were collected, lyophilized, and pooled into 
20 equal-mass fractions. The 20 equal-mass fractions were digested and also pooled into 10 and 
5 equal-mass fractions. The set of 20, 10, and 5 equal-mass fractions were analyzed with a 
second dimension separation by the modified UHPLC-MS at 32 kpsi. The spectral data were 
searched against a genomic database to identify the proteins.   
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a) b) 




Figure 5.2. The normalized ΣAbsorbance trace is plotted versus the first dimension separation 
time to determine the equal-mass prefractionation timings. The y-axis is equally divided into 20 
(a), 10 (b), and 5 (c) fractions. A line is drawn from the Σ Absorbance trace to the x-axis to 
determine when to take fractions from the first dimension. The UV chromatogram is overlaid on 












































































































Figure 5.3. The number of protein identifications is plotted versus number of first dimension 
fractions. The green line is for the prefractionation experiment, described in this chapter, run on 
the modified UHPLC at 32 kpsi. As a comparison, the results from this chapter where 
superimposed on Figure 2.5 (red and blue traces) for a prefractionation study with a standard 
UPLC. The number of protein identifications greatly increased through use of long columns on 
the UHPLC.  
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a) Modified UHPLC b) Standard UPLC 





Figure 5.4. Two-dimensional chromatograms for 20 (a,b), 10 (c,d), and 5 (e,f) first dimension 
fractions are plotted with the first dimension (protein) fraction number versus the second 
dimension (peptide) separation. Base peak intensity BPI is plotted in the z-direction. 
Chromatograms on the left (a,c,e) are from the modified UHPLCat 32 kpsi with a 110 cm 
column, and chromatograms on the right (b,d,f) are run on a standard UPLC at 8 kpsi with a 
25 cm commercial column. The same amount of protein was loaded onto the column in both 






Figure 5.5. On average, more unique proteins were identified per fraction as prefractionation 
frequency decreased but total proteins identifications per fraction remained constant. The light 
gray bars show the total protein identifications in each fraction, and the dark gray bars signify the 
unique protein identifications in each fraction for 20 (a), 10 (b), and 5 (c) first dimensional 
fractions analyzed on the modified UHPLC at 32 kpsi. The x-axis is the first dimension 
separation time with the UV absorbance overlaid in red.  
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a)  Modified UHPLC b)  Standard UPLC 
  
 
Figure 5.6. More proteins were identified per fraction when the fractions were run on the 110 cm 
column at 32 kpsi (a) as compared to the standard UPLC (b). The light gray bars show the total 
protein identifications in each fraction, and the dark gray bars signify the unique protein 
identifications in each fraction for 20 first dimension fractions.  
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a)  Modified UHPLC b)  Standard UPLC 
  
Figure 5.7. More proteins were identified per fraction when the fractions were run on the 110 cm 
column at 32 kpsi (a) as compared to the standard UPLC (b).The light gray bars show the total 
protein identifications in each fraction, and the dark gray bars signify the unique protein 
identifications in each fraction for 10 first dimension fractions.  
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a)  Modified UHPLC b)  Standard UPLC 
  
 
Figure 5.8. More proteins were identified per fraction when the fractions were run on the 110 cm 
column at 32 kpsi (a) as compared to the standard UPLC (b).The light gray bars show the total 
protein identifications in each fraction, and the dark gray bars signify the unique protein 
identifications in each fraction for 5 first dimension fractions.  
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a)  Modified UHPLC b)  Standard UPLC 
  
 
Figure 5.9. These histograms display the protein molecular weight distributions for the 
separations at 32 kpsi (a) and for the separations at 8 kpsi (b). The mass distribution 
corresponding to the 5, 10 and 20 fractions are portrayed by the black, gray and white bars, 
respectively. Proteins were identified with masses up to 250 kDa. For all methods, the median 
molecular weight was 39-40 kDa. For the fractions run at 32 kpsi, the increase in identifications 
occurred mostly for lower mass proteins 20-70 kDa.  
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Figure 5.10. The mass chromatograms for 20 (a,b), 10 (c,d), and 5 (e,f) first dimension fractions 
are plotted as protein mass versus first dimension fraction. The log quantitative value for each 
protein is plotted in the z-direction. Chromatograms on the left (a,c,e) are from the modified 
UHPLC at 32 kpsi on a 110 cm column, and chromatograms on the right (b,d,f) are from the 
standard UPLC at 8 kpsi on a 25 cm commercial column.   
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a) 5 Fractions 
110 cm column 25 cm column 
32 kpsi 8 kpsi 
567 Identifications 225 Identifications 
 






b) 10 Fractions 
110 cm column 25 cm column 
32 kpsi 8 kpsi 
719 Identifications 353 Identifications 
 






c) 20 Fractions 
110 cm column 25 cm column 
32 kpsi 8 kpsi 
880 Identifications 492 Identifications 
 






Figure 5.11. Similarities in protein identifications are compared for 5 (a), 10 (b), and 20 (c) first 




   10 Fractions 
     719 Identifications 
 5 Fractions  
















Figure 5.12. The Venn diagram demonstrates the overlap in protein identifications for 5, 10, and 
20 equal-mass fractions run on the 110 cm column at 32 kpsi. 
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a)  Modified UHPLC b)  Standard UPLC 
  
 
Figure 5.13. Fractions per protein describe the percentage of proteins that were identified in one, 
two or more (3+) fractions run on the 110 cm column at 32 kpsi (a) and the standard UPLC (b). 
As prefractionation frequency increased, more proteins were identified in multiple fractions. A 
larger percentage of the proteins were identified in multiple fractions with the modified system. 
The increased identification of proteins across multiple fractions was mostly likely related to the 
increased peak intensities in the second dimension separation.   
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Figure 5.14. To compare the 5 fractions run on the modified system to the 5 fractions run on the 
standard UPLC, the NDPC is plotted with proteins with higher coverage on the left, and proteins 
with lower coverage on the right. If a protein was identified with higher sequence coverage when 
analyzed on the modified UHPLC, its NDPC value is positive (blue bars). The red bars signify 
higher coverage in the analysis on the standard UPLC. Differences in coverage were minimal for 
highly covered proteins. As protein coverage decreased, more proteins were identified with 
higher coverage from the analysis on the modified UHPLC. The dashed lines indicate a level of 
two-fold greater protein coverage. (This was a large graph and split into multiple parts.) 
  
 201 
Figure 5.14. (continued)  
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Figure 5.14. (continued)  
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Figure 5.14. (continued)  
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Figure 5.15. The NDPC plotted here compare proteins identified with the modified and standard 
UHPLCs for 5 (a), 10 (b), and 20 (c) first dimension fractions. If a protein was identified with 
higher sequence coverage with the modified UHPLC, the NDPC value is positive (blue lines). 
The red lines signify higher coverage with the standard UPLC. Proteins with higher coverage are 
plotted on the left, and proteins with lower coverage are on the right. More proteins were 
identified with higher coverage by with the modified UHPLC. 
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CHAPTER 6. Multidimensional Separations at 32 kpsi using Long Microcapillary 
Columns for the Differential Proteomics Analysis of Saccharomyces cerevisiae 
6.1 Introduction 
The study of protein expression has been important in understanding biological pathways. 
Studying the differential protein expression of an organism with two different phenotypes has 
brought light to the role proteins play in these pathways.
1,2
 Saccharomyces cerevisiae, commonly 
known as baker’s yeast, is a model organism for testing new analysis methods because its 
proteome is relatively well understood.
3
 The validity of several common proteomics methods 
was first demonstrated by analyzing baker’s yeast.4,5 Since the yeast proteome is a complex 
biological mixture, many of these methods begin with a separation by liquid chromatography 
(LC) before analysis by mass spectrometry (MS).
6
  
Though great improvements have been made in the field of liquid chromatography,
7,8
 no 
single separation exists with the peak capacity necessary to effectively separate an entire 
proteome.
9
 Multidimensional separations were developed as a means to improve peak capacity.
10
 
Early multidimensional separations coupled a long size exclusion or cation-exchange column to 
a reversed phase column.
11,12,13
 Other scientists packed biphasic columns with reversed phase 
sorbent at the outlet and strong cation-exchange sorbent at the inlet to separate proteome 
digests.
14,15
 More recent work focused on the separation of intact proteins by three modes before 
analysis by ESI-FTICR-MS. The three separation modes included two electrophoretic 




To aid in sample solubility, proteomics experiments commonly start with digestion prior to 
separation. This shotgun approach increases the complexity of the biological mixture prior to 
analysis.
18
 More recently, a prefractionation approach has been implemented in which the intact 
proteins are fractionated by the first dimension separation, and fractions are enzymatically 
digested prior to analysis by LC-MS.
19,20
 Experimentally, prefractionation methods are more 
orthogonal than other multidimensional separations because the sample is completely changed 
via digestion between separations.
21
 Digestion between the separations enables the use of 
reversed phase columns in both dimensions which tend to have higher peak capacity than other 
LC separation modes such as ion exchange and size exclusion chromatography.
22
 The number of 
fractions collected will determine the peak capacity of the first dimension separation. However, 
high prefractionation frequencies will increase analysis time and increase the probability of 
splitting a protein between two fractions, and thus dilute the analyte. A study of prefractionation 
frequency was completed in Chapter 5. The results indicated that five fractions yielded adequate 
information about the yeast proteome if a long microcapillary column is used in the second 
dimension.  
In concert with improvements to separation techniques, scientists have improved mass 
spectrometric detection of large biomolecules. The development of ion mobility added a post 
ionization separation.
23
 High resolution mass spectrometers such as FTICR and especially 
orbitraps have become more common laboratory instruments.
24
 Time-of-flight (TOF) 
instruments are also widely used for proteomics experiments.
25
 However, ionization suppression 





To help with the quantitative analysis of mass spectral data, many sample labeling 
techniques such as iTRAQ and SILAC have been developed. However, the label-free technique 
remains popular for relative quantification.
28
 The major advantage to label-free relative 
quantification is that no further manipulation of the sample is required. Also, the spectra are not 
busy with isobaric and isotopic data. The validity of quantification based on spectral counts with 
the label-free method has been demonstrated in the literature.
14,15,24
  
The differential study in this manuscript investigated yeast grown on dextrose and 
glycerol. Dextrose is the preferred growth medium. Growth on an alternative carbon source 
yields protein expressions characteristic of an environmental stress response.
29
 A previous study 
of this differential expression from the Jorgenson Lab separated the soluble portion of the yeast 
proteome by RPLC into 20 equal-time fractions. The fractions were digested before analysis by a 
standard UPLC-qTOF-MS.
21
 Herein, a method is described which samples the first dimension by 
equal-mass prefractionation into just five fractions. A UHPLC capable of separations above 30 
kpsi increased the peak capacity of the second dimension separation. This prefractionation 
experiment reduced the previously reported separation time by four fold. With the improved 
separation, 527 proteins were identified in the dextrose sample and 539 in the glycerol sample 
which is more than the previously reported analysis. 
6.2 Materials and method 
6.2.1 Materials 
Water, acetonitrile, isopropyl alcohol and ammonium hydroxide were purchased from 
Fisher Scientific (Fair Lawn, NJ). Ammonium acetate, ammonium bicarbonate, formic acid, 
trifluoroacetic acid and iodoacetamide were purchased from Sigma-Aldrich Co. (St. Louis, MO). 
Rapigest
TM
 SF acid-labile surfactant and bovine serum album digest standard (BSA) were 
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obtained from Waters Corporation (Milford, MA). Dithiothreitol was purchased from Research 
Products International (Mt. Prospect, IL), and TPCK-modified trypsin was purchased from 
Pierce (Rockford, IL). Water and acetonitrile were Optima LC-MS grade, and all other chemicals 
were ACS reagent grade or higher. Growth, harvesting, and lysis of S. cerevisiae from glycerol 
and dextrose media were previously described.
21
  
6.2.2 Intact protein prefractionation 
The prefractionation of intact proteins, outlined in Figure 6.1., was performed on a 4.6 x 
250 mm PLRP-S column with 5 µm particles (Agilent, Santa Clara, CA) heated to 80 °C. Four 
milligrams of total protein were injected onto the column. The gradient profile is shown in Table 
6.1. The separation was followed by UV spectrophotometry to give a qualitative chromatogram 
of the separation. The wavelength was set to 214 nm, which is the lambda max of the peptide 
bond. One-minute wide fractions, containing 1 mL of effluent each, were collected in 
microcentrifuge tubes. To concentrate the fractions, they were lyophilized and then reconstituted 
in 25 µL of 5  mM ammonium bicarbonate. Three microliters of 6.6 % (w/v)  api est™ SF in 
buffer were added. Solutions were vortexed, sonicated for 15 minutes, and incubated at 80 ºC for 
15 minutes to denature the proteins..  
6.2.3 Equal-mass prefractionation 
To determine fractionation by equal-mass, each absorbance value for the UV 
chromatogram was summed with all previous absorbance values from 10 to 48 minutes which 
corresponded to the time after the injection plug until just before the wash. Summed absorbance 
was calculated as follows  





where A = absorbance, t = time, td = dead time, and tg = gradient time. The Σ absorbance 
was normalized and plotted versus first dimension separation time in Figure 6.2. The 
Σ absorbance was divided into increments of 0.05 which split the axis into 20 even parts. The 
times associated with the 20 Σ absorbance values were rounded to the nearest minute. These 
times were used to redistribute the 38 one-minute-wide fractions into 20 equal-mass fractions. 
Each of the 20 fractions has an equal-mass of total protein but a varying amount of solvent. 
6.2.4 Protein digestion 
The digestion is more efficient when carried out in a minimal amount of solvent. 
Therefore, the 20 equal-mass fractions were also lyophilized and reconstituted in 25 µL of 50 
mM ammonium bicarbonate. Three microliters of 6.6 % (w/v)  api est™ SF in buffer were 
added. Solutions were vortexed, sonicated for 15 minutes, and incubated at 80 ºC for 15 minutes 
to denature the proteins. The proteins were reduced by adding 1 µL of 100 mM dithiothreitol, 
vortexed, sonicated for 5 minutes, and incubated for 30 min at 60ºC. Proteins were then alkylated 
with 1 µL of 200 mM iodoacetamide, vortexed, sonicated for 5 minutes, and stored protected 
from light for 30 min at room temperature. The proteins were then digested by adding 10 µL of 
667 ng/µL TPCK-modified trypsin in 50 mM ammonium bicarbonate, pH 8 (overnight, 37ºC). 
The trypsin amount was approximated to be a 50:1 (w/w) protein to enzyme ratio if the initial 
protein amount was equally distributed across the 20 fractions. The digestion was quenched, and 
the  api est™ SF was degraded using 44 µL  8:1:1 (v:v:v) water:acetonitrile:trifluoroacetic 
acid (45 min, 37ºC). The fractions were centrifuged for 10 minutes at 14,000 Xg to pellet the 
hydrolyzed surfactant, after which they were ready for analysis. The samples were transferred to 
LC vials and spiked with 1.3 µL of a 1 pmol/L internal standard BSA digest (Waters).  
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To form the sets of 5 fractions, 20 µL of every four consecutive fractions from the set of 
20 were combined, lyophilized, and reconstituted with 10 µL 50 mM ammonium bicarbonate 
and 10 µL 98:1:1 (v:v:v) water:acetonitrile:trifluoroacetic acid. The fractionation schemes are 
outlined in Table 6.2.  
6.2.5 Peptide analysis by UHPLC-MSE  
Each fraction was analyzed in triplicate by capillary RPLC-MS using the UHPLC system 
described in Chapter 3 coupled to a QTOF Premier MS. Mobile phase A was Optima Grade 
water with 0.1% formic acid (Fisher), and mobile phase B was Optima-grade acetonitrile with 
0.1% formic acid (Fisher). The samples were pre-concentrated on a 110 cm x 75 µm ID, 1.9 µm 
BEH C18 column with 0.5% mobile phase B, and then separated with a 25 µL gradient from 4-
40%B followed by a wash at 85% and equilibration at initial conditions. The gradient program is 
listed in Table 6.3. The column was run at 32 kpsi at 65°C to produce a 300 nL/min flow rate. 
The outlet of the RPLC column was connected via a 30 cm x 20 µm ID piece of silica capillary 
to an uncoated fused silica nanospray emitter with a 20 µm ID and pulled to a 10 µm tip (New 
Objective, Woburn, MA) operated at 2.6 kV. Data-independent acquisition (MS
E
) was performed 
with the instrument set to acquire parent ion scans from m/z 50-1990 over 0.6 sec at 5.0 V. The 
collision energy was then ramped from 15-40 V over 0.6 sec with 0.1 sec interscan delay.  
6.2.6 Peptide data processing 
The peptide LC-MS/MS data were processed using ProteinLynx Global Server 2.5 
(Waters). The MS
E
 spectra were searched against a database of known yeast proteins from the 
Uni-Prot protein knowledgebase ( www.uniprot.org) with a reversed sequence appended to the 
end. The false discovery rate was set to 100% to yield data compatible for further processing. 
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After the database search was complete, the results were imported into Scaffold 4.2.0 
(Proteome Software, Portland, OR). The minimum protein probability and peptide probability 
filters were set to a 5% false discovery rate, and a minimum of three peptides were required to 
identify a protein. Peptides matching multiple proteins were exclusively assigned to the protein 
with the most evidence. The proteins were quantified by the normalized total precursor intensity. 
The precursor intensities assigned to a protein were totaled to give the quantitative value of that 
protein. The values were normalized by subtracting each sample’s median log intensity then 
adding back the median log intensity for all samples.
30,31,32,33
 A student’s 2-sided t-test was 
performed on the triplicate samples. Proteins with a p-value less than 0.050 between the two 
yeast samples and a fold change greater than 2.0 were considered to be differentially expressed 
with 95% confidence or greater. 
6.3 Discussion 
Reversed-phase prefractionation of the lysate from yeast grown on dextrose and glycerol 
produced 38 one-minute-wide fractions. Measures were taken during method development to 
evenly distribute the proteins across the first dimension separation. However, most observed 
peaks from the first dimension chromatogram occurred in the middle of the retention window. 
Analysis of all 38 fractions would be unproductive as many proteins were undoubtedly split 
between multiple fractions diluting the analyte. Fractions with less intense first dimensional 
peaks would yield little information in the second dimension analysis. The offline nature of this 
multidimensional separation gave us flexibility to further process the fractions before second 
dimension analysis. For these reasons, the fractions were recombined into equal-mass fractions 
before digestion, as outlined in Table 6.2. 
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According to the prefractionation frequency study in Chapter 5, it was determined that 5 
fractions were adequate to yield sufficient information from the yeast proteome when fractions 
were run on a long, 110 cm microcapillary column at 32 kpsi. The multidimensional 
chromatograms are shown in Figure 6.3. From these plots, it is observed that the separation space 
was well utilized, peaks fill most of the 2D space, and the peaks are orthogonal.  
6.3.1 Protein prefractionation 
To more deeply analyze the first dimension separation, the resulting chromatograms are 
overlaid onto bar graphs in Figure 6.4. The number of proteins identified in each fraction is 
displayed for yeast grown on dextrose (a) and glycerol (b). Between 96 and 176 total proteins 
were identified per fraction as drawn with light gray bars. Unique identifications are drawn with 
dark gray bars. The total protein count was defined as any protein found within a given fraction; 
thus, if a protein were to be found in multiple fractions it would be counted in each fraction. The 
unique protein values count each protein entry only once. A protein identified in multiple 
fractions is assigned to the fraction in which it had the highest quantitative value. Between 55 
and 122 unique proteins were identified per fraction. The area under the first dimension 
chromatogram should be equal for each fraction. There were few peaks towards the end of the 
chromatogram so a large portion of the first dimension separation was pooled into one fraction. 
A large number of proteins were identified from peptide analysis of the last fraction. By pooling 
this area into one fraction, information can be gained about the yeast proteome without a large 
commitment of analysis time.  
The crowded and over lapping peaks in the first dimension separation prohibited the 
measurement of peak widths. As an alternative, the number of fractions per protein, as shown in 
Figure 6.5., was used to describe in how many first dimension fractions a protein was identified. 
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Most proteins were identified in only one fraction. For yeast on dextrose, 68% of the proteins 
were identified in only one fraction, 16% were identified in two fractions, and the remaining 
16% were identified in three or more fractions. Similarly for yeast grown on glycerol, 66% of the 
proteins were identified in one fraction, 19% were identified in two fractions, and 14% were 
identified in three or more fractions. This was a slight improvement over our lab’s previous 
results in which 60% of the proteins were identified in one fraction, 20% were identified in two 
fractions, and 20% were identified in three or more fractions.
21
 Our previous method had twenty 
first dimension fractions which increased the odds of splitting first dimension protein peaks 
between multiple fractions. The improvement was only slight because the intensities of the 
second dimension peptide peaks were much greater for the experiment described in this 
manuscript. With a longer column run at higher pressure, peaks were narrower and more intense 
increasing the likelihood of identifying proteins with lower abundance in multiple factions (See 
Chapter 5).  
6.3.2 Benefits of increasing second dimension peak capacity 
The total number of proteins identified in the dextrose and glycerol sample was 527 and 
539, respectively, with 350 or 65% of the proteins being identified in both samples as portrayed 
by the Venn diagram in Figure 6.6. These results were similar to our previously reported 
differential proteomics study using the prefractionation method.
21
 However, the peak capacity of 
the second dimension separation described in this chapter was approximately 450, about 
2.5 times the peak capacity of our earlier work, even though second dimension separation times 
were similar. The gain in second dimension peak capacity took burden off the prefractionation 
step. Therefore, more information could be elucidated out of only five fractions as opposed to the 
20 fractions described previously.  
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The theoretical two-dimensional peak capacity was 2,250 with this experiment and 4,000 
for our earlier experiment.
21
 The experiment described here better distributed the sample 
throughout the multidimensional separation space which would increase fractional coverage. 
Stoll and coworkers suggested multiplying the theoretical peak capacity by the fractional 
coverage factor to give a better estimate of the practical peak capacity for 2D separations.
34
 The 
results from Chapter 2 suggested that improving peak capacity in the first dimension alone had a 
limit as to how many proteins may be identified. Proteomics experiments involve many steps and 
techniques. Improvements to not one but all techniques will be necessary to more deeply mine 
information from the proteome. Ultrahigh pressure separation on long, microcapillary columns 
increased to the number of proteins identified and decreased total separation time.  
6.3.3 Increasing protein coverage 
The improvements to the multidimensional separation did not only improve the number 
of protein identifications but also the protein coverage. The coverage and number of peptides 
identified for several proteins involved in yeast metabolism are listed in Table 6.4. Chapter 2 
proposed the Normalized Difference Protein Coverage (NDPC) to compare protein coverage 
between multiple methods. The same metric was used to compare the difference in coverage for 
proteins identified in this chapter and our earlier work
21
 normalized by the total coverage 
between both experiments. The Grand NDPC combines the NDPC for all proteins into a single 
value by calculating the difference between the grand total protein coverage normalized by the 
grand sum of protein coverage in both methods as follows: 





 The Grand NDPC can be related to a Fold-Change in Coverage as follows: 






1  rand NDPC
1- rand NDPC
  (6-3) 
If the fold-change is less than one, the negative reciprocal of the value is used as is 
conventional with fold-change calculations. The Grand NDPC and Fold-Change in Coverage are 
listed in Table 6.5. The positive values represent higher coverage with the 5 equal-mass fractions 
run on the 110 cm long column at 32 kpsi as described in this chapter. A negative value would 
have indicated higher coverage by our previous results from the 20 equal-time fraction run on the 
25 cm commercial column at 8 kpsi on the standard UPLC.
21
 The improvement is small but 
impressive when one considers that separation time was reduced four fold.  
6.3.4 Differential proteins 
The differential proteins were qualified with a fold change of greater than two and a p-
value of less than 0.05 which corresponds to a negative log10 p-value of 1.3 and 95% confidence. 
The volcano plot in Figure 6.7.a. graphs the negative log10 p-value versus log2 fold change. A 
negative or positive fold change is a convention for up-regulation of the protein in yeast grown 
on dextrose or glycerol, respectively. The points in the upper left and right of the plot represent 
proteins with the largest difference in abundance between the two samples and with the most 
confidence. Protein quantity is not captured in the volcano plot so the log quantitative values of 
all significantly different proteins are plotted in Figure 6.7.b. Proteins up-regulated in the 
dextrose or glycerol sample are closer to the y-axis or x-axis, respectively. Points falling along 
the axes were only identified in the sample corresponding to that axis. There were 274 proteins 
that were determined to be significantly different. The most interesting of these proteins would 
have a large abundance in only one sample and are represented by points in the top-left and 
bottom-right of Figure 6.7.b.  
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Of the significantly different proteins, several were identified to be part of the metabolic 
pathways of yeast which, according to the literature, would have differences in expression when 
exposed to different carbon sources.
35
 Proteins involved in the metabolic pathways of interest are 
listed in Table 6.6. with their associated p-value, intensity, and fold change. Several metabolic 
pathways of S. cervisiae including glycerol catabolism/glycerolneogenesis, glycolysis/ 
gluconeogenesis, fermentation, the TCA cycle, and the glyoxylate cycle are depicted in Figure 
6.8. Proteins identified in blue or red represent up-regulation of the protein in yeast which was 
grown on the dextrose or glycerol media, respectively. The differential protein fold-changes 
measured by the methods described here follow the trends in protein expression predicted by the 




Glycolysis is the digestion of glucose to pyruvate, which can then be converted into 
energy through the TCA cycle, glyoxylate cycle, or fermentation. The first step in glycolysis is to 
phosphorylate glucose with the hexokinase family of enzymes (HXKA, HXKB). Glucokinase 
(HXKG) has a slightly different role because it acts as a regulator for glucose consumption. 
Previous studies reported increased transcription of glucokinase when yeast was grown on 
glycerol
36,37
 which was confirmed in the results from this study.  
In the pathway from glucose to pyruvate are the transketolase (TKT1, TKT2) and 
transaldolase (TAL1, TAL2) protein families. These proteins are also involved in metabolizing 
carbon energy sources through the pentose phosphate pathway (PPP). In normal cell function, 
TKT1 and TAL1 are the predominant proteins involved in the conversion of fructose-6-P to 
glyceraldehyde-3-P.
38,39
 TKT1 and TAL1 were identified by this method but not differentially. In 
the absence of glucose, it has been previously concluded that TKT2 will dominate the conversion 
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of fructose-6-P to glyceraldehyde-3-P. The literature is inconclusive on the role of TAL2.
40
 The 
results from this manuscript found both TKT2 and TAL2 proteins to be up-regulated in yeast 
grown on glycerol.  
Through the pentose phosphate pathway (PPP), glucose is transformed into ribulose-5-
phosphate which is a step in the formation of ribonucleic acids and ribosomal proteins. Cells 
grown under stress conditions, such as a dextrose deficient environment, will exhibit a lack of 
ribosomal protein.
29
 Therefore, an abundance of ribosomal proteins should exist in the yeast 
grown on dextrose. A total of 67 ribosomal proteins were identified with 19 up-regulated and 
only one down-regulated in the dextrose sample. 
Analogous to glycolysis is glycerol metabolism, which converts glycerol into pyruvate. 
For the yeast grown on glycerol, it is predicted that the proteins used in glycerol catabolism such 
as GLPK and GPD1 would be up-regulated
41,42
 while the proteins used in glycerolneogenesis, 
such as GPP1 and GPP2, would be down-regulated.
43
 This phenomenon was observed for 
GLPK, GPD1 and GPP1. No significant difference was observed for GPP2 and GPD2 
expression.  
After its biogenesis, pyruvate is fermented into ethanol if there is an excess amount of 
glucose present. A protein complex is formed by PDC1, PDC5 and PDC6. This complex is 
involved in the conversion of pyruvate to acetaldehyde during fermentation.
44
 These three 
subunits were identified with PDC5 and PDC6 being up-regulated in the dextrose sample. 
Acetaldehyde is then converted into ethanol. The alcohol dehydrogenases (ADH1, ADH3, 
ADH6) involved in the conversion were all identified with ADH6 being more abundant in yeast 
grown on dextrose.  
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In the absence of dextrose, pyruvate enters the TCA and glyoxylate cycles
45
 which can 
occur directly by conversion to oxaloacetate with pyruvate carboxylases (PYC1, PYC2) or 
through the acetyl-CoA bypass mechanism involving pyruvate dehydrogenase (ODPB) and 
dihydrolipoyl dehydrogenase (DLDH). Additionally, any ethanol that may be present is 
metabolized by alcohol dehydrogenase (ADH2), aldehyde dehydrogenases (ALDH2, ALDH4) 
and acetyl-coenzyme A synthetase (ACS1) for entrance into the TCA or glyoxylate 
cycle.
42,46,47,48,49
 Of the 24 proteins involved in processing pyruvate through the TCA and 
glyosylate cycles, 18 were significantly more abundant in the yeast grown on glycerol. The other 
six proteins showed no significant fold change in abundance between the two samples.  
The roles of ALDH5 and ACS2 are not completely defined in the literature but some 
studies indicate that their function differs from that of other aldehyde dehydrogenases and acetyl-
coenzyme A synthetases.
50
 One theory is that ALDH5 and ACS2 regulate ethanol to keep it 
below toxicity levels, maintaining a healthy environment for the biosynthesis other metabolites 
important to cell growth.
51,52
 In this experiment, ALDH5 and ACS2 were found to be up-
regulated in dextrose.  
A final difference between yeast grown on alternative carbon sources is the location of 
metabolism in the cell. Fermentation with dextrose occurs in the cytoplasm, while the TCA and 
glyoxylate cycles, metabolizing glycerol, occur in the mitochondria.
53
 To support increased 
activity in the mitochondria, more mitochondrial proteins would have to be transcribed. The 
results from this study identified 65 mitochondrial proteins with 26 up-regulated and only one 
down-regulated in the yeast sample grown on glycerol.  
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6.4 Conclusions 
The multidimensional UHPLC-MS analysis identified 527 proteins in yeast grown on 
dextrose and 539 proteins in yeast grown on glycerol. The differential abundances were 
determined for many proteins involved in yeast metabolism of the two different carbon sources. 
By utilizing the first dimension chromatographic intensity to prefractionate the sample by equal-
mass, the digestion was improved by better estimating the protein to enzyme ratio. This 
prefractionation technique better estimated column loading for the second dimension and 
improved the practical peak capacity of the multidimensional separation. Increased peak capacity 
of the second dimension separation, with a long microcapillary column run at elevated pressure, 
reduced the need for a high prefractionation frequency without reducing the number of protein 
identifications. With fewer first dimension fractions, analysis time was decreased by 75% as 
compared to a previously reported study by the Jorgenson Lab.
21
 Proteomic experiments involve 
many steps and techniques. Improvements to not one but all techniques will be necessary to more 
deeply mine information from the proteome. Ultrahigh pressure separations on long, 
microcapillary columns provided improvement to the number and coverage of proteins 







Flow Rate  
(mL/min) 





+ 0.2% TFA 
(%B) 
0 1.0 100 0 
2 1.0 100 0 
5 1.0 75 25 
40 1.0 50 50 
45 1.0 35 65 
45.1 1.0 0 100 
50 1.0 0 100 
50.1 1.0 100 0 
 






First Dimension Time 
(min) Dextrose 
First Dimension Time 
(min) Glycerol 
1 0.2 10-18 10-18 
2 0.4 19-22 19-22 
3 0.6 23-26 23-26 
4 0.8 27-31 27-30 
5 1 32-48 31-48 
Table 6.2. The first dimension prefractionation times of yeast grown on dextrose and glycerol 


















High Pressure Isolation Valve 
Freeze/Thaw Valve 
 &Vent Valve 
Pneumatic Amplier 
Pump Initiation 
Gradient Loading Method 
Initial 5 96.0 4.0 - Off On Off 
1.0 5 15.0 85 11 Off On Off 
1.8 5 60.0 40 11 Off On Off 
6.8 5 96.0 4 6 Off On Off 
7.4 5 99.5 0.5 11 Off On Off 
8.0 4 99.5 0.5 11 Off On Off 
8.1 3 99.5 0.5 11 Off On Off 
8.2 2 99.5 0.5 11 Off On Off 
8.3 1 99.5 0.5 11 Off On Off 
8.4 0.01 99.5 0.5 11 Off On Off 
9.0 (end) 0.01 99.5 0.5 11 Off On Off 
Sample Loading Method 
Initial 0.01 99.5 0.5 - Off On Off 
0.1 1 99.5 0.5 11 Off On Off 
0.2 2 99.5 0.5 11 Off On Off 
0.3 3 99.5 0.5 11 Off On Off 
0.4 4 99.5 0.5 11 Off On Off 
0.5 5 99.5 0.5 11 Off On Off 
2.0 5 99.5 0.5 11 Off On Off 
2.5 0.01 50 50 11 On Off Off 
5.0 0.01 50 50 11 On Off On 
35.0 (end) 0.01 50 50 11 On Off On 
Ultra High Pressure Separation Method 
Initial 0.01 50 50 11 On Off On 
150.0 0.01 96 4 11 On On Off 
155.0 (end) 0.01 96 4 11 On On Off 
 
Table 6.3. The method for the second dimension separation at ultrahigh pressure, as programmed into MassLynx, is listed along with 
the valve timings. 
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Aldehyde dehydrogenase 5 ALDH5 21 - 8 - 


































































































































































































































Table 6.4. The protein coverage (%) and number of peptides used to identify each protein are 
reported for the some of the proteins involved in S. cerevisiae metabolism.  
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Sample Grand NDPC Fold Change In Coverage 
Dextrose 0.074 1.1 
Glycerol 0.033 1.1 
 
Table 6.5. The Grand NDPC and Fold-Change in Coverage are listed for each fractionation 
frequency. The positive values represent higher coverage with the 5 equal-mass fractions run on 
the 110 cm long column at 32 kpsi as described in this chapter. A negative value would have 
indicated higher coverage by our previous results from the 20 equal-time fraction run on the 25 
cm commercial column at 8 kpsi on the standard UPLC.
21
 The improvement is small but 
impressive when one considers that the total separation time was reduced four fold.   
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T-Test P-Value Fold Change 
 
Dextrose Glycerol 
Isocitrate lyase ACEA 
 
0% 0.082000 - 
 
n.d. 857 
Aconitate hydratase ACON 
 
95% < 0.00010 4.8 
 
2204 10493 
Acetyl-coenzyme A synthetase 1 ACS1 
 
95% < 0.00010 G Only 
 
n.d. 20339 
Acetyl-coenzyme A synthetase 2 ACS2 
 
95% 0.020000 -9.0 
 
663 73 
Alcohol dehydrogenase 1 ADH1 
 
0% 0.530000 - 
 
53597 50028 
Alcohol dehydrogenase 2 ADH2 
 
95% 0.000300 4.2 
 
22123 93634 
Alcohol dehydrogenase 3 ADH3 
 
0% 0.080000 - 
 
848 1825 
Alcohol dehydrogenase 6 ADH6 
 
95% 0.001800 D Only 
 
612 n.d. 
Aldehyde dehydrogenase 2 ALDH2 
 
95% 0.000150 20.4 
 
32 658 
K-activated aldehyde dehydrogenase ALDH4 
 
95% < 0.00010 46.1 
 
2099 96753 
Aldehyde dehydrogenase 5 ALDH5  95% 0.0048 D Only  183 n.d. 
Fructose-bisphosphate aldolase ALF 
 
0% 0.420000 - 
 
34954 30292 
Citrate synthase CISY1 
 
95% < 0.00010 41.3 
 
301 12399 
Succinate dehydrogenase DHSA 
 
95% 0.005100 G Only 
 
n.d. 419 
Dihydrolipoyl dehydrogenase DLDH 
 
95% 0.000130 G Only 
 
n.d. 8330 
Enolase 1 ENO1 
 
0% 0.310000 - 
 
54308 65808 
Enolase 2 ENO2 
 
0% 0.130000 - 
 
74304 56488 
Fumarate reductase FRDS 
 
0% 0.830000 - 
 
908 884 
Fumarate hydratase FUMH 
 
95% 0.000540 40.3 
 
117 4725 
Glyceraldehyde-3-P dehydrogenase 1 G3P1 
 
0% 0.068000 - 
 
47511 62124 
Glyceraldehyde-3-P dehydrogenase 2 G3P2 
 
0% 0.680000 - 
 
61006 57022 
Glyceraldehyde-3-P dehydrogenase 3 G3P3 
 
0% 0.081000 - 
 
92025 100055 
Glucose-6-phosphate isomerase G6PI 
 
95% 0.009400 -2.8 
 
37367 13228 
Glycerol-3-phosphate dehydrogenase GPD1 
 
95% 0.002200 80.0 
 
52 4163 
Glycerol-3-phosphate dehydrogenase GPD2 
 
0% 0.370000 - 
 
n.d. 118 
Glycerol-3-phosphatase 1 GPP1 
 
95% < 0.00010 D Only 
 
6633 n.d. 
Glycerol-3-phosphatase 2 GPP2 
 















95% 0.000320 67.7 
 
294 19918 
Isocitrate dehydrogenase 1 IDH1 
 
95% 0.002300 4.1 
 
1579 6403 
Isocitrate dehydrogenase 2 IDH2 
 
95% 0.002700 63.6 
 
49 3130 
6-phosphofructokinase subunit α K6PF1 
 
95% 0.015000 -1.7 
 
8623 4993 
Pyruvate kinase 1 KPYK1 
 
95% 0.001100 -1.7 
 
77980 45254 
Malate synthase 1 MASY 
 
95% 0.006700 G Only 
 
n.d. 2237 
NAD-dependent malic enzyme MAOM 
 
0% 0.200000 - 
 
80 n.d. 
Malate dehydrogenase, cyto MDHC 
 
95% 0.018000 G Only 
 
n.d. 2842 
Malate dehydrogenase, mito MDHM 
 
95% 0.003100 12.3 
 
1360 16737 
2-oxoglutarate dehydrogenase E1 ODO1 
 
95% 0.000840 G Only 
 
n.d. 2355 
γ-glutamyl phosphate reductase ODO2 
 
95% < 0.00010 G Only 
 
n.d. 1464 
Pyruvate dehydrogenase E1 comp β ODPB 
 
95% 0.005700 -1.4 
 
2054 1478 
Phosphoenolpyruvate carboxykinase PCKA 
 
95% 0.000530 615.2 
 
31 19101 
Pyruvate decarboxylase isozyme 1 PDC1 
 
0% 0.440000 - 
 
62000 52551 
Pyruvate decarboxylase isozyme 5 PDC5 
 
95% < 0.00010 D Only 
 
12020 n.d. 
Pyruvate decarboxylase isozyme 6 PDC6 
 
95% 0.000430 -2.9 
 
15540 5325 
Phosphoglycerate kinase PGK 
 
0% 0.450000 - 
 
76423 69924 
Phosphoglycerate mutase 1 PMG1 
 
95% 0.048000 -1.6 
 
30171 19396 
Pyruvate carboxylase 1 PYC1 
 
95% 0.011000 9.0 
 
377 3413 
Pyruvate carboxylase 2 PYC2 
 
0% 0.250000 - 
 
491 1826 
Succinyl-CoA ligase subunit α SUCA 
 
95% < 0.00010 14.1 
 
547 7687 
Succinyl-CoA ligase subunit β SUCB 
 
95% 0.036000 G Only 
 
n.d. 2594 
Transaldolase 1 TAL1 
 
0% 0.680000 - 
 
4930 6025 
Transaldolase 2 TAL2 
 
95% 0.002500 G Only 
 
n.d. 1763 
Transketolase 1 TKT1 
 
0% 0.083000 - 
 
7813 5823 
Transketolase 2 TKT2 
 
95% 0.017000 G Only 
 
n.d. 994 
Triosephosphate isomerase TPIS 
 
95% 0.028000 -1.4 
 
22844 16042 
Table 6.6. The T-test confidence value, p-value, fold change, and average quantitative value was 
reported for the some of the proteins involved in S. cerevisiae metabolism. The quantative value 
was determined as the Normalized Total Precursor Intensity (x10
-




Figure 6.1. The workflow for the prefractionation method started with HPLC-UV of the intact 
proteins. Thirty-eight one-minute-wide fractions were collected, lyophilized, and pooled into 
20 equal-mass fractions. The equal-mass fractions were digested and pooled into 5 equal-mass 
fractions before the second dimension analysis by the modified UHPLC-MS at 32 kpsi. The 
spectral data was searched against a genomic database to identify the proteins.   
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a) dextrose b) glycerol 
  
 
Figure 6.2. The normalized Σ absorbance, plotted here with the UV chromatograms, was used to 
distribute the first dimension separation for yeast grown on dextrose (a) and glycerol (b) into 
equal-mass fractions.   
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a) dextrose b) glycerol 
  
 
Figure 6.3. Two-dimensional chromatograms for yeast grown on dextrose (a) and glycerol (b) 
are plotted with the first dimension (protein) fraction number on the vertical axes and the second 







Figure 6.4. The light gray bars show the total protein identifications in each fraction, and the 
dark gray bars signify the unique protein identifications in each fraction for yeast grown on 






Figure 6.5. Fractions per protein describe the percentage of protein identifications that were 
detected in one, two, three, four, or all five fractions.  
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 Yeast on Dextrose    Yeast on Glycerol 
 527 Total Proteins    539 Total Proteins 
 
 






Figure 6.6. The overlap in identifications is shown for yeast grown on dextrose and glycerol.  
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 a) b) 
   
 
Figure 6.7. The –log10 (p-value) is plotted versus the log2 fold change (a). All points above the 
horizontal dashed line represent significantly different protein quantities with 95% minimum 
confidence. A negative or positive fold change is a convention for up-regulation of the protein in 
yeast grown on dextrose or glycerol, respectively. All points outside the vertical dashed lines 
represent a fold change greater that two. Protein quantity is not captured in the volcano plot so 
the log of the quantitative value for all significantly different proteins is plotted (b). Proteins up-
regulated in the dextrose or glycerol sample are closer to the y-axis or x-axis, respectively. Points 
falling along the axis were only identified in the sample corresponding to that axis. The solid line 




Figure 6.8. Several metabolic pathways of S. cervisiae including glycerol catabolism, 
glycerolneogenesis, glycolysis, gluconeogenesis, fermentation, TCA cycle, and glyoxylate cycle 
are depicted with protein identifiers in blue or red if the protein was up-regulated when yeast was 
grown on the dextrose or glycerol media, respectively. Identifiers in black represent proteins that 
were identified without a significant difference in abundance. They gray text shows what 
metabolite are involved in the pathways. 
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APPENDIX A. SUPPLEMENTAL DATA FOR CHAPTER 2 
 
Appendix A.1. To compare the 10 equal-mass and 10 equal-time fractions, the Normalized 
Difference Protein Coverage (NDPC) was plotted with proteins with higher coverage on the left, 
and proteins with lower coverage on the right. If a protein was identified with higher sequence 
coverage in the 10 equal-mass fractions, its NDPC value was positive (red bars). The blue bars 
signified higher coverage in the 10 equal-time fractions. Differences in coverage were minimal 
for highly covered proteins. As protein coverage decreased, more proteins were identified with 
higher coverage in the equal-mass fractions. The dashed lines indicate a level of two-fold greater 
protein coverage.  
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Appendix A.1. (continued) 
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Appendix A.1. (continued) 
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Appendix A.2. To compare the 20 equal-mass and 20 equal-time fractions, the Normalized 
Difference Protein Coverage (NDPC) was plotted with proteins with higher coverage on the left, 
and proteins with lower coverage on the right. If a protein was identified with higher sequence 
coverage in the 20 equal-mass fractions, its NDPC value was positive (red bars). The blue bars 
signified higher coverage in the 20 equal-time fractions. Differences in coverage were minimal 
for highly covered proteins. For 20 fractions, the NDPC did not favor the equal-mass or the 
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Appendix A.2. (continued) 
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Appendix A.2. (continued) 
 250 
 
Appendix A.2. (continued)  
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APPENDIX B. SUPPLEMENTAL DATA FOR CHAPTER 3 
 
 
Appendix B.1. The NDPC comparing the analysis on the 98.2 cm column run at 30 kpsi to the 
44.1 cm column run at 15 kpsi for a 90 min gradient was plotted for each protein identified in an 
E. coli digest standard. If a protein was identified with higher sequence coverage with the 
separation on the 98.2 cm column, its NDPC value was positive (blue bars). The red bars 
signified higher coverage with the separation on the 44.1 cm column. Proteins with higher 
coverage were plotted on the left, and proteins with lower coverage were on the right. 
Differences in coverage were minimal for highly covered proteins. As protein coverage 
decreased, more proteins were identified with higher coverage with the separation on the 98.2 cm 















Appendix B.2. The NDPC comparing the analysis on the 98.2 cm column run at 30 kpsi to the 
44.1 cm column run at 15 kpsi for a 180 min gradient was plotted for each protein identified in 
an E. coli digest standard. If a protein was identified with higher sequence coverage with the 
separation on the 98.2 cm column, its NDPC value was positive (blue bars). The red bars 
signified higher coverage with the separation on the 44.1 cm column. Proteins with higher 
coverage were plotted on the left, and proteins with lower coverage were on the right. 
Differences in coverage were minimal for highly covered proteins. As protein coverage 
decreased, more proteins were identified with higher coverage with the separation on the 98.2 cm 
column. The dashed line represented a two-fold difference in protein coverage. 
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Appendix B.2. (continued) 
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Appendix B.3. Chromatograms of MassPREP
TM
 Digestion Standard Protein Expression Mixture 
2 were collected for separations with increasing pressure and flow rate on the 39.2 cm x 75 µm 
ID column packed with 1.4 µm BEH C18 particles. Separations were completed with a 50µL 
gradient volume. The insert of a representative peptide peak with 724 m/z extracted from all 
three chromatograms showed the decrease in peak width and constant signal intensity as pressure 














4-40 %B at 65°C, 50 µL 
1% Change MPB / Column Volume
39.2 cm x 75 µm ID, 1.4 µm BEH C18
 
15 kpsi, 190 nL/min
30 kpsi, 410 nL/min




Appendix B.4. Chromatograms of MassPREP
TM
 E. coli Digestion Standard were collected for 
separations with increasing gradient volume on the 39.2 cm x 75 µm ID column packed with 1.4 
µm BEH C18 particles. Separations were completed at 30 kpsi. Though the chromatograms were 
very busy, an increase in resolution was observed as gradient volume increased which was 






Appendix B.5. Chromatograms of MassPREP
TM
 E. coli Digestion Standard were collected for 
separations with increasing pressure and flow rate on the 39.2 cm x 75 µm ID column packed 
















4-40 %B at 65°C, 50 µL 
1% Change MPB / Column Volume
39.2 cm x 75 µm ID, 1.4 µm BEH C18
 
 
15 kpsi, 190 nL/min
30 kpsi, 410 nL/min
45 kpsi, 610 nL/min
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APPENDIX C. SUPPLEMENTAL DATA FOR CHAPTER 5 
 
Appendix C.1. To compare the 10 fractions run on the modified system to the 10 fractions run 
on the standard UPLC, the NDPC is plotted with proteins with higher coverage on the left, and 
proteins with lower coverage on the right. If a protein was identified with higher sequence 
coverage when analyzed on the modified UHPLC, its NDPC value is positive (blue bars). The 
red bars signify higher coverage in the analysis on the standard UPLC. Differences in coverage 
were minimal for highly covered proteins. As protein coverage decreased, more proteins were 
identified with higher coverage from the analysis on the modified UHPLC. The dashed lines 
indicate a level of two-fold greater protein coverage. (This was a large graph and split into 
multiple parts.)  
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Appendix C.1. (continued)  
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Appendix C.1. (continued) 
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Appendix C.1. (continued) 
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Appendix C.1. (continued) 
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Appendix C.2. To compare the 20 fractions run on the modified system to the 20 fractions run 
on the standard UPLC, the NDPC is plotted with proteins with higher coverage on the left, and 
proteins with lower coverage on the right. If a protein was identified with higher sequence 
coverage when analyzed on the modified UHPLC, its NDPC value is positive (blue bars). The 
red bars signify higher coverage in the analysis on the standard UPLC. Differences in coverage 
were minimal for highly covered proteins. As protein coverage decreased, more proteins were 
identified with higher coverage from the analysis on the modified UHPLC. The dashed lines 
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